entity;pathway
EEF1A1;Chaperone Mediated Autophagy
GFAP;Chaperone Mediated Autophagy
HSPA8;Chaperone Mediated Autophagy
LAMP2;Chaperone Mediated Autophagy
HSPA8;Late endosomal microautophagy
PRKAA2;Lipophagy
HSPA8;Lipophagy
VCP;Aggrephagy
PRKN;Aggrephagy
MFN2;PINK1-PRKN Mediated Mitophagy
VDAC1;PINK1-PRKN Mediated Mitophagy
SQSTM1;PINK1-PRKN Mediated Mitophagy
MTERF3;PINK1-PRKN Mediated Mitophagy
MFN1;PINK1-PRKN Mediated Mitophagy
PINK1;PINK1-PRKN Mediated Mitophagy
PRKN;PINK1-PRKN Mediated Mitophagy
ULK1;Receptor Mediated Mitophagy
FUNDC1;Receptor Mediated Mitophagy
PEX5;Pexophagy
ATM;Pexophagy
USP30;Pexophagy
NBR1;Pexophagy
SQSTM1;Pexophagy
MAP1LC3B;Pexophagy
STK11;Energy dependent regulation of mTOR by LKB1-AMPK
AMBRA1;Macroautophagy
ATG12;Macroautophagy
ATG10;Macroautophagy
ATG5;Macroautophagy
ATG16L1;Macroautophagy
ATG3;Macroautophagy
TSC2;TP53 Regulates Metabolic Genes
TSC1;TP53 Regulates Metabolic Genes
MAD1L1;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal
MAD2L1;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal
MAD2L1;Inactivation of APC/C via direct inhibition of the APC/C complex
BUB1B;Inactivation of APC/C via direct inhibition of the APC/C complex
BUB3;Inactivation of APC/C via direct inhibition of the APC/C complex
CDC20;Inactivation of APC/C via direct inhibition of the APC/C complex
BTRC;SCF-beta-TrCP mediated degradation of Emi1
FBXO5;Phosphorylation of Emi1
FBXO5;Regulation of APC/C activators between G1/S and early anaphase
CDC20;Regulation of APC/C activators between G1/S and early anaphase
CDC20;Phosphorylation of Emi1
PKMYT1;Polo-like kinase mediated events
PLK1;Regulation of PLK1 Activity at G2/M Transition
BORA;Regulation of PLK1 Activity at G2/M Transition
CDK1;Cyclin A/B1/B2 associated events during G2/M transition
CCNB2;Polo-like kinase mediated events
FOXM1;Polo-like kinase mediated events
MYBL2;Polo-like kinase mediated events
PLK1;Polo-like kinase mediated events
FOXM1;Cyclin A/B1/B2 associated events during G2/M transition
CDC25A;Polo-like kinase mediated events
EP300;Polo-like kinase mediated events
CDC25C;Cyclin A/B1/B2 associated events during G2/M transition
CDC25C;Polo-like kinase mediated events
CDC25C;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
TP53;Regulation of TP53 Expression
PRDM1;Regulation of TP53 Expression
TOPBP1;Processing of DNA double-strand break ends
RHNO1;Processing of DNA double-strand break ends
TOPBP1;Presynaptic phase of homologous DNA pairing and strand exchange
RHNO1;Presynaptic phase of homologous DNA pairing and strand exchange
RAD51;Presynaptic phase of homologous DNA pairing and strand exchange
CHEK1;Processing of DNA double-strand break ends
CLSPN;Processing of DNA double-strand break ends
SUMO1;SUMO is proteolytically processed
SUMO1;SUMO is conjugated to E1 (UBA2:SAE1)
UBE2I;SUMO is transferred from E1 to E2 (UBE2I, UBC9)
RAD50;Sensing of DNA Double Strand Breaks
MRE11;Sensing of DNA Double Strand Breaks
KPNA2;Sensing of DNA Double Strand Breaks
NBN;Sensing of DNA Double Strand Breaks
ATM;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
ATM;Sensing of DNA Double Strand Breaks
ATM;DNA Damage/Telomere Stress Induced Senescence
H2AX;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
NSD2;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
HERC2;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
PIAS4;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
UBE2I;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
RNF168;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
TP53BP1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
ABRAXAS1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
UIMC1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
BARD1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
BRCA1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
BRCC3;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
BABAM2;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
BABAM1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
CHEK2;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
CHEK2;G2/M DNA damage checkpoint
UBE2I;Processing of DNA double-strand break ends
NSD2;Processing of DNA double-strand break ends
ABRAXAS1;Processing of DNA double-strand break ends
UIMC1;Processing of DNA double-strand break ends
PIAS4;Processing of DNA double-strand break ends
RNF168;Processing of DNA double-strand break ends
TP53BP1;Processing of DNA double-strand break ends
BRCC3;Processing of DNA double-strand break ends
BABAM2;Processing of DNA double-strand break ends
HERC2;Processing of DNA double-strand break ends
BABAM1;Processing of DNA double-strand break ends
PALB2;Resolution of D-loop Structures through Holliday Junction Intermediates
KAT5;Resolution of D-loop Structures through Holliday Junction Intermediates
RAD51AP1;Resolution of D-loop Structures through Holliday Junction Intermediates
ATM;Resolution of D-loop Structures through Holliday Junction Intermediates
MUS81;Resolution of D-loop Structures through Holliday Junction Intermediates
RAD51C;Homologous DNA Pairing and Strand Exchange
XRCC3;Homologous DNA Pairing and Strand Exchange
PALB2;Homologous DNA Pairing and Strand Exchange
RAD51AP1;Homologous DNA Pairing and Strand Exchange
RAD51C;Presynaptic phase of homologous DNA pairing and strand exchange
RAD51D;Presynaptic phase of homologous DNA pairing and strand exchange
RAD51B;Presynaptic phase of homologous DNA pairing and strand exchange
XRCC2;Presynaptic phase of homologous DNA pairing and strand exchange
PALB2;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
KAT5;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
BRIP1;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
RAD51AP1;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
ATM;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
BRIP1;Resolution of D-loop Structures through Holliday Junction Intermediates
SPIDR;Resolution of D-loop Structures through Holliday Junction Intermediates
BRIP1;Processing of DNA double-strand break ends
TOPBP1;HDR through Single Strand Annealing (SSA)
RAD51;HDR through Single Strand Annealing (SSA)
KAT5;HDR through Single Strand Annealing (SSA)
BRIP1;HDR through Single Strand Annealing (SSA)
RHNO1;HDR through Single Strand Annealing (SSA)
ATM;HDR through Single Strand Annealing (SSA)
ABL1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
RAD52;HDR through Single Strand Annealing (SSA)
SEM1;Presynaptic phase of homologous DNA pairing and strand exchange
BRCA2;Presynaptic phase of homologous DNA pairing and strand exchange
COP1;Autodegradation of the E3 ubiquitin ligase COP1
POT1;DNA Damage/Telomere Stress Induced Senescence
POT1;Packaging Of Telomere Ends
DNA2;Removal of the Flap Intermediate from the C-strand
RFC3;Polymerase switching on the C-strand of the telomere
RFC4;Polymerase switching on the C-strand of the telomere
RFC5;Polymerase switching on the C-strand of the telomere
RFC2;Polymerase switching on the C-strand of the telomere
CHTF18;Polymerase switching on the C-strand of the telomere
DSCC1;Polymerase switching on the C-strand of the telomere
CHTF8;Polymerase switching on the C-strand of the telomere
RTEL1;Telomere Extension By Telomerase
NOP10;Telomere Extension By Telomerase
DKC1;Telomere Extension By Telomerase
TERT;Telomere Extension By Telomerase
GAR1;Telomere Extension By Telomerase
WRAP53;Telomere Extension By Telomerase
NHP2;Telomere Extension By Telomerase
CTC1;Telomere C-strand synthesis initiation
STN1;Telomere C-strand synthesis initiation
TEN1;Telomere C-strand synthesis initiation
CHEK1;Activation of ATR in response to replication stress
CHEK1;G2/M DNA damage checkpoint
CLSPN;Activation of ATR in response to replication stress
GTSE1;The role of GTSE1 in G2/M progression after G2 checkpoint
PLK1;The role of GTSE1 in G2/M progression after G2 checkpoint
WEE1;Polo-like kinase mediated events
AJUBA;Regulation of PLK1 Activity at G2/M Transition
CDC25B;Cyclin A/B1/B2 associated events during G2/M transition
WEE1;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
CDK1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A
CDC20;Cdc20:Phospho-APC/C mediated degradation of Cyclin A
NEK2;APC-Cdc20 mediated degradation of Nek2A
FZR1;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
CDC20;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
PTTG1;APC/C:Cdc20 mediated degradation of Securin
PTTG1;Separation of Sister Chromatids
CDK1;APC/C:Cdc20 mediated degradation of Cyclin B
FZR1;Regulation of APC/C activators between G1/S and early anaphase
CDK2;Cyclin A:Cdk2-associated events at S phase entry
CKS1B;SCF(Skp2)-mediated degradation of p27/p21
SKP2;SCF(Skp2)-mediated degradation of p27/p21
CDKN1B;SCF(Skp2)-mediated degradation of p27/p21
CDK2;Cyclin E associated events during G1/S transition 
CCNE1;G1/S-Specific Transcription
RB1;G1/S-Specific Transcription
RB1;Cyclin D associated events in G1
CCND1;Transcriptional Regulation by VENTX
CTNNB1;Transcriptional Regulation by VENTX
VENTX;Transcriptional Regulation by VENTX
CCND1;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CREB1;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CREB1;NGF-stimulated transcription
CREB1;CaMK IV-mediated phosphorylation of CREB
CREB1;PKA-mediated phosphorylation of CREB
CREB1;AKT phosphorylates targets in the nucleus
PIK3CA;PI-3K cascade:FGFR2
PIK3R1;PI-3K cascade:FGFR2
PIK3R1;PI-3K cascade:FGFR4
PIK3R1;PI-3K cascade:FGFR3
PIK3R1;PI-3K cascade:FGFR1
GAB1;GAB1 signalosome
FRS2;FRS-mediated FGFR2 signaling
EGFR;Signaling by EGFR,Epidermal Growth Factor Receptor (EGFR) signaling
EGF;Signaling by EGFR,Epidermal Growth Factor Receptor (EGFR) signaling
PIK3CA;PI-3K cascade:FGFR3
PTPN11;FRS-mediated FGFR3 signaling
FRS3;FRS-mediated FGFR3 signaling
FGF2;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
POU5F1;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
NANOG;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
SOX2;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
NANOG;Transcriptional regulation of pluripotent stem cells
POU5F1;Transcriptional regulation of pluripotent stem cells
SOX2;Transcriptional regulation of pluripotent stem cells
KLF4;Transcriptional regulation of pluripotent stem cells
PBX1;Transcriptional regulation of pluripotent stem cells
LIN28A;Transcriptional regulation of pluripotent stem cells
SALL4;Transcriptional regulation of pluripotent stem cells
ZSCAN10;Transcriptional regulation of pluripotent stem cells
PRDM14;Transcriptional regulation of pluripotent stem cells
FGF23;FGFR3c ligand binding and activation
FRS2;FRS-mediated FGFR3 signaling
ERBIN;Signaling by ERBB2
PIK3CA;PI-3K cascade:FGFR1
FRS2;FRS-mediated FGFR1 signaling
PTEN;TP53 Regulates Metabolic Genes
MECOM;Regulation of PTEN gene transcription
ATF2;Regulation of PTEN gene transcription
ATF2;Activation of the AP-1 family of transcription factors
FRS3;FRS-mediated FGFR2 signaling
FGFR4;FGFR4 ligand binding and activation
KLB;betaKlotho-mediated ligand binding
FGFR4;betaKlotho-mediated ligand binding
FGF19;betaKlotho-mediated ligand binding
CALM1;Smooth Muscle Contraction
CALM1;Inactivation, recovery and regulation of the phototransduction cascade
CALM1;FCGR3A-mediated IL10 synthesis
CALM1;VEGFR2 mediated cell proliferation
CALM1;CLEC7A (Dectin-1) induces NFAT activation
CALM1;FCERI mediated Ca+2 mobilization
CALM1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
CALM1;CaM pathway
PLCG2;GPVI-mediated activation cascade
LCP2;GPVI-mediated activation cascade
SYK;GPVI-mediated activation cascade
LYN;Platelet Adhesion to exposed collagen
FYN;Platelet Adhesion to exposed collagen
GP6;Platelet Adhesion to exposed collagen
PLCG1;
PLCG1;Phospholipase C-mediated cascade: FGFR1
PLCG1;PLC-gamma1 signalling
NTRK1;TRKA activation by NGF
NGF;NGF processing
PLCG1;VEGFR2 mediated cell proliferation
KDR;VEGFA-VEGFR2 Pathway
KDR;VEGF binds to VEGFR leading to receptor dimerization
PLCG1;EGFR interacts with phospholipase C-gamma
PLCG1;Generation of second messenger molecules
ITK;Generation of second messenger molecules
LCP2;Generation of second messenger molecules
LAT;Generation of second messenger molecules
GRAP2;Generation of second messenger molecules
ZAP70;Translocation of ZAP-70 to Immunological synapse
PAG1;Phosphorylation of CD3 and TCR zeta chains
CSK;Phosphorylation of CD3 and TCR zeta chains
SYK;FCGR3A-mediated phagocytosis
SYK;FCGR3A-mediated IL10 synthesis
AGPAT1;ChREBP activates metabolic gene expression
MLX;ChREBP activates metabolic gene expression
MLXIPL;ChREBP activates metabolic gene expression
MLXIPL;PP2A-mediated dephosphorylation of key metabolic factors
GCK;Regulation of gene expression in beta cells
PDX1;Regulation of gene expression in beta cells
TIGAR;TP53 Regulates Metabolic Genes
MMADHC;Cobalamin (Cbl) metabolism
MMACHC;Cobalamin (Cbl) metabolism
TCN2;Transport of RCbl within the body
CBLIF;Uptake of dietary cobalamins into enterocytes
TCN1;Uptake of dietary cobalamins into enterocytes
CD320;Transport of RCbl within the body
PEX3;ABC transporters in lipid homeostasis
PEX19;ABC transporters in lipid homeostasis
PI4KB;Synthesis of PIPs at the Golgi membrane
FRS3;FRS-mediated FGFR4 signaling
FRS2;FRS-mediated FGFR4 signaling
PTPN11;FRS-mediated FGFR4 signaling
PIK3CA;PI-3K cascade:FGFR4
KIT;Signaling by SCF-KIT
TRAT1;Downstream TCR signaling
TBXA2R;Thromboxane signalling through TP receptor
TBXA2R;Prostanoid ligand receptors
GPR31;Free fatty acid receptors
HCAR3;Hydroxycarboxylic acid-binding receptors
CCL13;Chemokine receptors bind chemokines
SLC18A2;Serotonin Neurotransmitter Release Cycle
RAB3A;Serotonin Neurotransmitter Release Cycle
CPLX1;Serotonin Neurotransmitter Release Cycle
SYT1;Serotonin Neurotransmitter Release Cycle
STX1A;Serotonin Neurotransmitter Release Cycle
SNAP25;Serotonin Neurotransmitter Release Cycle
AGT;Peptide ligand-binding receptors
AGTR1;Peptide ligand-binding receptors
AGT;Metabolism of Angiotensinogen to Angiotensins
AGT;PPARA activates gene expression
FABP1;Cytoprotection by HMOX1
FABP1;Regulation of lipid metabolism by PPARalpha,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TBL1XR1;Regulation of lipid metabolism by PPARalpha,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TBL1X;Regulation of lipid metabolism by PPARalpha,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
PPARA;Regulation of lipid metabolism by PPARalpha,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
RXRA;Regulation of lipid metabolism by PPARalpha,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
PPARA;PPARA activates gene expression
PPARA;BMAL1:CLOCK,NPAS2 activates circadian gene expression
BMAL1;Circadian Clock
BMAL1;Heme signaling
EP300;Circadian Clock
PPARGC1A;Circadian Clock
RORA;Circadian Clock
NRIP1;Circadian Clock
PPARGC1A;Transcriptional activation of mitochondrial biogenesis
PPARGC1A;Heme signaling
CREB1;Transcriptional activation of mitochondrial biogenesis
CREB1;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
CAMK4;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
CAMK4;CaMK IV-mediated phosphorylation of CREB
KPNA2;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
KPNA2;CaMK IV-mediated phosphorylation of CREB
CLOCK;Circadian Clock
CLOCK;Heme signaling
NPAS2;PPARA activates gene expression
NPAS2;Circadian Clock
NPAS2;Heme signaling
CXCR1;Chemokine receptors bind chemokines
CCL1;Chemokine receptors bind chemokines
CCR8;Chemokine receptors bind chemokines
P2RY12;ADP signalling through P2Y purinoceptor 12
P2RY12;P2Y receptors
GPR18;Class A/1 (Rhodopsin-like receptors)
GPR37;Peptide ligand-binding receptors
GPR37L1;Peptide ligand-binding receptors
OXGR1;Class A/1 (Rhodopsin-like receptors)
CXCR2;Chemokine receptors bind chemokines
P2RY13;P2Y receptors
RXFP3;Relaxin receptors
GPER1;Peptide ligand-binding receptors
FPR3;Formyl peptide receptors bind formyl peptides and many other ligands
RXFP4;Relaxin receptors
KNG1;Peptide ligand-binding receptors
CCL5;Chemokine receptors bind chemokines
CXCL12;Chemokine receptors bind chemokines
APLNR;Peptide ligand-binding receptors
P2RY14;P2Y receptors
OPRL1;Peptide ligand-binding receptors
PNOC;Peptide ligand-binding receptors
NMUR2;Peptide ligand-binding receptors
NMS;Peptide ligand-binding receptors
SUCNR1;Class A/1 (Rhodopsin-like receptors)
CCR7;Chemokine receptors bind chemokines
NMU;Peptide ligand-binding receptors
CCL16;Chemokine receptors bind chemokines
RAB3A;GABA synthesis, release, reuptake and degradation
DNAJC5;GABA synthesis, release, reuptake and degradation
RIMS1;GABA synthesis, release, reuptake and degradation
HSPA8;GABA synthesis, release, reuptake and degradation
CPLX1;GABA synthesis, release, reuptake and degradation
SYT1;GABA synthesis, release, reuptake and degradation
SLC32A1;GABA synthesis, release, reuptake and degradation
STX1A;GABA synthesis, release, reuptake and degradation
SNAP25;GABA synthesis, release, reuptake and degradation
CCL25;Chemokine receptors bind chemokines
CCR9;Chemokine receptors bind chemokines
PMCH;Peptide ligand-binding receptors
GPR183;Class A/1 (Rhodopsin-like receptors)
CCL20;Chemokine receptors bind chemokines
CCR6;Chemokine receptors bind chemokines
CCR10;Chemokine receptors bind chemokines
CX3CR1;Chemokine receptors bind chemokines
CX3CL1;Chemokine receptors bind chemokines
C3;Purinergic signaling in leishmaniasis infection
C3;Peptide ligand-binding receptors
C3;Regulation of Complement cascade
C3AR1;Purinergic signaling in leishmaniasis infection
C3AR1;Peptide ligand-binding receptors
C3AR1;Regulation of Complement cascade
C3;Activation of C3 and C5
C3;Alternative complement activation
CFB;Alternative complement activation
C2;Initial triggering of complement
HRH4;Histamine receptors
AGTR2;Peptide ligand-binding receptors
C5;Peptide ligand-binding receptors
C5;Regulation of Complement cascade
C5AR1;Peptide ligand-binding receptors
C5AR1;Regulation of Complement cascade
C5;Activation of C3 and C5
FPR1;Formyl peptide receptors bind formyl peptides and many other ligands
CXCL16;Chemokine receptors bind chemokines
CXCR6;Chemokine receptors bind chemokines
P2RY4;P2Y receptors
FPR2;Formyl peptide receptors bind formyl peptides and many other ligands
PLA2G4A;phospho-PLA2 pathway
PLA2G4A;Platelet sensitization by LDL
PLA2G4A;ADP signalling through P2Y purinoceptor 1
MAPK14;Platelet sensitization by LDL
FGR;Platelet sensitization by LDL
LRP8;Platelet sensitization by LDL
MAPK14;ADP signalling through P2Y purinoceptor 1
P2RY1;ADP signalling through P2Y purinoceptor 1
P2RY1;P2Y receptors
CXCR5;Chemokine receptors bind chemokines
CXCL13;Chemokine receptors bind chemokines
CXCR3;Chemokine receptors bind chemokines
CASR;Class C/3 (Metabotropic glutamate/pheromone receptors)
HCAR2;Hydroxycarboxylic acid-binding receptors
HCAR2;Class A/1 (Rhodopsin-like receptors)
HCAR1;Hydroxycarboxylic acid-binding receptors
P2RY2;P2Y receptors
HRH1;Histamine receptors
GNRHR;Hormone ligand-binding receptors
FFAR3;Free fatty acid receptors
NPSR1;Peptide ligand-binding receptors
NPS;Peptide ligand-binding receptors
FFAR2;Free fatty acid receptors
OPN4;Opsins
TRHR;Peptide ligand-binding receptors
FFAR4;Free fatty acid receptors
LPAR4;P2Y receptors
GPR39;Class A/1 (Rhodopsin-like receptors)
LPAR6;P2Y receptors
GCGR;Glucagon-type ligand receptors
GCGR;Glucagon signaling in metabolic regulation
GCG;Glucagon-type ligand receptors
GCG;Glucagon signaling in metabolic regulation
FFAR1;Free fatty acid receptors
P2RY6;P2Y receptors
GAST;Gastrin-CREB signalling pathway via PKC and MAPK
CCKBR;Gastrin-CREB signalling pathway via PKC and MAPK
AVP;Vasopressin-like receptors
GHSR;Peptide ligand-binding receptors
P2RY10;P2Y receptors
MLN;Peptide ligand-binding receptors
MLNR;Peptide ligand-binding receptors
UTS2R;Peptide ligand-binding receptors
WLS;WNT ligand biogenesis and trafficking
AVP;Vasopressin regulates renal water homeostasis via Aquaporins
AVPR2;Vasopressin regulates renal water homeostasis via Aquaporins
AVPR2;Vasopressin-like receptors
PTGIR;Prostacyclin signalling through prostacyclin receptor
PTGIR;Prostanoid ligand receptors
CALCA;Calcitonin-like ligand receptors
CALCR;Calcitonin-like ligand receptors
RXFP2;Relaxin receptors
TSHR;Hormone ligand-binding receptors
VIP;Glucagon-type ligand receptors
LHCGR;Hormone ligand-binding receptors
GHRHR;Glucagon-type ligand receptors
GHRH;Glucagon-type ligand receptors
ADRB1;Adrenoceptors
FSHR;Hormone ligand-binding receptors
GLP2R;Glucagon-type ligand receptors
RXFP1;Relaxin receptors
ADCYAP1R1;Glucagon-type ligand receptors
GPBAR1;Class A/1 (Rhodopsin-like receptors)
GCG;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
SCT;Glucagon-type ligand receptors
SCTR;Glucagon-type ligand receptors
IAPP;Calcitonin-like ligand receptors
GIP;Glucagon-type ligand receptors
GIPR;Glucagon-type ligand receptors
HRH2;Histamine receptors
FFAR1;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
CHRM3;Acetylcholine regulates insulin secretion
BTK;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
PLCG2;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
VAV1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
NCK1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
SYK;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
TRPC1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
SOS1;Insulin receptor signalling cascade
SOS1;GRB2 events in EGFR signaling
SHC1;SHC1 events in EGFR signaling
SYK;DAP12 signaling
TYROBP;DAP12 interactions
TREM2;DAP12 interactions
SHC1;SHC1 events in ERBB4 signaling
SOS1;Tie2 Signaling
TEK;Tie2 Signaling
ANGPT1;Tie2 Signaling
SHC1;RET signaling
RET;RET signaling
PSPN;RET signaling
GFRA4;RET signaling
ARTN;RET signaling
SOS1;MET activates RAS signaling
RANBP9;MET activates RAS signaling
MET;MET Receptor Activation
HGF;MET Receptor Activation
SHC1;SHC1 events in ERBB2 signaling
FRS3;FRS-mediated FGFR1 signaling
SOS1;NCAM signaling for neurite out-growth
PTK2;NCAM signaling for neurite out-growth
PTPRA;NCAM signaling for neurite out-growth
FYN;NCAM signaling for neurite out-growth
ATP6AP1;Ion channel transport
ATP6AP1;Insulin receptor recycling
ATP6AP1;Transferrin endocytosis and recycling
SHC1;Interleukin-2 signaling
IL2RG;Interleukin-4 and Interleukin-13 signaling
IL2RG;Interleukin-7 signaling
IL2RG;Interleukin-2 signaling
IL2RG;Interleukin-9 signaling
JAK3;Interleukin-4 and Interleukin-13 signaling
JAK3;Interleukin-7 signaling
JAK3;Interleukin-2 signaling
JAK3;Interleukin-9 signaling
IL2;Interleukin-2 signaling
IL2RA;Interleukin-2 signaling
JAK1;Interleukin-2 signaling
IL2RB;Interleukin-2 signaling
SHC1;Interleukin-3, Interleukin-5 and GM-CSF signaling
JAK2;Interleukin-3, Interleukin-5 and GM-CSF signaling
CSF2RB;Interleukin-3, Interleukin-5 and GM-CSF signaling
CSF2;Interleukin-3, Interleukin-5 and GM-CSF signaling
CSF2RA;Interleukin-3, Interleukin-5 and GM-CSF signaling
IL5RA;Interleukin-3, Interleukin-5 and GM-CSF signaling
IL5;Interleukin-3, Interleukin-5 and GM-CSF signaling
IL3RA;Interleukin-3, Interleukin-5 and GM-CSF signaling
IL3;Interleukin-3, Interleukin-5 and GM-CSF signaling
EGFR;EGFR Transactivation by Gastrin
HBEGF;EGFR Transactivation by Gastrin
MMP3;EGFR Transactivation by Gastrin
PRKCA;Acetylcholine regulates insulin secretion
PRKCA;EGFR Transactivation by Gastrin
SHC1;Insulin receptor signalling cascade
SOS1;FLT3 Signaling
FLT3;FLT3 Signaling
MAP2K1;MAPK3 (ERK1) activation
MAPK3;MAPK3 (ERK1) activation
TNIP2;MAP3K8 (TPL2)-dependent MAPK1/3 activation
MAP3K8;MAP3K8 (TPL2)-dependent MAPK1/3 activation
TRAF6;IRAK2 mediated activation of TAK1 complex
TRAF6;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
IRAK4;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
MYD88;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
BTK;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
CD36;Toll Like Receptor TLR6:TLR2 Cascade
CD14;Toll Like Receptor TLR6:TLR2 Cascade
CD14;Toll Like Receptor TLR1:TLR2 Cascade
LBP;Transfer of LPS from LBP carrier to CD14
CD14;Transfer of LPS from LBP carrier to CD14
LBP;Toll Like Receptor 4 (TLR4) Cascade
HMGB1;Regulation of TLR by endogenous ligand
HMGB1;Pyroptosis
TRAF6;MyD88 cascade initiated on plasma membrane
IRAK4;MyD88 cascade initiated on plasma membrane
MYD88;MyD88 cascade initiated on plasma membrane
TLR10;Toll Like Receptor 10 (TLR10) Cascade
TLR5;Toll Like Receptor 5 (TLR5) Cascade
UBE2E1;IRAK2 mediated activation of TAK1 complex
UBE2E1;Alpha-protein kinase 1 signaling pathway,ALPK1 signaling pathway
TRAF6;Alpha-protein kinase 1 signaling pathway,ALPK1 signaling pathway
ALPK1;Alpha-protein kinase 1 signaling pathway,ALPK1 signaling pathway
UBE2E1;TICAM1,TRAF6-dependent induction of TAK1 complex
TRAF6;TICAM1,TRAF6-dependent induction of TAK1 complex
TICAM1;Toll Like Receptor 3 (TLR3) Cascade
TLR3;Toll Like Receptor 3 (TLR3) Cascade
IKBKG;TAK1-dependent IKK and NF-kappa-B activation  
CHUK;TAK1-dependent IKK and NF-kappa-B activation  
IKBKB;TAK1-dependent IKK and NF-kappa-B activation  
NLRC5;Regulation of NF-kappa B signaling
CHUK;Regulation of NF-kappa B signaling
IKBKB;Regulation of NF-kappa B signaling
RIPK2;NOD1/2 Signaling Pathway
NOD2;NOD1/2 Signaling Pathway
NOD1;NOD1/2 Signaling Pathway
UBE2N;TRAF6-mediated induction of TAK1 complex within TLR4 complex
UBE2V1;TRAF6-mediated induction of TAK1 complex within TLR4 complex
TRAF6;TRAF6-mediated induction of TAK1 complex within TLR4 complex
TICAM1;MyD88-independent TLR4 cascade 
NFKB1;MAP3K8 (TPL2)-dependent MAPK1/3 activation
RAPGEF1;Frs2-mediated activation
CRKL;Frs2-mediated activation
FRS2;Frs2-mediated activation
MAPK1;MAPK1 (ERK2) activation
MAP2K2;MAPK1 (ERK2) activation
MAP2K7;FCERI mediated MAPK activation
MAP3K1;FCERI mediated MAPK activation
MAP3K5;Oxidative Stress Induced Senescence
TXN;Oxidative Stress Induced Senescence
EGR1;Regulation of PTEN gene transcription
JUN;Regulation of PTEN gene transcription
SALL4;Regulation of PTEN gene transcription
MAF1;Regulation of PTEN gene transcription
PTEN;Regulation of PTEN localization
PTEN;Regulation of PTEN mRNA translation
CD86;CD28 co-stimulation
PIK3AP1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
PDPK1;GPVI-mediated activation cascade
PDPK1;VEGFR2 mediated vascular permeability
PDPK1;CD28 dependent PI3K/Akt signaling
PDPK1;PIP3 activates AKT signaling,PI3K/AKT Signaling
CREB1;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
CREB1;NCAM signaling for neurite out-growth
CREB1;CREB phosphorylation
RPS6KA5;NCAM signaling for neurite out-growth
RPS6KA5;ERK/MAPK targets
CREB1;ADORA2B mediated anti-inflammatory cytokines production
CREB1;FCGR3A-mediated IL10 synthesis
CREB1;CREB1 phosphorylation through the activation of Adenylate Cyclase
ADORA2B;ADORA2B mediated anti-inflammatory cytokines production
CCND1;Estrogen-dependent gene expression
POU2F1;Estrogen-dependent gene expression
EP300;Estrogen-dependent gene expression
HDAC1;Estrogen-dependent gene expression
YY1;Estrogen-dependent gene expression
GATA3;Estrogen-dependent gene expression
FOXA1;Estrogen-dependent gene expression
PTGES3;ESR-mediated signaling
PTK6;PTK6 Regulates Cell Cycle
PTK6;SCF(Skp2)-mediated degradation of p27/p21
PTK6;ERBB2 Activates PTK6 Signaling
PTK6;PTK6 Expression
PELP1;PTK6 Expression
EPAS1;PTK6 Expression
CDKN1B;Cyclin A:Cdk2-associated events at S phase entry
CDKN1B;Cyclin E associated events during G1/S transition 
CDKN1A;FOXO-mediated transcription of cell cycle genes
CDKN1A;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
CDKN1A;Transcriptional  activation of  cell cycle inhibitor p21 
ZNF385A;Regulation of TP53 Activity through Association with Co-factors
ZNF385A;Transcriptional  activation of  cell cycle inhibitor p21 
PCBP4;FOXO-mediated transcription of cell cycle genes
PCBP4;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
PCBP4;Transcriptional  activation of  cell cycle inhibitor p21 
SMAD4;Signaling by Activin
SMAD4;Signaling by NODAL
SMAD4;TGF-beta receptor signaling activates SMADs
SMAD4;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
FKBP1A;TGF-beta receptor signaling activates SMADs
TGFBR2;TGF-beta receptor signaling activates SMADs
ACVR1C;Signaling by Activin
ACVR1B;Signaling by Activin
TDGF1;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
USP9X;Ub-specific processing proteases
USP9X;Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMAD4;Ub-specific processing proteases
SMAD4;Downregulation of SMAD2/3:SMAD4 transcriptional activity
TRIM33;Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMURF2;Downregulation of SMAD2/3:SMAD4 transcriptional activity
RNF111;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SMAD7;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SMAD7;Interferon gamma signaling
SMAD7;Downregulation of SMAD2/3:SMAD4 transcriptional activity
ATP1B4;Downregulation of SMAD2/3:SMAD4 transcriptional activity
SNW1;Downregulation of SMAD2/3:SMAD4 transcriptional activity
WWTR1;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CDKN1A;Cyclin A:Cdk2-associated events at S phase entry
CDKN1A;Cyclin E associated events during G1/S transition 
CDKN1A;DNA Damage/Telomere Stress Induced Senescence
EP400;DNA Damage/Telomere Stress Induced Senescence
CDC25A;Cyclin A:Cdk2-associated events at S phase entry
CDC25A;Transcription of E2F targets under negative control by DREAM complex
CDC25A;Cyclin E associated events during G1/S transition 
MYC;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
MYC;NOTCH1 Intracellular Domain Regulates Transcription
CREBBP;NOTCH1 Intracellular Domain Regulates Transcription
EP300;NOTCH1 Intracellular Domain Regulates Transcription
NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription
NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus
JAG2;Activated NOTCH1 Transmits Signal to the Nucleus
NOTCH2;Pre-NOTCH Transcription and Translation
NOTCH1;Pre-NOTCH Transcription and Translation
NOTCH3;Pre-NOTCH Transcription and Translation
NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
RBPJ;NOTCH3 Intracellular Domain Regulates Transcription
NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
JAG2;NOTCH3 Activation and Transmission of Signal to the Nucleus
DLL4;NOTCH3 Activation and Transmission of Signal to the Nucleus
DLL1;NOTCH3 Activation and Transmission of Signal to the Nucleus
JAG1;NOTCH3 Activation and Transmission of Signal to the Nucleus
ELF3;Pre-NOTCH Transcription and Translation
NOTCH4;Pre-NOTCH Transcription and Translation
JAG1;Activated NOTCH1 Transmits Signal to the Nucleus
DLL4;Activated NOTCH1 Transmits Signal to the Nucleus
DLL1;Activated NOTCH1 Transmits Signal to the Nucleus
MYC;RUNX3 regulates WNT signaling
MYC;Binding of TCF/LEF:CTNNB1 to target gene promoters
RUNX3;RUNX3 regulates WNT signaling
RUNX3;Regulation of RUNX3 expression and activity
RBL2;Cyclin D associated events in G1
RB1;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
SKP2;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
CDC20;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
MAD2L1;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
CDC25C;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
CDC25C;RHO GTPases activate PKNs
PKN1;RHO GTPases activate PKNs
PXN;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
CDC25C;Activation of ATR in response to replication stress
GTSE1;G2/M Checkpoints
MDM2;Stabilization of p53
MDM2;Regulation of TP53 Degradation
SGK1;Regulation of TP53 Degradation
SGK1;PIP3 activates AKT signaling,PI3K/AKT Signaling
MDM2;AKT phosphorylates targets in the cytosol
CDC25A;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
CDC25A;Activation of ATR in response to replication stress
WAPL;Cohesin Loading onto Chromatin
CDCA5;Establishment of Sister Chromatid Cohesion
CDC45;Activation of the pre-replicative complex
CDC45;G1/S-Specific Transcription
CDT1;Activation of the pre-replicative complex
MCM10;Activation of the pre-replicative complex
DNA2;Removal of the Flap Intermediate
GINS2;Unwinding of DNA
GINS1;Unwinding of DNA
GINS3;Unwinding of DNA
GINS4;Unwinding of DNA
CDC45;Unwinding of DNA
RB1;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
CDT1;Switching of origins to a post-replicative state
GMNN;Switching of origins to a post-replicative state
GMNN;Activation of the pre-replicative complex
CDC6;CDC6 association with the ORC:origin complex
CDC6;G1/S-Specific Transcription
CDC6;Transcription of E2F targets under negative control by DREAM complex
MCM8;CDC6 association with the ORC:origin complex
MCM5;Assembly of the pre-replicative complex
MCM3;Assembly of the pre-replicative complex
MCM2;Assembly of the pre-replicative complex
MCM7;Assembly of the pre-replicative complex
MCM6;Assembly of the pre-replicative complex
MCM4;Assembly of the pre-replicative complex
CDT1;Assembly of the pre-replicative complex
GMNN;Assembly of the pre-replicative complex
ORC2;Assembly of the ORC complex at the origin of replication
ORC3;Assembly of the ORC complex at the origin of replication
ORC4;Assembly of the ORC complex at the origin of replication
ORC5;Assembly of the ORC complex at the origin of replication
ORC1;Assembly of the ORC complex at the origin of replication
ORC6;Assembly of the ORC complex at the origin of replication
RBL1;Transcription of E2F targets under negative control by DREAM complex
E2F1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
E2F1;Transcription of E2F targets under negative control by DREAM complex
HDAC1;G0 and Early G1
PCNA;G1/S-Specific Transcription
PCNA;Transcription of E2F targets under negative control by DREAM complex
TOP2A;Transcription of E2F targets under negative control by DREAM complex
RBL1;G0 and Early G1
RBL1;Cyclin D associated events in G1
CCNA2;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
CDK1;G1/S-Specific Transcription
CDK1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
MYBL2;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
RBL2;G0 and Early G1
CDKN2B;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SP1;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CDKN2A;Transcriptional Regulation by VENTX
CDKN2A;Oxidative Stress Induced Senescence
CDKN2A;Oncogene Induced Senescence
KDM6B;Oxidative Stress Induced Senescence
FOS;Oxidative Stress Induced Senescence
FOS;FCERI mediated MAPK activation
FOS;Activation of the AP-1 family of transcription factors
JUN;Oxidative Stress Induced Senescence
JUN;FCERI mediated MAPK activation
JUN;Activation of the AP-1 family of transcription factors
RBBP4;Oxidative Stress Induced Senescence
SUZ12;Oxidative Stress Induced Senescence
EZH2;Oxidative Stress Induced Senescence
EED;Oxidative Stress Induced Senescence
RBBP7;Oxidative Stress Induced Senescence
ETS2;Oncogene Induced Senescence
ETS1;Oncogene Induced Senescence
SP1;Oncogene Induced Senescence
CDKN2B;Senescence-Associated Secretory Phenotype (SASP)
CEBPB;Senescence-Associated Secretory Phenotype (SASP)
MAPK7;Signalling to ERK5
NEDD4L;Downregulation of SMAD2/3:SMAD4 transcriptional activity
HDAC1;Downregulation of SMAD2/3:SMAD4 transcriptional activity
PARP1;Downregulation of SMAD2/3:SMAD4 transcriptional activity
PPM1A;Downregulation of SMAD2/3:SMAD4 transcriptional activity
RAF1;IFNG signaling activates MAPKs
EP300;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
FURIN;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
YBX1;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
YBX1;Interferon gamma signaling
MEN1;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
COL1A2;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SERPINE1;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
JUNB;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
LTBP4;Molecules associated with elastic fibres
LTBP4;TGF-beta receptor signaling activates SMADs
CBL;TGF-beta receptor signaling activates SMADs
UBE2M;TGF-beta receptor signaling activates SMADs
SMAD7;Downregulation of TGF-beta receptor signaling
NEDD4L;Downregulation of TGF-beta receptor signaling
STRAP;Downregulation of TGF-beta receptor signaling
STUB1;Downregulation of TGF-beta receptor signaling
SMAD3;Downregulation of TGF-beta receptor signaling
SMURF1;Downregulation of TGF-beta receptor signaling
XPO1;Downregulation of TGF-beta receptor signaling
SMAD2;Downregulation of TGF-beta receptor signaling
SMURF2;Downregulation of TGF-beta receptor signaling
MTMR4;Downregulation of TGF-beta receptor signaling
BAMBI;Downregulation of TGF-beta receptor signaling
PMEPA1;Downregulation of TGF-beta receptor signaling
SMURF1;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
FKBP1A;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
PIAS1;Regulation of IFNG signaling
SUMO1;Regulation of IFNG signaling
CIITA;Interferon gamma signaling
B2M;Interferon gamma signaling
IFI30;Interferon gamma signaling
PTAFR;Interferon gamma signaling
SP100;Interferon gamma signaling
PML;Interferon gamma signaling
MT2A;Interferon gamma signaling
ACE2;Attachment and Entry
UBE2I;Maturation of nucleoprotein
ACE2;Potential therapeutics for SARS
ISCU;Maturation of replicase proteins
PHAX;snRNP Assembly
SNRPF;snRNP Assembly
SNRPD3;snRNP Assembly
SNRPE;snRNP Assembly
SNRPB;snRNP Assembly
SNRPG;snRNP Assembly
SNRPD2;snRNP Assembly
SNRPD1;snRNP Assembly
IL17RA;SARS-CoV-2 activates/modulates innate and adaptive immune responses
KPNA2;SARS-CoV-2 activates/modulates innate and adaptive immune responses
IRF3;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TBK1;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
MAVS;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TOMM70;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
IL17RA;Interleukin-17 signaling
IL17RC;Interleukin-17 signaling
IL17RC;SARS-CoV-2 activates/modulates innate and adaptive immune responses
CNBP;SARS-CoV-2 activates/modulates innate and adaptive immune responses
TRIM25;SARS-CoV-2 activates/modulates innate and adaptive immune responses
TOMM70;SARS-CoV-2 activates/modulates innate and adaptive immune responses
PDIA3;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
TAPBP;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
CALR;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
B2M;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
RIGI;SARS-CoV-2 activates/modulates innate and adaptive immune responses
STING1;SARS-CoV-2 activates/modulates innate and adaptive immune responses
STAT2;Interferon alpha/beta signaling
STAT2;Evasion by RSV of host interferon responses
MAVS;SARS-CoV-2 activates/modulates innate and adaptive immune responses
IRF3;SARS-CoV-2 activates/modulates innate and adaptive immune responses
ISG15;SARS-CoV-2 activates/modulates innate and adaptive immune responses
UBE2L6;ISG15 antiviral mechanism
IRF3;ISG15 antiviral mechanism
UBA7;ISG15 antiviral mechanism
ISG15;ISG15 antiviral mechanism
NLRP12;SARS-CoV-2 activates/modulates innate and adaptive immune responses
RIGI;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TBK1;SARS-CoV-2 activates/modulates innate and adaptive immune responses
SIKE1;TRAF3-dependent IRF activation pathway
SIKE1;SARS-CoV-2 activates/modulates innate and adaptive immune responses
TRAF3;TRAF3-dependent IRF activation pathway
TKFC;DDX58/IFIH1-mediated induction of interferon-alpha/beta,RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
LARP1;SARS-CoV-2 activates/modulates innate and adaptive immune responses
TKFC;SARS-CoV-2 activates/modulates innate and adaptive immune responses
TAB1;SARS-CoV-2 activates/modulates innate and adaptive immune responses
NLRP3;SARS-CoV-2 activates/modulates innate and adaptive immune responses
MAP1LC3B;SARS-CoV-2 modulates autophagy
TUFM;SARS-CoV-2 modulates autophagy
UVRAG;SARS-CoV-2 modulates autophagy
CAV1;SARS-CoV-2 targets host intracellular signalling and regulatory pathways
CAV1;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
PDPK1;SARS-CoV-2 targets host intracellular signalling and regulatory pathways
TJP1;SARS-CoV-2 targets PDZ proteins in cell-cell junction
CRB3;Tight junction interactions
CRB3;SARS-CoV-2 targets PDZ proteins in cell-cell junction
PATJ;Tight junction interactions
PATJ;SARS-CoV-2 targets PDZ proteins in cell-cell junction
PALS1;Tight junction interactions
PALS1;SARS-CoV-2 targets PDZ proteins in cell-cell junction
PALS1;SARS-CoV-1 targets PDZ proteins in cell-cell junction
TJP1;Regulation of gap junction activity
CFH;Regulation of Complement cascade
CFI;Regulation of Complement cascade
CD46;Regulation of Complement cascade
C2;Regulation of Complement cascade
CFB;Regulation of Complement cascade
CR1;Regulation of Complement cascade
C5AR2;Peptide ligand-binding receptors
C5AR2;Regulation of Complement cascade
SERPING1;Regulation of Complement cascade
CR2;Regulation of Complement cascade
CD55;Regulation of Complement cascade
C9;Regulation of Complement cascade
CD59;Regulation of Complement cascade
C7;Terminal pathway of complement
C6;Terminal pathway of complement
PROS1;Regulation of Complement cascade
VTN;Regulation of Complement cascade
C9;Terminal pathway of complement
MYO6;Gap junction degradation
DAB2;Formation of annular gap junctions
GJA1;Gap junction assembly
GJA1;Oligomerization of connexins into connexons
GJA1;Transport of connexins along the secretory pathway
GJB1;Oligomerization of connexins into connexons
GJB1;Gap junction assembly
GJB2;Oligomerization of connexins into connexons
GJB2;Gap junction assembly
CASP1;The IPAF inflammasome
NLRC4;The IPAF inflammasome
NLRC4;TP53 Regulates Transcription of Caspase Activators and Caspases
PANX1;The NLRP3 inflammasome
P2RX7;The NLRP3 inflammasome
CASP1;Purinergic signaling in leishmaniasis infection
CASP1;The NLRP3 inflammasome
PYCARD;Purinergic signaling in leishmaniasis infection
PYCARD;The NLRP3 inflammasome
NLRP3;Purinergic signaling in leishmaniasis infection
NLRP3;The NLRP3 inflammasome
HSP90AB1;Purinergic signaling in leishmaniasis infection
HSP90AB1;The NLRP3 inflammasome
SUGT1;Purinergic signaling in leishmaniasis infection
SUGT1;The NLRP3 inflammasome
NLRP3;Cytoprotection by HMOX1
TXNIP;Purinergic signaling in leishmaniasis infection
TXNIP;Cytoprotection by HMOX1
TXNIP;The NLRP3 inflammasome
TXN;Purinergic signaling in leishmaniasis infection
TXN;The NLRP3 inflammasome
NLRP1;The NLRP1 inflammasome
PYCARD;The AIM2 inflammasome
AIM2;Cytosolic sensors of pathogen-associated DNA 
AIM2;The AIM2 inflammasome
CASP1;The AIM2 inflammasome
MAP2K6;Interleukin-1 signaling
MAP2K6;NOD1/2 Signaling Pathway
IKBKG;NOD1/2 Signaling Pathway
CARD9;NOD1/2 Signaling Pathway
AAMP;NOD1/2 Signaling Pathway
PIN1;ISG15 antiviral mechanism
PIN1;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
RIGI;Ub-specific processing proteases
RIGI;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
PCBP2;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
NLRC5;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
ITCH;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
RNF125;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
TRAF3;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
MAVS;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
NLRX1;Negative regulators of DDX58/IFIH1 signaling,Negative regulators of RIG-I/MDA5 signaling
IFNB1;TRAF3-dependent IRF activation pathway
MAP3K1;TRAF6 mediated NF-kB activation
RIPK1;TICAM1, RIP1-mediated IKK complex recruitment
RIPK3;RIP-mediated NFkB activation via ZBP1
RIPK1;RIP-mediated NFkB activation via ZBP1
ZBP1;ZBP1(DAI) mediated induction of type I IFNs
CASP8;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
CASP10;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
FADD;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
RIPK1;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
CASP10;TP53 Regulates Transcription of Caspase Activators and Caspases
IRF7;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
IRF7;TRAF6 mediated IRF7 activation
SIKE1;TRAF6 mediated IRF7 activation
TANK;TRAF6 mediated IRF7 activation
TRAF6;MyD88 dependent cascade initiated on endosome
IRAK4;MyD88 dependent cascade initiated on endosome
MYD88;MyD88 dependent cascade initiated on endosome
TLR3;Trafficking and processing of endosomal TLR
UNC93B1;Trafficking and processing of endosomal TLR
CNPY3;Trafficking and processing of endosomal TLR
CX3CR1;Respiratory syncytial virus (RSV) attachment and entry
CX3CR1;RSV-host interactions
CREBBP;Evasion by RSV of host interferon responses
TRIM25;Evasion by RSV of host interferon responses
MAVS;Evasion by RSV of host interferon responses
RIGI;Evasion by RSV of host interferon responses
EIF2AK2;PKR-mediated signaling
EIF2AK2;Evasion by RSV of host interferon responses
BCAP31;RSV-host interactions
TLR3;RSV-host interactions
MAP1B;RSV-host interactions
H2BC15;RSV-host interactions
RIGI;RSV-host interactions
UBE2L6;RSV-host interactions
BECN1;RSV-host interactions
OAS2;OAS antiviral response
OAS2;RSV-host interactions
IKBIP;Regulation of NF-kappa B signaling
USP18;Regulation of NF-kappa B signaling
LRRC14;Regulation of NF-kappa B signaling
IKBKG;Regulation of NF-kappa B signaling
N4BP1;Regulation of NF-kappa B signaling
NLRX1;Regulation of NF-kappa B signaling
FADD;TRIF-mediated programmed cell death
CASP8;TRIF-mediated programmed cell death
RIPK1;IKK complex recruitment mediated by RIP1
FADD;TLR3-mediated TICAM1-dependent programmed cell death
CASP8;TLR3-mediated TICAM1-dependent programmed cell death
ELK1;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
ELK1;ERK/MAPK targets
CREB1;Gastrin-CREB signalling pathway via PKC and MAPK
ATF1;CREB phosphorylation
PEA15;RAF/MAP kinase cascade
PEA15;RAF-independent MAPK1/3 activation
TRAF6;Downstream TCR signaling
BCL10;Downstream TCR signaling
CARD11;Downstream TCR signaling
PRKCQ;FCERI mediated NF-kB activation
PRKCQ;Downstream TCR signaling
PDPK1;Role of LAT2/NTAL/LAB on calcium mobilization
PDPK1;Downstream TCR signaling
GAB2;Role of LAT2/NTAL/LAB on calcium mobilization
LAT2;Role of LAT2/NTAL/LAB on calcium mobilization
SYK;FCGR activation
FCGR2A;FCGR activation
SYK;Fc epsilon receptor (FCERI) signaling
LYN;Fc epsilon receptor (FCERI) signaling
UBE2E1;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
UBE2E1;TRAF6-mediated induction of TAK1 complex within TLR4 complex
TRAF6;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
NFKBIA;NF-kB is activated and signals survival
SQSTM1;p75NTR recruits signalling complexes
TRAF6;p75NTR recruits signalling complexes
NGFR;NFG and proNGF binds to p75NTR
TRAF6;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
MAP3K1;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
MAP3K1;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
MAP3K1;MyD88 cascade initiated on plasma membrane
RIPK3;TRIF-mediated programmed cell death
TANK;Activation of IRF3, IRF7 mediated by TBK1, IKBKE
TRAF3;Activation of IRF3, IRF7 mediated by TBK1, IKBKE
MLKL;RIPK1-mediated regulated necrosis
RIPK3;RIPK1-mediated regulated necrosis
RIPK1;RIPK1-mediated regulated necrosis
RIPK3;Regulation of necroptotic cell death
CASP8;Dimerization of procaspase-8
CASP8;TNFR1-induced proapoptotic signaling
FADD;TNFR1-induced proapoptotic signaling
RIPK1;TNF signaling
TRADD;TNF signaling
TRAF2;TNF signaling
BAG4;TNF signaling
CASP8;TRAIL  signaling
FADD;TRAIL  signaling
TNFSF10;TRAIL  signaling
CASP8;FasL/ CD95L signaling
FADD;FasL/ CD95L signaling
FAS;FasL/ CD95L signaling
FASLG;FasL/ CD95L signaling
UBA1;Regulation of necroptotic cell death
MLKL;Regulation of necroptotic cell death
UBE2L3;Regulation of necroptotic cell death
ITCH;Regulation of necroptotic cell death
PDCD6IP;Regulation of necroptotic cell death
SDCBP;Regulation of necroptotic cell death
RIPK1;Regulation of TNFR1 signaling
RIPK1;Regulation of necroptotic cell death
PRKN;Regulation of necroptotic cell death
PELI1;Regulation of necroptotic cell death
DIABLO;SMAC, XIAP-regulated apoptotic response
DIABLO;SMAC (DIABLO) binds to IAPs 
DIABLO;Release of apoptotic factors from the mitochondria
BAX;Activation, translocation and oligomerization of BAX
BID;Activation, translocation and oligomerization of BAX
BAX;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
BID;Activation, myristolyation of BID and translocation to mitochondria,Activation of BID and translocation to mitochondria
BID;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
BAK1;Activation and oligomerization of BAK protein
BID;Activation and oligomerization of BAK protein
DCC;Caspase activation via Dependence Receptors in the absence of ligand,Ligand-independent caspase activation via DCC
APPL1;Caspase activation via Dependence Receptors in the absence of ligand,Ligand-independent caspase activation via DCC
CASP9;Formation of apoptosome
CYCS;Formation of apoptosome
APAF1;TP53 Regulates Transcription of Caspase Activators and Caspases
CYCS;Pyroptosis
CYCS;Cytochrome c-mediated apoptotic response
CYCS;Release of apoptotic factors from the mitochondria
DFFB;Apoptosis induced DNA fragmentation
DFFA;Apoptosis induced DNA fragmentation
APC;Apoptotic cleavage of cellular proteins
PRKCQ;Apoptotic cleavage of cellular proteins
PTK2;Apoptotic cleavage of cellular proteins
SPTAN1;Caspase-mediated cleavage of cytoskeletal proteins
GAS2;Caspase-mediated cleavage of cytoskeletal proteins
DBNL;Caspase-mediated cleavage of cytoskeletal proteins
GSN;Caspase-mediated cleavage of cytoskeletal proteins
PLEC;Caspase-mediated cleavage of cytoskeletal proteins
VIM;Caspase-mediated cleavage of cytoskeletal proteins
ADD1;Caspase-mediated cleavage of cytoskeletal proteins
MAPT;Caspase-mediated cleavage of cytoskeletal proteins
CLSPN;Apoptotic cleavage of cellular proteins
DSG2;Apoptotic cleavage of cell adhesion  proteins
OCLN;Apoptotic cleavage of cell adhesion  proteins
DSG1;Apoptotic cleavage of cell adhesion  proteins
DSP;Apoptotic cleavage of cell adhesion  proteins
CDH1;Apoptotic cleavage of cell adhesion  proteins
PKP1;Apoptotic cleavage of cell adhesion  proteins
CTNNB1;Apoptotic cleavage of cell adhesion  proteins
TJP2;Apoptotic cleavage of cell adhesion  proteins
DSG3;Apoptotic cleavage of cell adhesion  proteins
TJP1;Apoptotic cleavage of cell adhesion  proteins
ROCK1;Apoptotic cleavage of cellular proteins
SATB1;Apoptotic cleavage of cellular proteins
LMNB1;Breakdown of the nuclear lamina
PRKCD;Apoptotic cleavage of cellular proteins
FNTA;Apoptotic cleavage of cellular proteins
BMX;Apoptotic cleavage of cellular proteins
BIRC2;Apoptotic cleavage of cellular proteins
BCAP31;Apoptotic cleavage of cellular proteins
STK24;Apoptotic cleavage of cellular proteins
ACIN1;Apoptotic cleavage of cellular proteins
STK26;Apoptotic cleavage of cellular proteins
DNM1L;Apoptotic execution phase
PAK2;Stimulation of the cell death response by PAK-2p34
STK24;Apoptotic execution phase
ARHGAP10;Regulation of PAK-2p34 activity by PS-GAP/RHG10
PAK2;Regulation of PAK-2p34 activity by PS-GAP/RHG10
PAK2;Regulation of activated PAK-2p34 by proteasome mediated degradation
OPA1;Regulation of Apoptosis
BMF;Activation of BMF and translocation to mitochondria
BAD;Activation of BAD and translocation to mitochondria 
BAD;AKT phosphorylates targets in the cytosol
BID;Activation of BAD and translocation to mitochondria 
BID;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
BCL2;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
BCL2L11;Activation of BIM and translocation to mitochondria 
PMAIP1;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
PMAIP1;Activation of NOXA and translocation to mitochondria
BBC3;Activation of PUMA and translocation to mitochondria
BBC3;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
BCL2L1;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
JAK1;Interleukin-4 and Interleukin-13 signaling
IL4;Interleukin-4 and Interleukin-13 signaling
JAK2;Interleukin-4 and Interleukin-13 signaling
IL4R;Interleukin-4 and Interleukin-13 signaling
APIP;Regulation of the apoptosome activity
XIAP;Regulation of the apoptosome activity
AVEN;Regulation of the apoptosome activity
CASP9;Regulation of the apoptosome activity
CARD8;Regulation of the apoptosome activity
UACA;Regulation of the apoptosome activity
XIAP;SMAC, XIAP-regulated apoptotic response
XIAP;SMAC (DIABLO) binds to IAPs 
CDKN2A;Apoptotic factor-mediated response
NR4A1;AKT phosphorylates targets in the nucleus
RPS6KB2;AKT phosphorylates targets in the nucleus
CHUK;AKT phosphorylates targets in the cytosol
TSC2;AKT phosphorylates targets in the cytosol
AKT1S1;AKT phosphorylates targets in the cytosol
MKRN1;Regulation of PTEN stability and activity
MKRN1;AKT phosphorylates targets in the cytosol
CASP9;AKT phosphorylates targets in the cytosol
AKT1;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
IER3;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
PTEN;Regulation of PTEN stability and activity
TRIM27;Regulation of PTEN stability and activity
FRK;Regulation of PTEN stability and activity
PREX2;Regulation of PTEN stability and activity
PTPN11;GAB1 signalosome
PAG1;GAB1 signalosome
CSK;GAB1 signalosome
CBL;EGFR downregulation
SPRY2;EGFR downregulation
EPS15L1;EGFR downregulation
EPN1;EGFR downregulation
AAMP;Signaling by EGFR,Epidermal Growth Factor Receptor (EGFR) signaling
AAMP;Signaling by VEGF,Signaling by Vascular Epithelial Growth Factors (VEGF)
NBEA;PKA activation
PRKAR2A;PKA activation
GRK2;Calmodulin induced events
RCE1;RAS processing
PDE6D;RAS processing
BCL2L1;RAS processing
IL17RD;MAP2K and MAPK activation
MAPK12;Negative regulation of MAPK pathway
PTPN3;Negative regulation of MAPK pathway
PTPN7;Negative regulation of MAPK pathway
PAQR3;Negative regulation of MAPK pathway
PEBP1;Negative regulation of MAPK pathway
BRAP;Negative regulation of MAPK pathway
BRAF;Negative feedback regulation of MAPK pathway
RAF1;Negative feedback regulation of MAPK pathway
NF1;Regulation of RAS by GAPs
PTPN12;SHC1 events in ERBB2 signaling
PLCG1;PLCG1 events in ERBB2 signaling
MATK;Downregulation of ERBB2 signaling
RNF41;Downregulation of ERBB2:ERBB3 signaling
USP8;Downregulation of ERBB2:ERBB3 signaling
PTPN18;Downregulation of ERBB2 signaling
GRB7;GRB7 events in ERBB2 signaling
MEMO1;ERBB2 Regulates Cell Motility
DAAM1;PCP/CE pathway
DAAM1;RHO GTPases Activate Formins
SRGAP2;RHO GTPases Activate Formins
MRTFA;RHO GTPases Activate Formins
SCAI;RHO GTPases Activate Formins
SRF;RHO GTPases Activate Formins
ITGB1;RHO GTPases Activate Formins
PECAM1;PECAM1 interactions
PECAM1;Integrin cell surface interactions
VTN;Integrin cell surface interactions
BSG;Basigin interactions
BSG;Integrin cell surface interactions
FN1;Integrin cell surface interactions
VCAM1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
VCAM1;Integrin cell surface interactions
HSPG2;Integrin cell surface interactions
THBS1;Integrin cell surface interactions
LUM;Integrin cell surface interactions
AGRN;Integrin cell surface interactions
CDH1;Integrin cell surface interactions
FBN1;Integrin cell surface interactions
JAM2;Cell surface interactions at the vascular wall
JAM3;Cell surface interactions at the vascular wall
JAM3;Integrin cell surface interactions
SPP1;Integrin cell surface interactions
TNC;Integrin cell surface interactions
IBSP;Integrin cell surface interactions
CD44;Integrin cell surface interactions
F11R;Cell surface interactions at the vascular wall
F11R;Integrin cell surface interactions
KDR;Integrin cell surface interactions
MAP3K7;Ca2+ pathway
NLK;Ca2+ pathway
PRKCA;Ca2+ pathway
NFATC1;Ca2+ pathway
WNT5A;Asymmetric localization of PCP proteins
PRICKLE1;Asymmetric localization of PCP proteins
FZD3;Asymmetric localization of PCP proteins
SCRIB;Asymmetric localization of PCP proteins
VANGL2;Asymmetric localization of PCP proteins
RYK;PCP/CE pathway
VANGL2;PCP/CE pathway
WNT5A;PCP/CE pathway
WNT5A;WNT5A-dependent internalization of FZD2, FZD5 and ROR2
ARRB2;WNT5A-dependent internalization of FZD4
DVL2;WNT5A-dependent internalization of FZD4
FZD4;WNT5A-dependent internalization of FZD4
WNT5A;WNT5A-dependent internalization of FZD4
PFN1;PCP/CE pathway
ROR2;PCP/CE pathway
RBBP5;Deactivation of the beta-catenin transactivating complex
MEN1;Deactivation of the beta-catenin transactivating complex
ASH2L;Deactivation of the beta-catenin transactivating complex
KMT2D;Deactivation of the beta-catenin transactivating complex
BTRC;Deactivation of the beta-catenin transactivating complex
APC;Deactivation of the beta-catenin transactivating complex
CTBP1;Deactivation of the beta-catenin transactivating complex
RBBP5;Formation of the beta-catenin:TCF transactivating complex
MEN1;Formation of the beta-catenin:TCF transactivating complex
ASH2L;Formation of the beta-catenin:TCF transactivating complex
KMT2D;Formation of the beta-catenin:TCF transactivating complex
CTNNB1;Formation of the beta-catenin:TCF transactivating complex
HDAC1;Formation of the beta-catenin:TCF transactivating complex
CTNNB1;TCF dependent signaling in response to WNT
CSNK1A1;Disassembly of the destruction complex and recruitment of AXIN to the membrane
AMER1;Disassembly of the destruction complex and recruitment of AXIN to the membrane
APC;Disassembly of the destruction complex and recruitment of AXIN to the membrane
CTNNB1;Disassembly of the destruction complex and recruitment of AXIN to the membrane
YWHAZ;Deactivation of the beta-catenin transactivating complex
CTNNB1;Deactivation of the beta-catenin transactivating complex
CBY1;Deactivation of the beta-catenin transactivating complex
XPO1;Deactivation of the beta-catenin transactivating complex
XIAP;Deactivation of the beta-catenin transactivating complex
CHD8;Deactivation of the beta-catenin transactivating complex
CTNNBIP1;Deactivation of the beta-catenin transactivating complex
CXXC4;Negative regulation of TCF-dependent signaling by DVL-interacting proteins
CCDC88C;Negative regulation of TCF-dependent signaling by DVL-interacting proteins
GSK3B;Disassembly of the destruction complex and recruitment of AXIN to the membrane
RYK;TCF dependent signaling in response to WNT
DVL1;Degradation of DVL
HECW1;Degradation of DVL
DACT1;Degradation of DVL
DVL2;Degradation of DVL
SMURF2;Degradation of AXIN
RNF146;Degradation of AXIN
WNT3A;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
WIF1;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
SOST;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
TERT;Formation of the beta-catenin:TCF transactivating complex
SMARCA4;Formation of the beta-catenin:TCF transactivating complex
KAT5;Formation of the beta-catenin:TCF transactivating complex
TRRAP;Formation of the beta-catenin:TCF transactivating complex
RUVBL1;Formation of the beta-catenin:TCF transactivating complex
AXIN2;Binding of TCF/LEF:CTNNB1 to target gene promoters
LEO1;Formation of the beta-catenin:TCF transactivating complex
CDC73;Formation of the beta-catenin:TCF transactivating complex
PIP5K1B;WNT mediated activation of DVL
CTNNB1;Degradation of beta-catenin by the destruction complex
CSNK1A1;Degradation of beta-catenin by the destruction complex
AMER1;Degradation of beta-catenin by the destruction complex
AXIN1;Degradation of beta-catenin by the destruction complex
APC;Degradation of beta-catenin by the destruction complex
GSK3B;Degradation of beta-catenin by the destruction complex
ZRANB1;Ovarian tumor domain proteases
ZRANB1;Degradation of beta-catenin by the destruction complex
APC;Ovarian tumor domain proteases
TLE5;Repression of WNT target genes
HDAC1;Repression of WNT target genes
SNX3;WNT ligand biogenesis and trafficking
ANGPTL4;Regulation of CDH11 function
CDH11;Regulation of CDH11 function
CTNND1;Regulation of CDH11 function
CDH11;Regulation of CDH11 mRNA translation by microRNAs
CTNNA1;Regulation of CDH11 function
CTNNB1;Regulation of CDH11 function
BHLHE22;Regulation of CDH11 gene transcription
HEYL;Regulation of CDH11 gene transcription
HOXC8;Regulation of CDH11 gene transcription
ILF3;Regulation of CDH11 gene transcription
SP1;Regulation of CDH11 gene transcription
ZEB2;Regulation of CDH11 gene transcription
FOXF1;Regulation of CDH11 gene transcription
PRDM8;Regulation of CDH11 gene transcription
ZC3H12A;Regulation of CDH19 Expression and Function
CDH19;Regulation of CDH19 Expression and Function
CTNNA1;Regulation of CDH19 Expression and Function
CTNND1;Regulation of CDH19 Expression and Function
SOX10;Regulation of CDH19 Expression and Function
ANG;Adherens junctions interactions
CADM3;Nectin/Necl  trans heterodimerization
NECTIN1;Nectin/Necl  trans heterodimerization
CADM1;Nectin/Necl  trans heterodimerization
NECTIN3;Nectin/Necl  trans heterodimerization
PVR;Nectin/Necl  trans heterodimerization
CTNNA1;Adherens junctions interactions
CTNND1;Adherens junctions interactions
SDK1;SDK interactions
SDK2;SDK interactions
F11R;Tight junction interactions
ILK;Localization of the PINCH-ILK-PARVIN complex to focal adhesions
ILK;Cell-extracellular matrix interactions
PXN;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
PXN;Localization of the PINCH-ILK-PARVIN complex to focal adhesions
PARVA;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
PARVA;Localization of the PINCH-ILK-PARVIN complex to focal adhesions
ITGB1;Localization of the PINCH-ILK-PARVIN complex to focal adhesions
RSU1;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
LIMS1;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
TESK1;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
PARVB;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
ACTN1;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
ARHGEF6;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
FBLIM1;Cell-extracellular matrix interactions
FERMT2;Cell-extracellular matrix interactions
VASP;Cell-extracellular matrix interactions
CD151;Type I hemidesmosome assembly
COL17A1;Type I hemidesmosome assembly
PLEC;Type I hemidesmosome assembly
STAP2;PTK6 Activates STAT3
PTK6;PTK6 Activates STAT3
STAT3;PTK6 Activates STAT3
STAT3;Signaling by Leptin
STAT3;MET activates STAT3
LEP;Signaling by Leptin
SOCS3;PTK6 Activates STAT3
GPNMB;PTK6 promotes HIF1A stabilization
HIF1A;PTK6 promotes HIF1A stabilization
PTK6;PTK6 promotes HIF1A stabilization
LRRK2;PTK6 promotes HIF1A stabilization
PTPN1;PTK6 Down-Regulation
PTK6;PTK6 Down-Regulation
RASA1;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
ARHGAP35;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
BCAR1;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
AKT1;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
DOK1;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
CBL;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
ARAP1;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
SFPQ;PTK6 Regulates Proteins Involved in RNA Processing
PTK6;PTK6 Regulates Proteins Involved in RNA Processing
KHDRBS3;PTK6 Regulates Proteins Involved in RNA Processing
KHDRBS1;PTK6 Regulates Proteins Involved in RNA Processing
KHDRBS2;PTK6 Regulates Proteins Involved in RNA Processing
PAK2;RHO GTPases activate PAKs
VAV1;CD28 dependent Vav1 pathway
NCK1;DCC mediated attractive signaling
PTK2;DCC mediated attractive signaling
DCC;DCC mediated attractive signaling
NTN1;DCC mediated attractive signaling
MYLK;Smooth Muscle Contraction
MYLK;RHO GTPases activate PAKs
PAK1;Regulation of actin dynamics for phagocytic cup formation
PAK1;RHO GTPases activate PAKs
PAK3;RHO GTPases activate PAKs
ARHGEF1;G alpha (12/13) signalling events
ARHGEF12;G alpha (12/13) signalling events
LIMK1;Regulation of actin dynamics for phagocytic cup formation
LIMK1;RHO GTPases activate PAKs
NF2;RHO GTPases activate PAKs
CTTN;RHO GTPases activate PAKs
BAIAP2;FCGR3A-mediated phagocytosis
BAIAP2;VEGFA-VEGFR2 Pathway
BAIAP2;RHO GTPases Activate WASPs and WAVEs
BAIAP2;Regulation of actin dynamics for phagocytic cup formation
CRK;VEGFA-VEGFR2 Pathway
BCAR1;VEGFA-VEGFR2 Pathway
PTK2B;VEGFA-VEGFR2 Pathway
HSP90AA1;VEGFA-VEGFR2 Pathway
PTK2;VEGFA-VEGFR2 Pathway
SHB;VEGFA-VEGFR2 Pathway
NGEF;EPHA-mediated growth cone collapse
PXN;VEGFA-VEGFR2 Pathway
AXL;VEGFA-VEGFR2 Pathway
SH2D2A;VEGFA-VEGFR2 Pathway
WAS;Generation of second messenger molecules
CFL1;Sema3A PAK dependent Axon repulsion
CFL1;Regulation of actin dynamics for phagocytic cup formation
LIMK1;Sema3A PAK dependent Axon repulsion
CFL1;EPHB-mediated forward signaling
CFL1;RHO GTPases Activate ROCKs
ARHGEF28;EPHB-mediated forward signaling
PTK2;EPHB-mediated forward signaling
NRP1;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
FARP2;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
FES;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
TLN1;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
CD72;Other semaphorin interactions
SEMA4D;Other semaphorin interactions
SEMA6D;Other semaphorin interactions
SEMA4A;Other semaphorin interactions
PLXND1;Other semaphorin interactions
SEMA6A;Other semaphorin interactions
PTPRC;Other semaphorin interactions
SEMA7A;Other semaphorin interactions
PLXNC1;Other semaphorin interactions
SEMA5A;Other semaphorin interactions
PLXNB3;Other semaphorin interactions
SEMA3E;Other semaphorin interactions
ARHGAP35;Sema4D mediated inhibition of cell attachment and migration
MYO6;Trafficking of AMPA receptors
DLG1;Trafficking of AMPA receptors
EPB41L1;Trafficking of AMPA receptors
AKAP5;Trafficking of AMPA receptors
PICK1;Trafficking of GluR2-containing AMPA receptors
RAB3A;Glutamate Neurotransmitter Release Cycle
SLC17A7;Glutamate Neurotransmitter Release Cycle
CPLX1;Glutamate Neurotransmitter Release Cycle
SYT1;Glutamate Neurotransmitter Release Cycle
STX1A;Glutamate Neurotransmitter Release Cycle
SNAP25;Glutamate Neurotransmitter Release Cycle
GRIN2A;Assembly and cell surface presentation of NMDA receptors
GRIN1;Assembly and cell surface presentation of NMDA receptors
GRIN2B;Assembly and cell surface presentation of NMDA receptors
GRIN2D;Assembly and cell surface presentation of NMDA receptors
GRIN2C;Assembly and cell surface presentation of NMDA receptors
GRIN3A;Assembly and cell surface presentation of NMDA receptors
NEFL;Assembly and cell surface presentation of NMDA receptors
DLG4;Assembly and cell surface presentation of NMDA receptors
GRIN3B;Assembly and cell surface presentation of NMDA receptors
DLG3;Assembly and cell surface presentation of NMDA receptors
NBEA;Assembly and cell surface presentation of NMDA receptors
LRRC7;Assembly and cell surface presentation of NMDA receptors
NRGN;Long-term potentiation
CALM1;Long-term potentiation
CAMK1;Activation of RAC1 downstream of NMDARs
CLEC5A;DAP12 interactions
CD300E;DAP12 interactions
TREM1;DAP12 interactions
TYROBP;Signal regulatory protein family interactions
SIRPB1;Signal regulatory protein family interactions
SIRPB1;DAP12 interactions
NCR2;DAP12 interactions
CD300LB;DAP12 interactions
BTK;DAP12 signaling
PTPN22;Phosphorylation of CD3 and TCR zeta chains
FYB1;Generation of second messenger molecules
NCK1;Generation of second messenger molecules
MALT1;FCERI mediated NF-kB activation
BCL10;FCERI mediated NF-kB activation
CARD11;FCERI mediated NF-kB activation
TRAF6;FCERI mediated NF-kB activation
PLCG2;CLEC7A (Dectin-1) signaling
SYK;CLEC7A (Dectin-1) signaling
CLEC7A;CLEC7A (Dectin-1) signaling
PRKCD;CLEC7A (Dectin-1) signaling
CARD9;CLEC7A (Dectin-1) signaling
BCL10;CLEC7A (Dectin-1) signaling
MALT1;CLEC7A (Dectin-1) signaling
TRAF6;CLEC7A (Dectin-1) signaling
UBA3;NIK-->noncanonical NF-kB signaling
UBA3;Dectin-1 mediated noncanonical NF-kB signaling
UBE2M;NIK-->noncanonical NF-kB signaling
UBE2M;Dectin-1 mediated noncanonical NF-kB signaling
NOS3;eNOS activation
CAV1;eNOS activation
HSP90AA1;VEGFR2 mediated vascular permeability
HSP90AA1;eNOS activation
CAV1;VEGFR2 mediated vascular permeability
AKT1;VEGFR2 mediated vascular permeability
AKT1;eNOS activation
NOSIP;NOSIP mediated eNOS trafficking
WASL;NOSTRIN mediated eNOS trafficking
DNM2;NOSTRIN mediated eNOS trafficking
USP7;Regulation of TP53 Degradation
DAXX;Regulation of TP53 Degradation
CCNG1;Regulation of TP53 Degradation
CDKN2A;Regulation of TP53 Degradation
USP2;Ub-specific processing proteases
USP2;Regulation of TP53 Degradation
BAP1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
MAPK8;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
APBB1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
UBXN1;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
ABRAXAS1;Nonhomologous End-Joining (NHEJ)
UIMC1;Nonhomologous End-Joining (NHEJ)
BRCC3;Nonhomologous End-Joining (NHEJ)
BABAM2;Nonhomologous End-Joining (NHEJ)
BABAM1;Nonhomologous End-Joining (NHEJ)
PAXIP1;Nonhomologous End-Joining (NHEJ)
RIF1;Nonhomologous End-Joining (NHEJ)
NSD2;Nonhomologous End-Joining (NHEJ)
RNF168;Nonhomologous End-Joining (NHEJ)
PIAS4;Nonhomologous End-Joining (NHEJ)
TP53BP1;Nonhomologous End-Joining (NHEJ)
KAT5;Nonhomologous End-Joining (NHEJ)
HERC2;Nonhomologous End-Joining (NHEJ)
ATM;Nonhomologous End-Joining (NHEJ)
PRKDC;Nonhomologous End-Joining (NHEJ)
DCLRE1C;Nonhomologous End-Joining (NHEJ)
FEN1;HDR through MMEJ (alt-NHEJ)
DYRK2;Regulation of TP53 Activity through Phosphorylation
NOC2L;Regulation of TP53 Activity through Phosphorylation
AURKB;Regulation of TP53 Activity through Phosphorylation
NUAK1;Regulation of TP53 Activity through Phosphorylation
STK11;Regulation of TP53 Activity through Phosphorylation
HIPK1;Regulation of TP53 Activity through Phosphorylation
TP53INP1;Regulation of TP53 Activity through Phosphorylation
TP53INP1;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
ASF1A;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
CABIN1;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
UBN1;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
HIRA;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
HMGA2;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
HMGA1;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
CCND1;Ubiquitin-dependent degradation of Cyclin D
RB1;Inhibition of replication initiation of damaged DNA by RB1/E2F1
ERF;Oncogene Induced Senescence
ID1;Oncogene Induced Senescence
GSDME;Pyroptosis
GSDMD;Pyroptosis
CASP1;Interleukin-1 processing
CD36;Scavenging by Class B Receptors
CD14;Regulation of TLR by endogenous ligand
LBP;Regulation of TLR by endogenous ligand
TIRAP;MyD88:MAL(TIRAP) cascade initiated on plasma membrane
IL1RL1;Interleukin-33 signaling
IL33;Interleukin-33 signaling
IL18BP;Interleukin-37 signaling
IL37;Interleukin-37 signaling
TBK1;Interleukin-37 signaling
SIGIRR;Interleukin-37 signaling
IL18R1;Interleukin-37 signaling
SMAD3;Interleukin-37 signaling
STAT3;Interleukin-37 signaling
IL1RL2;Interleukin-36 pathway
IL1R1;Potential therapeutics for SARS
IL1R1;Interleukin-1 signaling
TOLLIP;Interleukin-1 signaling
TRAF6;Interleukin-1 signaling
NFKBIA;Interleukin-1 signaling
IRAK1;Interleukin-1 signaling
IRAK4;Interleukin-1 signaling
IRAK2;Interleukin-1 signaling
IL1RN;Interleukin-1 signaling
IL1R2;Interleukin-1 signaling
IL1F10;Interleukin-38 signaling
IL1RAPL1;Interleukin-38 signaling
MAPK8;Interleukin-38 signaling
IL1RL2;Interleukin-38 signaling
IL18;Interleukin-18 signaling
IL18R1;Interleukin-18 signaling
IL18RAP;Interleukin-18 signaling
IL18BP;Interleukin-18 signaling
JAK2;Growth hormone receptor signaling
GHR;Growth hormone receptor signaling
JAK2;Prolactin receptor signaling
PRLR;Prolactin receptor signaling
YAP1;Nuclear signaling by ERBB4
WWOX;Nuclear signaling by ERBB4
CSN2;Nuclear signaling by ERBB4
APOE;Nuclear signaling by ERBB4
S100B;Nuclear signaling by ERBB4
STMN1;Nuclear signaling by ERBB4
GFAP;Nuclear signaling by ERBB4
CXCL12;Estrogen-dependent gene expression
CXCL12;Nuclear signaling by ERBB4
SPARC;Nuclear signaling by ERBB4
PGR;Estrogen-dependent gene expression
PGR;Nuclear signaling by ERBB4
MXD4;Nuclear signaling by ERBB4
ADAP1;Nuclear signaling by ERBB4
NEDD4;Downregulation of ERBB4 signaling
SRC;Downregulation of ERBB4 signaling
YAP1;Signaling by Hippo,Hippo signaling cascade
YAP1;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD2;YAP1- and WWTR1 (TAZ)-stimulated gene expression
WWTR1;Signaling by Hippo,Hippo signaling cascade
WWTR1;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD1;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD3;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TBX5;YAP1- and WWTR1 (TAZ)-stimulated gene expression
KAT2B;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD4;YAP1- and WWTR1 (TAZ)-stimulated gene expression
CBFB;Transcriptional regulation by RUNX2
TWIST1;Regulation of RUNX2 expression and activity
NKX3-2;Regulation of RUNX2 expression and activity
MSX2;Regulation of RUNX2 expression and activity
SOX9;Transcriptional regulation by RUNX2
RBM14;RUNX2 regulates bone development
ZFYVE16;Signaling by BMP
SMAD4;Signaling by BMP
YAP1;RUNX2 regulates osteoblast differentiation
HDAC3;RUNX2 regulates osteoblast differentiation
ZNF521;RUNX2 regulates osteoblast differentiation
WWTR1;RUNX2 regulates osteoblast differentiation
RB1;RUNX2 regulates osteoblast differentiation
SP7;RUNX2 regulates osteoblast differentiation
BGLAP;RUNX2 regulates osteoblast differentiation
MAF;RUNX2 regulates osteoblast differentiation
COL1A1;RUNX2 regulates osteoblast differentiation
HDAC6;RUNX2 regulates osteoblast differentiation
SATB2;RUNX2 regulates osteoblast differentiation
UCMA;RUNX2 regulates osteoblast differentiation
GLI3;RUNX2 regulates osteoblast differentiation
GLI3;Hedgehog 'off' state
SUFU;GLI3 is processed to GLI3R by the proteasome
GLI3;GLI3 is processed to GLI3R by the proteasome
GPR161;Hedgehog 'off' state
TULP3;Hedgehog 'off' state
SMAD6;RUNX2 regulates bone development
IHH;RUNX2 regulates chondrocyte maturation
GLI2;RUNX2 regulates chondrocyte maturation
SUFU;Hedgehog 'on' state
SUFU;Hedgehog 'off' state
GLI2;Hedgehog 'off' state
GLI1;Hedgehog 'off' state
ULK3;Hedgehog 'on' state
HDAC4;RUNX2 regulates chondrocyte maturation
STUB1;Regulation of RUNX2 expression and activity
WWP1;Regulation of RUNX2 expression and activity
HIVEP3;Regulation of RUNX2 expression and activity
STAT1;Regulation of RUNX2 expression and activity
GSK3B;Regulation of RUNX2 expression and activity
SMURF1;Regulation of RUNX2 expression and activity
RUNX1;Regulation of RUNX1 Expression and Activity
CBFB;Regulation of RUNX1 Expression and Activity
ELF2;RUNX1 regulates transcription of genes involved in BCR signaling
PAX5;RUNX1 regulates transcription of genes involved in BCR signaling
BLK;RUNX1 regulates transcription of genes involved in BCR signaling
ELF1;RUNX1 regulates transcription of genes involved in interleukin signaling
LIFR;RUNX1 regulates transcription of genes involved in interleukin signaling
IL3;RUNX1 regulates transcription of genes involved in interleukin signaling
PTPN11;Regulation of RUNX1 Expression and Activity
SRC;Regulation of RUNX1 Expression and Activity
PML;Regulation of RUNX1 Expression and Activity
CDK6;Regulation of RUNX1 Expression and Activity
AXIN1;Estrogen-dependent gene expression
AXIN1;RUNX1 regulates estrogen receptor mediated transcription
AXIN1;RUNX1 regulates transcription of genes involved in WNT signaling
RSPO3;RUNX1 regulates transcription of genes involved in WNT signaling
CTSK;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
SERPINB13;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
SOCS3;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
SOCS4;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
HDAC1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
PRMT6;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
KAT2B;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
EP300;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
PRMT1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
MYL9;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
PRKCQ;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
NFE2;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
NR4A3;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
ITGA2B;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
GP1BA;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
YAP1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
KMT2A;RUNX1 regulates transcription of genes involved in differentiation of HSCs
ITCH;RUNX1 regulates transcription of genes involved in differentiation of HSCs
SPI1;Transcriptional regulation of granulopoiesis
SPI1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
MYB;RUNX1 regulates transcription of genes involved in differentiation of HSCs
KCTD6;Estrogen-dependent gene expression
KCTD6;RUNX1 regulates estrogen receptor mediated transcription
GPAM;Estrogen-dependent gene expression
GPAM;RUNX1 regulates estrogen receptor mediated transcription
FOXP3;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
NFATC2;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
IL2;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
CTLA4;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
TNFRSF18;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
IL2RA;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
CR1;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
IFNG;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
CREBBP;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
PRKCB;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
CSF2;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
LGALS3;RUNX2 regulates genes involved in differentiation of myeloid cells
LGALS3;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
EP300;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
ITCH;Activated NOTCH1 Transmits Signal to the Nucleus
DNER;Activated NOTCH1 Transmits Signal to the Nucleus
CNTN1;Activated NOTCH1 Transmits Signal to the Nucleus
DLK1;Activated NOTCH1 Transmits Signal to the Nucleus
NUMB;Activated NOTCH1 Transmits Signal to the Nucleus
RUNX1;Pre-NOTCH Transcription and Translation
SIRT6;Pre-NOTCH Transcription and Translation
NOTCH4;Negative regulation of NOTCH4 signaling
NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus
JAG1;NOTCH4 Activation and Transmission of Signal to the Nucleus
DLL4;NOTCH4 Activation and Transmission of Signal to the Nucleus
TACC3;Negative regulation of NOTCH4 signaling
NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
RBPJ;NOTCH4 Intracellular Domain Regulates Transcription
HEY1;NOTCH4 Intracellular Domain Regulates Transcription
SMAD3;NOTCH4 Intracellular Domain Regulates Transcription
FLT4;NOTCH4 Intracellular Domain Regulates Transcription
HES1;NOTCH4 Intracellular Domain Regulates Transcription
ACTA2;NOTCH4 Intracellular Domain Regulates Transcription
HEY2;NOTCH4 Intracellular Domain Regulates Transcription
HES5;NOTCH4 Intracellular Domain Regulates Transcription
WWP2;NOTCH3 Activation and Transmission of Signal to the Nucleus
YBX1;Noncanonical activation of NOTCH3
NOTCH3;Noncanonical activation of NOTCH3
TACC3;NOTCH3 Activation and Transmission of Signal to the Nucleus
DLGAP5;NOTCH3 Intracellular Domain Regulates Transcription
PLXND1;NOTCH3 Intracellular Domain Regulates Transcription
FABP7;NOTCH3 Intracellular Domain Regulates Transcription
HES5;NOTCH3 Intracellular Domain Regulates Transcription
PBX1;NOTCH3 Intracellular Domain Regulates Transcription
WWC1;NOTCH3 Intracellular Domain Regulates Transcription
HEY2;NOTCH3 Intracellular Domain Regulates Transcription
PTCRA;NOTCH3 Intracellular Domain Regulates Transcription
HES1;NOTCH3 Intracellular Domain Regulates Transcription
HEY1;NOTCH3 Intracellular Domain Regulates Transcription
HEYL;NOTCH3 Intracellular Domain Regulates Transcription
NBEA;NOTCH1 Intracellular Domain Regulates Transcription
HES5;NOTCH1 Intracellular Domain Regulates Transcription
HES1;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
HES1;RUNX3 regulates NOTCH signaling
HES1;NOTCH1 Intracellular Domain Regulates Transcription
HIF1A;NOTCH1 Intracellular Domain Regulates Transcription
CDC6;CDK-mediated phosphorylation and removal of Cdc6
MCM2;Switching of origins to a post-replicative state
MCM5;Switching of origins to a post-replicative state
MCM3;Switching of origins to a post-replicative state
ORC1;Orc1 removal from chromatin
CLCF1;IL-6-type cytokine receptor ligand interactions
CRLF1;IL-6-type cytokine receptor ligand interactions
LIFR;IL-6-type cytokine receptor ligand interactions
IL11;IL-6-type cytokine receptor ligand interactions
IL11RA;IL-6-type cytokine receptor ligand interactions
IL6ST;IL-6-type cytokine receptor ligand interactions
LIF;IL-6-type cytokine receptor ligand interactions
OSM;IL-6-type cytokine receptor ligand interactions
OSMR;IL-6-type cytokine receptor ligand interactions
IL6ST;Interleukin-27 signaling
IL6ST;Interleukin-6 signaling
CTF1;IL-6-type cytokine receptor ligand interactions
CNTFR;IL-6-type cytokine receptor ligand interactions
CNTF;IL-6-type cytokine receptor ligand interactions
IL6;Interleukin-6 signaling
IL6R;Interleukin-6 signaling
PTPN11;Interleukin-6 signaling
CBL;Interleukin-6 signaling
IL6R;Potential therapeutics for SARS
SOCS3;Interleukin-6 signaling
GAB1;MET activates PI3K/AKT signaling
GGA3;MET receptor recycling
MET;Negative regulation of MET activity
LRIG1;Negative regulation of MET activity
MET;Drug-mediated inhibition of MET activation
TNS3;MET interacts with TNS proteins
RAPGEF1;MET activates RAP1 and RAC1
PTK2;MET activates PTK2 signaling
SRC;MET activates PTK2 signaling
RANBP10;MET activates RAS signaling
MUC20;MET activates RAS signaling
PTPN11;MET activates PTPN11
NCAM1;NCAM signaling for neurite out-growth
NCAM1;NCAM1 interactions
CNTN2;NCAM1 interactions
AGRN;NCAM1 interactions
PRNP;NCAM1 interactions
NCAN;NCAM1 interactions
GDNF;NCAM1 interactions
IRS2;IRS-related events triggered by IGF1R
PIK3R1;FLT3 Signaling
PIK3R1;PI3K Cascade
GAB2;FLT3 Signaling
PDE3B;PDE3B signalling
PDPK1;Activation of AKT2,Activation of PKB
IL32;Other interleukin signaling
PRTN3;Other interleukin signaling
PTPRZ1;Other interleukin signaling
STX4;Other interleukin signaling
TXLNA;Other interleukin signaling
STX3;Other interleukin signaling
CSF3R;Other interleukin signaling
IL34;Other interleukin signaling
SDC1;Other interleukin signaling
CSF1;Other interleukin signaling
CSF1R;Other interleukin signaling
STX1A;Other interleukin signaling
JAK1;Interleukin-20 family signaling
IFNLR1;Interleukin-20 family signaling
TYK2;Interleukin-20 family signaling
IL10RB;Interleukin-20 family signaling
IFNL1;Interleukin-20 family signaling
IFNL1;Other interleukin signaling
IL16;Other interleukin signaling
CD4;Other interleukin signaling
AKT1S1;MTOR signalling
LAMTOR4;MTOR signalling
LAMTOR3;MTOR signalling
LAMTOR2;MTOR signalling
LAMTOR1;MTOR signalling
LAMTOR5;MTOR signalling
SLC38A9;MTOR signalling
YWHAB;MTOR signalling
EEF2K;mTORC1-mediated signalling
FKBP1A;Potential therapeutics for SARS
FKBP1A;mTORC1-mediated signalling
EIF4EBP1;mTORC1-mediated signalling
EIF4E;mTORC1-mediated signalling
RPS6;mTORC1-mediated signalling
EIF4G1;mTORC1-mediated signalling
RPS6KB1;mTORC1-mediated signalling
EIF4B;mTORC1-mediated signalling
TSC2;Inhibition of TSC complex formation by PKB
FN1;Fibronectin matrix formation
OLR1;Cell surface interactions at the vascular wall
CD84;Cell surface interactions at the vascular wall
F3;Extrinsic Pathway of Fibrin Clot Formation,Generation of extrinsic Factor X activating complex
F10;Extrinsic Pathway of Fibrin Clot Formation,Generation of extrinsic Factor X activating complex
F2;Common Pathway of Fibrin Clot Formation
F5;Common Pathway of Fibrin Clot Formation
F10;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
F9;Extrinsic Pathway of Fibrin Clot Formation,Generation of extrinsic Factor X activating complex
F8;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
KNG1;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
KLKB1;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
F12;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
F9;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
THBD;Common Pathway of Fibrin Clot Formation
PROCR;Common Pathway of Fibrin Clot Formation
PROC;Common Pathway of Fibrin Clot Formation
PROC;Cell surface interactions at the vascular wall
SELE;Cell surface interactions at the vascular wall
JAML;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
JAML;Cell surface interactions at the vascular wall
CXADR;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CXADR;Cell surface interactions at the vascular wall
MERTK;Cell surface interactions at the vascular wall
CD48;Cell surface interactions at the vascular wall
CD244;Cell surface interactions at the vascular wall
PLCG1;PECAM1 interactions
INPP5D;PECAM1 interactions
PECAM1;Platelet sensitization by LDL
PTPN11;Platelet sensitization by LDL
PTPN11;PECAM1 interactions
PTPN6;Platelet sensitization by LDL
PTPN6;PECAM1 interactions
TNFRSF10D;TRAIL  signaling
TNFRSF10D;Cell surface interactions at the vascular wall
PECAM1;Cell surface interactions at the vascular wall
CD177;Cell surface interactions at the vascular wall
GRB14;Tie2 Signaling
ANGPT2;Tie2 Signaling
SHC1;Tie2 Signaling
GRB7;Tie2 Signaling
DOK2;Tie2 Signaling
ANGPT4;Tie2 Signaling
PTPN11;Tie2 Signaling
PPIL2;Basigin interactions
MMP1;Degradation of the extracellular matrix
MMP1;Basigin interactions
BSG;Degradation of the extracellular matrix
SPN;Basigin interactions
CAV1;Basigin interactions
PPIA;Basigin interactions
EPCAM;Cell surface interactions at the vascular wall
CD58;Cell surface interactions at the vascular wall
CD2;Cell surface interactions at the vascular wall
CD47;Cell surface interactions at the vascular wall
TREM1;Cell surface interactions at the vascular wall
FCAMR;Cell surface interactions at the vascular wall
PICK1;Cell surface interactions at the vascular wall
TSPAN7;Cell surface interactions at the vascular wall
CD99;Cell surface interactions at the vascular wall
CD99L2;Cell surface interactions at the vascular wall
SELPLG;Cell surface interactions at the vascular wall
PTPN11;Signaling by SCF-KIT
GAB2;Signaling by SCF-KIT
JAK2;Signaling by SCF-KIT
PTPRU;Signaling by SCF-KIT
VAV1;Signaling by SCF-KIT
KIT;Regulation of KIT signaling
PRKCA;Regulation of KIT signaling
PTPN6;Regulation of KIT signaling
CBL;Regulation of KIT signaling
SH2B3;Regulation of KIT signaling
SOCS1;Regulation of KIT signaling
SOCS6;Regulation of KIT signaling
PTPN11;FRS-mediated FGFR1 signaling
ANOS1;FGFR1c ligand binding and activation
ANOS1;Negative regulation of FGFR1 signaling
CBL;Spry regulation of FGF signaling
BRAF;Spry regulation of FGF signaling
SPRY2;Spry regulation of FGF signaling
EPAS1;Transcriptional regulation of pluripotent stem cells
HIF3A;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
HIF1A;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
EPAS1;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
HIGD1A;Regulation of gene expression by Hypoxia-inducible Factor
ARNT;Regulation of gene expression by Hypoxia-inducible Factor
CREBBP;Regulation of gene expression by Hypoxia-inducible Factor
EP300;Regulation of gene expression by Hypoxia-inducible Factor
CA9;Regulation of gene expression by Hypoxia-inducible Factor
EPO;Regulation of gene expression by Hypoxia-inducible Factor
VEGFA;Regulation of gene expression by Hypoxia-inducible Factor
CDCA5;Resolution of Sister Chromatid Cohesion
NUDC;EML4 and NUDC in mitotic spindle formation
EML4;EML4 and NUDC in mitotic spindle formation
CC2D1B;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP4A;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP2A;Sealing of the nuclear envelope (NE) by ESCRT-III
IST1;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP6;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP3;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP4B;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP2B;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP4C;Sealing of the nuclear envelope (NE) by ESCRT-III
LEMD2;Sealing of the nuclear envelope (NE) by ESCRT-III
CHMP7;Sealing of the nuclear envelope (NE) by ESCRT-III
SPAST;Sealing of the nuclear envelope (NE) by ESCRT-III
VPS4A;Sealing of the nuclear envelope (NE) by ESCRT-III
ANKLE2;Initiation of Nuclear Envelope (NE) Reformation
LBR;Initiation of Nuclear Envelope (NE) Reformation
KPNB1;Initiation of Nuclear Envelope (NE) Reformation
UBE2I;SUMOylation of nuclear envelope proteins
UBE2I;Postmitotic nuclear pore complex (NPC) reformation
POM121;Postmitotic nuclear pore complex (NPC) reformation
AHCTF1;Postmitotic nuclear pore complex (NPC) reformation
NUP188;Postmitotic nuclear pore complex (NPC) reformation
NDC1;Postmitotic nuclear pore complex (NPC) reformation
FBXO5;Mitotic Metaphase/Anaphase Transition
ESPL1;Separation of Sister Chromatids
WAPL;Separation of Sister Chromatids
RAD21;Separation of Sister Chromatids
CDCA5;Separation of Sister Chromatids
PLK1;Golgi Cisternae Pericentriolar Stack Reorganization
MASTL;MASTL Facilitates Mitotic Progression
ENSA;MASTL Facilitates Mitotic Progression
ARPP19;MASTL Facilitates Mitotic Progression
SET;Condensation of Prophase Chromosomes
MCPH1;Condensation of Prophase Chromosomes
RB1;Condensation of Prophase Chromosomes
PLK1;Condensation of Prophase Chromosomes
FBXL7;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
AURKA;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
RBX1;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
CUL1;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
SKP1;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
AURKA;Interaction between PHLDA1 and AURKA
PHLDA1;Interaction between PHLDA1 and AURKA
OPTN;Regulation of PLK1 Activity at G2/M Transition
HMMR;AURKA Activation by TPX2
TPX2;AURKA Activation by TPX2
CDKN1A;The role of GTSE1 in G2/M progression after G2 checkpoint
FKBPL;The role of GTSE1 in G2/M progression after G2 checkpoint
CENPF;Polo-like kinase mediated events
CCNB1;Polo-like kinase mediated events
CEP250;Loss of proteins required for interphase microtubule organization from the centrosome
NINL;Loss of Nlp from mitotic centrosomes
PLK1;Recruitment of mitotic centrosome proteins and complexes
KIF23;Mitotic Telophase/Cytokinesis,cell division
KIF20A;Mitotic Telophase/Cytokinesis,cell division
BRD7;Regulation of TP53 Activity through Acetylation
EP300;Regulation of TP53 Activity through Acetylation
PML;Regulation of TP53 Activity through Acetylation
ING2;PI5P Regulates TP53 Acetylation
EP300;PI5P Regulates TP53 Acetylation
PIP4P1;Synthesis of PIPs in the nucleus
PIP4P1;PI5P Regulates TP53 Acetylation
PIN1;PI5P Regulates TP53 Acetylation
NPTN;GABA receptor activation
STX1A;Norepinephrine Neurotransmitter Release Cycle
SNAP25;Norepinephrine Neurotransmitter Release Cycle
CPLX1;Norepinephrine Neurotransmitter Release Cycle
RAB3A;Norepinephrine Neurotransmitter Release Cycle
SLC18A2;Norepinephrine Neurotransmitter Release Cycle
SYT1;Norepinephrine Neurotransmitter Release Cycle
STX1A;Dopamine Neurotransmitter Release Cycle
SNAP25;Dopamine Neurotransmitter Release Cycle
CPLX1;Dopamine Neurotransmitter Release Cycle
RAB3A;Dopamine Neurotransmitter Release Cycle
SLC18A2;Dopamine Neurotransmitter Release Cycle
SYT1;Dopamine Neurotransmitter Release Cycle
CASK;Dopamine Neurotransmitter Release Cycle
APBA1;Dopamine Neurotransmitter Release Cycle
STX1A;Acetylcholine Neurotransmitter Release Cycle
SNAP25;Acetylcholine Neurotransmitter Release Cycle
CPLX1;Acetylcholine Neurotransmitter Release Cycle
RAB3A;Acetylcholine Neurotransmitter Release Cycle
SLC18A3;Acetylcholine Neurotransmitter Release Cycle
SYT1;Acetylcholine Neurotransmitter Release Cycle
NBEA;Neurotransmitter receptors and postsynaptic signal transmission
RALGDS;p38MAPK events
FYN;VEGFA-VEGFR2 Pathway
CHD4;NGF-stimulated transcription
NAB2;NGF-stimulated transcription
EGR1;NGF-stimulated transcription
SRF;NGF-stimulated transcription
ADGRG6;EGR2 and SOX10-mediated initiation of Schwann cell myelination
DRP2;EGR2 and SOX10-mediated initiation of Schwann cell myelination
PRX;EGR2 and SOX10-mediated initiation of Schwann cell myelination
EGR2;EGR2 and SOX10-mediated initiation of Schwann cell myelination
SOX10;EGR2 and SOX10-mediated initiation of Schwann cell myelination
HDAC2;EGR2 and SOX10-mediated initiation of Schwann cell myelination
SMARCA4;EGR2 and SOX10-mediated initiation of Schwann cell myelination
SCD5;EGR2 and SOX10-mediated initiation of Schwann cell myelination
UTRN;EGR2 and SOX10-mediated initiation of Schwann cell myelination
CYP51A1;EGR2 and SOX10-mediated initiation of Schwann cell myelination
MPZ;EGR2 and SOX10-mediated initiation of Schwann cell myelination
POU3F2;EGR2 and SOX10-mediated initiation of Schwann cell myelination
POU3F1;EGR2 and SOX10-mediated initiation of Schwann cell myelination
PMP22;EGR2 and SOX10-mediated initiation of Schwann cell myelination
MBP;EGR2 and SOX10-mediated initiation of Schwann cell myelination
MAG;EGR2 and SOX10-mediated initiation of Schwann cell myelination
HMGCR;EGR2 and SOX10-mediated initiation of Schwann cell myelination
ARC;NGF-stimulated transcription
MEF2D;NGF-stimulated transcription
EP300;NGF-stimulated transcription
LYL1;NGF-stimulated transcription
TRIB1;NGF-stimulated transcription
F3;NGF-stimulated transcription
VGF;NGF-stimulated transcription
ASCL1;NGF-stimulated transcription
TCF12;NGF-stimulated transcription
CDK5;NGF-stimulated transcription
CDK5R1;NGF-stimulated transcription
EGR2;NGF-stimulated transcription
TPH1;NGF-stimulated transcription
DNM2;NGF-stimulated transcription
SH3GL3;NGF-stimulated transcription
REST;NGF-stimulated transcription
RRAD;NGF-stimulated transcription
ELK1;NGF-stimulated transcription
RHOA;G beta:gamma signalling through PI3Kgamma
RHOA;PI3K/AKT activation
PTK2;Extra-nuclear estrogen signaling
SRC;Extra-nuclear estrogen signaling
STRN;Extra-nuclear estrogen signaling
FOXO3;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CDKN1B;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
SRF;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
FOS;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
BCL2;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
PRKCZ;GPVI-mediated activation cascade
PRKCZ;Estrogen-stimulated signaling through PRKCZ
ARID3A;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
E2F8;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
E2F7;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
E2F1;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
SFN;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
CARM1;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
EP300;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
PRMT1;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
GADD45A;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
BAX;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
AURKA;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
EIF4B;Deadenylation of mRNA
EIF4G1;Deadenylation of mRNA
EIF4E;Deadenylation of mRNA
PAIP1;Deadenylation of mRNA
PABPC1;Deadenylation of mRNA
CDC40;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF1;Transport of Mature mRNA derived from an Intron-Containing Transcript
SARNP;Transport of Mature mRNA derived from an Intron-Containing Transcript
DHX38;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF5;Transport of Mature mRNA derived from an Intron-Containing Transcript
CHTOP;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF7;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF6;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF11;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF4;Transport of Mature mRNA derived from an Intron-Containing Transcript
U2AF2;Transport of Mature mRNA derived from an Intron-Containing Transcript
SLU7;Transport of Mature mRNA derived from an Intron-Containing Transcript
ZC3H11A;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF9;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF3;Transport of Mature mRNA derived from an Intron-Containing Transcript
SRSF2;Transport of Mature mRNA derived from an Intron-Containing Transcript
PAPOLA;mRNA 3'-end processing
PABPN1;mRNA 3'-end processing
SARNP;mRNA 3'-end processing
CHTOP;mRNA 3'-end processing
ZC3H11A;mRNA 3'-end processing
POLDIP3;mRNA 3'-end processing
DHX15;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
GCFC2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
TFIP11;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CWF19L2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
C9orf78;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CACTIN;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
LENG1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CWC22;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPIL3;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SRRM2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SLU7;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
STEEP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
FAM50A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DHX8;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
FAM32A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SDE2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CCDC12;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPIG;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SRRT;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRKRIP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPWD1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DDX5;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DDX41;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
NKAP;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPIL2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRPF18;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPIL4;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DDX39B;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
MTREX;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
GPATCH1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
NSRP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
YJU2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
WDR70;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CWC25;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DHX38;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DHX35;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
A1CF;Formation of the Editosome
TUT7;Zygotic genome activation (ZGA)
TUT4;Zygotic genome activation (ZGA)
RABGGTB;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
RABGGTA;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
CHM;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
BIRC5;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
TP53I3;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
NDRG1;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
PERP;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
BCL2L14;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
BCL6;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
UNC5B;Caspase activation via Dependence Receptors in the absence of ligand,Ligand-independent caspase activation via DCC
UNC5A;Caspase activation via Dependence Receptors in the absence of ligand,Ligand-independent caspase activation via DCC
MAGED1;Caspase activation via Dependence Receptors in the absence of ligand,Ligand-independent caspase activation via DCC
MIB2;Regulation of TNFR1 signaling
CYLD;Regulation of TNFR1 signaling
UBE2D1;Regulation of TNFR1 signaling
CASP8;Regulation by c-FLIP
CASP8;Regulation of TNFR1 signaling
OPTN;Regulation of TNFR1 signaling
UBE2L3;Regulation of TNFR1 signaling
SPATA2;Regulation of TNFR1 signaling
RACK1;Regulation of TNFR1 signaling
OTULIN;Regulation of TNFR1 signaling
TRAF1;Regulation of TNFR1 signaling
UBE2D3;Regulation of TNFR1 signaling
TRADD;Regulation of TNFR1 signaling
TRAF2;Regulation of TNFR1 signaling
CLIP3;Regulation of TNFR1 signaling
TNF;Regulation of TNFR1 signaling
RACK1;TNFR1-mediated ceramide production
NSMAF;TNFR1-mediated ceramide production
CASP10;FasL/ CD95L signaling
CASP10;TRAIL  signaling
NGFR;Axonal growth stimulation
LINGO1;Axonal growth inhibition (RHOA activation)
NGFR;Axonal growth inhibition (RHOA activation)
BEX3;NADE modulates death signalling
ITGB3BP;NRIF signals cell death from the nucleus
MAPK8;NRAGE signals death through JNK
BCL2L11;NRAGE signals death through JNK
BAD;NRAGE signals death through JNK
MAGED1;NRAGE signals death through JNK
AATF;NRAGE signals death through JNK
SQSTM1;NRIF signals cell death from the nucleus
MAPK8;NRIF signals cell death from the nucleus
RIPK2;p75NTR recruits signalling complexes
PRKCI;p75NTR recruits signalling complexes
NGFR;Regulated proteolysis of p75NTR
TRAF6;Regulated proteolysis of p75NTR
SH3GL2;Retrograde neurotrophin signalling
SMPD2;Ceramide signalling
PRDM4;p75NTR negatively regulates cell cycle via SC1
ADCYAP1;NGF-independant TRKA activation
ADCYAP1R1;NGF-independant TRKA activation
ADORA2A;NGF-independant TRKA activation
STAT3;Signalling to STAT3
MAP3K7;Activation of NF-kappaB in B cells
MALT1;Activation of NF-kappaB in B cells
BCL10;Activation of NF-kappaB in B cells
PRKCB;Activation of NF-kappaB in B cells
FKBP1A;Calcineurin activates NFAT
DAPP1;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
CD22;CD22 mediated BCR regulation
PTPN6;CD22 mediated BCR regulation
PTPN11;CTLA4 inhibitory signaling
MAP3K14;CD28 dependent PI3K/Akt signaling
MAP3K8;CD28 dependent PI3K/Akt signaling
GRAP2;CD28 co-stimulation
BTLA;Costimulation by the CD28 family
TNFRSF14;Costimulation by the CD28 family
ICOSLG;Costimulation by the CD28 family
PDCD1;PD-1 signaling
PDCD1;Potential therapeutics for SARS
STAT1;Interleukin-9 signaling
STAT3;Interleukin-9 signaling
IL9;Interleukin-9 signaling
JAK1;Interleukin-9 signaling
IL9R;Interleukin-9 signaling
JAK3;Potential therapeutics for SARS
STAT3;Interleukin-15 signaling
IL15;Interleukin-15 signaling
IL15RA;Interleukin-15 signaling
SHC1;Interleukin-15 signaling
GAB2;Interleukin-15 signaling
GRB2;Interleukin-15 signaling
HAVCR2;Interleukin-2 family signaling
LGALS9;Interleukin-2 family signaling
EPO;Signaling by Erythropoietin
IL7;Interleukin-7 signaling
IL7R;Interleukin-7 signaling
JAK1;Interleukin-7 signaling
SYK;Interleukin-2 signaling
PTK2B;Interleukin-2 signaling
IL21;Interleukin-21 signaling
MAP2K4;FCERI mediated MAPK activation
CDC25C;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
PLK3;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
PLK2;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
CENPJ;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
BTG2;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
RGCC;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
NPM1;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
PLAGL1;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
TRIAP1;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
ZNF420;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
STEAP3;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
BNIP3L;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
CREBBP;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
AIFM2;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
TP53AIP1;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
CAND1;Iron uptake and transport
CUL1;Iron uptake and transport
TF;Transferrin endocytosis and recycling
TF;Iron uptake and transport
HFE;Transferrin endocytosis and recycling
TFR2;Transferrin endocytosis and recycling
ACO1;Iron uptake and transport
FBXL5;Iron uptake and transport
SKP1;Iron uptake and transport
IREB2;Iron uptake and transport
NEDD8;Iron uptake and transport
MAFK;Regulation of BACH1 activity
MAFK;Heme signaling
BACH1;Regulation of BACH1 activity
BACH1;Heme signaling
FBXL17;Regulation of BACH1 activity
SLC22A17;Iron uptake and transport
PHF20;Regulation of TP53 Activity through Association with Co-factors
POU4F1;Regulation of TP53 Activity through Association with Co-factors
PPP1R13L;Regulation of TP53 Activity through Association with Co-factors
POU4F2;Regulation of TP53 Activity through Association with Co-factors
BANP;Regulation of TP53 Activity through Association with Co-factors
CCNK;TP53 Regulates Transcription of DNA Repair Genes
CDK13;TP53 Regulates Transcription of DNA Repair Genes
CDK12;TP53 Regulates Transcription of DNA Repair Genes
PMS2;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
MLH1;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
PMS2;TP53 Regulates Transcription of DNA Repair Genes
MLH1;TP53 Regulates Transcription of DNA Repair Genes
MSH6;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
MSH2;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
MSH2;TP53 Regulates Transcription of DNA Repair Genes
EXO1;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
EXO1;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
MSH3;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
MSH2;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
CETN2;DNA Damage Recognition in GG-NER
XPC;DNA Damage Recognition in GG-NER
XPA;Formation of Incision Complex in GG-NER
CHD1L;Formation of Incision Complex in GG-NER
UBE2I;Formation of Incision Complex in GG-NER
ERCC5;Formation of Incision Complex in GG-NER
ERCC1;Formation of Incision Complex in GG-NER
ERCC4;Formation of Incision Complex in GG-NER
XPA;Dual Incision in GG-NER
ERCC5;Dual Incision in GG-NER
CHD1L;Dual Incision in GG-NER
ERCC6;Formation of TC-NER Pre-Incision Complex
HMGN1;Formation of TC-NER Pre-Incision Complex
XPA;Formation of TC-NER Pre-Incision Complex
EP300;Formation of TC-NER Pre-Incision Complex
TCEA1;Formation of TC-NER Pre-Incision Complex
XPA;Dual incision in TC-NER
ERCC5;Dual incision in TC-NER
HMGN1;Transcription-Coupled Nucleotide Excision Repair (TC-NER)
EP300;Transcription-Coupled Nucleotide Excision Repair (TC-NER)
TCEA1;Transcription-Coupled Nucleotide Excision Repair (TC-NER)
FANCI;Fanconi Anemia Pathway
FANCD2;Fanconi Anemia Pathway
UBE2T;Fanconi Anemia Pathway
FAAP100;Fanconi Anemia Pathway
FANCB;Fanconi Anemia Pathway
FAAP20;Fanconi Anemia Pathway
FANCC;Fanconi Anemia Pathway
FANCG;Fanconi Anemia Pathway
FANCF;Fanconi Anemia Pathway
FANCL;Fanconi Anemia Pathway
FANCA;Fanconi Anemia Pathway
FANCE;Fanconi Anemia Pathway
FAAP24;Fanconi Anemia Pathway
FANCM;Fanconi Anemia Pathway
FANCC;TP53 Regulates Transcription of DNA Repair Genes
FAN1;Fanconi Anemia Pathway
POLN;Fanconi Anemia Pathway
DDB2;TP53 Regulates Transcription of DNA Repair Genes
TXN;TP53 Regulates Metabolic Genes
TXN;Interconversion of nucleotide di- and triphosphates
TXN;Detoxification of Reactive Oxygen Species
NFE2L2;KEAP1-NFE2L2 pathway
NFE2L2;Regulation of NFE2L2 gene expression
NOTCH1;Regulation of NFE2L2 gene expression
MYC;Regulation of NFE2L2 gene expression
SRXN1;NFE2L2 regulating anti-oxidant/detoxification enzymes
GLRX;Interconversion of nucleotide di- and triphosphates
DDIT4;TP53 Regulates Metabolic Genes
TXN2;Detoxification of Reactive Oxygen Species
ATOX1;Detoxification of Reactive Oxygen Species
SOD3;Detoxification of Reactive Oxygen Species
P4HB;Detoxification of Reactive Oxygen Species
PDIA3;Calnexin/calreticulin cycle
MLEC;N-glycan trimming in the ER and Calnexin/Calreticulin cycle
SAR1B;COPII-mediated vesicle transport
SEC23A;COPII-mediated vesicle transport
GOSR2;COPII-mediated vesicle transport
BET1;COPII-mediated vesicle transport
SCFD1;COPII-mediated vesicle transport
GRIA1;Cargo concentration in the ER
CNIH1;Cargo concentration in the ER
SEC23A;Cargo concentration in the ER
SEC22B;Cargo concentration in the ER
PREB;Cargo concentration in the ER
SEC24C;Cargo concentration in the ER
MIA2;Cargo concentration in the ER
MIA3;Cargo concentration in the ER
TBC1D20;COPII-mediated vesicle transport
GBF1;COPI-mediated anterograde transport
YKT6;COPI-mediated anterograde transport
TMEM115;COPI-mediated anterograde transport
GOSR1;COPI-mediated anterograde transport
GOSR2;COPI-mediated anterograde transport
STX5;COPI-mediated anterograde transport
BET1;COPI-mediated anterograde transport
BET1L;COPI-mediated anterograde transport
LHB;Glycoprotein hormones
CGA;Glycoprotein hormones
PSAP;Glycosphingolipid catabolism
GM2A;Glycosphingolipid catabolism
SUMF2;The activation of arylsulfatases
SUMF2;Glycosphingolipid catabolism
SUMF1;The activation of arylsulfatases
SUMF1;Glycosphingolipid catabolism
SPHK2;Sphingolipid de novo biosynthesis
PTGER3;Prostanoid ligand receptors
PTGDR2;Prostanoid ligand receptors
PTGDR;Prostanoid ligand receptors
PTGFR;Prostanoid ligand receptors
PTGER1;Prostanoid ligand receptors
CYSLTR2;Leukotriene receptors
CYSLTR1;Leukotriene receptors
CYSLTR1;Potential therapeutics for SARS
GPR17;Leukotriene receptors
OXER1;Eicosanoid ligand-binding receptors
HRH3;Histamine receptors
GPR143;Amine ligand-binding receptors
DRD2;Dopamine receptors
HTR1A;Serotonin receptors
ADRB3;Adrenoceptors
ADRB2;Adrenoceptors
CHRM2;Muscarinic acetylcholine receptors
CHRM4;Muscarinic acetylcholine receptors
CMKLR1;Class A/1 (Rhodopsin-like receptors)
PTAFR;Class A/1 (Rhodopsin-like receptors)
GPR35;Class A/1 (Rhodopsin-like receptors)
EDNRA;Peptide ligand-binding receptors
TAC1;Tachykinin receptors bind tachykinins
TACR2;Tachykinin receptors bind tachykinins
TACR1;Tachykinin receptors bind tachykinins
TACR3;Tachykinin receptors bind tachykinins
TAC3;Tachykinin receptors bind tachykinins
EDN1;Peptide ligand-binding receptors
ACKR4;Chemokine receptors bind chemokines
ACKR2;Chemokine receptors bind chemokines
XCR1;Chemokine receptors bind chemokines
CCRL2;Chemokine receptors bind chemokines
CCL19;Chemokine receptors bind chemokines
CCK;Peptide ligand-binding receptors
MC2R;Peptide ligand-binding receptors
POMC;Peptide ligand-binding receptors
NTS;Peptide ligand-binding receptors
OXT;Vasopressin-like receptors
OXTR;Vasopressin-like receptors
EDN3;Peptide ligand-binding receptors
QRFPR;Orexin and neuropeptides FF and QRFP bind to their respective receptors
QRFP;Orexin and neuropeptides FF and QRFP bind to their respective receptors
HCRTR2;Orexin and neuropeptides FF and QRFP bind to their respective receptors
HCRT;Orexin and neuropeptides FF and QRFP bind to their respective receptors
NPFF;Orexin and neuropeptides FF and QRFP bind to their respective receptors
HCRTR1;Orexin and neuropeptides FF and QRFP bind to their respective receptors
GAL;Peptide ligand-binding receptors
CXCL8;Peptide ligand-binding receptors
ACKR1;Peptide ligand-binding receptors
KISS1R;Peptide ligand-binding receptors
KISS1;Peptide ligand-binding receptors
PRLHR;Peptide ligand-binding receptors
GPR17;P2Y receptors
P2RY11;P2Y receptors
S1PR1;Potential therapeutics for SARS
S1PR1;Lysosphingolipid and LPA receptors
GNRHR2;Hormone ligand-binding receptors
PDE3A;G alpha (s) signalling events
PDPK1;G beta:gamma signalling through PI3Kgamma
BTK;G beta:gamma signalling through BTK
ARHGEF6;G beta:gamma signalling through CDC42
PAK1;G beta:gamma signalling through CDC42
CDC42;G beta:gamma signalling through CDC42
PDE4A;G alpha (s) signalling events
PDCL;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
SRC;G alpha (s) signalling events
SRC;G alpha (i) signalling events
PPP1CA;DARPP-32 events
PRKACA;DARPP-32 events
OPRM1;Opioid Signalling
GRK2;G alpha (q) signalling events
BTK;G alpha (q) signalling events
GRK5;G alpha (q) signalling events
GRB10;Signal attenuation
SHC1;Signal attenuation
ODC1;Regulation of ornithine decarboxylase (ODC)
NQO1;Regulation of ornithine decarboxylase (ODC)
AZIN1;Regulation of ornithine decarboxylase (ODC)
SQOR;Sulfide oxidation to sulfate
MPST;Degradation of cysteine and homocysteine
TXN2;Degradation of cysteine and homocysteine
SECISBP2;Selenocysteine synthesis
NDUFAB1;Glyoxylate metabolism and glycine degradation
GCSH;Glyoxylate metabolism and glycine degradation
GCSH;Glycine degradation
NDUFAF2;Complex I biogenesis
NDUFS4;Complex I biogenesis
NDUFA12;Complex I biogenesis
NDUFV3;Complex I biogenesis
NDUFS6;Complex I biogenesis
NUBPL;Complex I biogenesis
NDUFV1;Complex I biogenesis
NDUFV2;Complex I biogenesis
NDUFS3;Complex I biogenesis
TIMMDC1;Complex I biogenesis
NDUFAF4;Complex I biogenesis
NDUFAF3;Complex I biogenesis
MT-ND6;Complex I biogenesis
NDUFB6;Complex I biogenesis
NDUFAF6;Complex I biogenesis
MT-ND1;Complex I biogenesis
NDUFAF5;Complex I biogenesis
NDUFS5;Complex I biogenesis
MT-ND5;Complex I biogenesis
MT-ND4;Complex I biogenesis
NDUFAF7;Complex I biogenesis
ACBD6;Mitochondrial Fatty Acid Beta-Oxidation
NDUFAB1;Mitochondrial Fatty Acid Beta-Oxidation
RRM2B;TP53 Regulates Metabolic Genes
PSMB8;Interferon alpha/beta signaling
IFITM3;Interferon alpha/beta signaling
IP6K2;Interferon alpha/beta signaling
RNASEL;Interferon alpha/beta signaling
IFITM2;Interferon alpha/beta signaling
XAF1;Interferon alpha/beta signaling
IFI6;Interferon alpha/beta signaling
BST2;Interferon alpha/beta signaling
RSAD2;Interferon alpha/beta signaling
SAMHD1;Interferon alpha/beta signaling
EGR1;Interferon alpha/beta signaling
IFITM1;Interferon alpha/beta signaling
ISG15;Interferon alpha/beta signaling
IFI35;Interferon alpha/beta signaling
IFIT5;Interferon alpha/beta signaling
IFIT3;Interferon alpha/beta signaling
IFI27;Interferon alpha/beta signaling
ADAR;Interferon alpha/beta signaling
IFIT1;Interferon alpha/beta signaling
IFIT2;Interferon alpha/beta signaling
GBP2;Interferon alpha/beta signaling
ISG20;Interferon alpha/beta signaling
EIF2AK2;Interferon alpha/beta signaling
KPNB1;Interferon alpha/beta signaling
KPNA1;Interferon alpha/beta signaling
IRF9;Interferon alpha/beta signaling
BTK;G alpha (12/13) signalling events
PLXNB1;G alpha (12/13) signalling events
HPSE2;HS-GAG degradation
HYAL2;Hyaluronan uptake and degradation
UMOD;Asparagine N-linked glycosylation
CUBN;Vitamin D (calciferol) metabolism
GC;Vitamin D (calciferol) metabolism
VDR;Vitamin D (calciferol) metabolism
VDR;SUMOylation of intracellular receptors
UBE2I;SUMOylation of intracellular receptors
UBE2I;Vitamin D (calciferol) metabolism
SUMO2;SUMO is conjugated to E1 (UBA2:SAE1)
SUMO2;SUMO is proteolytically processed
PPP1R3C;Glycogen synthesis
EPM2A;Glycogen synthesis
GCK;Regulation of Glucokinase by Glucokinase Regulatory Protein
GCKR;Regulation of Glucokinase by Glucokinase Regulatory Protein
LALBA;Lactose synthesis
B4GALT1;Lactose synthesis
RHCE;Rhesus blood group biosynthesis
RHD;Rhesus blood group biosynthesis
SCO2;TP53 Regulates Metabolic Genes
MAP3K14;NIK-->noncanonical NF-kB signaling
MAP3K14;Dectin-1 mediated noncanonical NF-kB signaling
MAP3K14;TNFR2 non-canonical NF-kB pathway,TNFRSF mediated non-canonical NF-kB pathway
TNFRSF1B;TNFR2 non-canonical NF-kB pathway,TNFRSF mediated non-canonical NF-kB pathway
PYCARD;CLEC7A/inflammasome pathway
MALT1;CLEC7A/inflammasome pathway
IL1B;CLEC7A/inflammasome pathway
CD209;CD209 (DC-SIGN) signaling
RAF1;CD209 (DC-SIGN) signaling
RELB;CD209 (DC-SIGN) signaling
RELA;CD209 (DC-SIGN) signaling
ICAM2;CD209 (DC-SIGN) signaling
ICAM3;CD209 (DC-SIGN) signaling
CLEC4A;Dectin-2 family
CLEC10A;Dectin-2 family
SYK;Dectin-2 family
PLCG2;Dectin-2 family
MRE11;Cytosolic sensors of pathogen-associated DNA 
DTX4;Regulation of innate immune responses to cytosolic DNA
NLRP4;Regulation of innate immune responses to cytosolic DNA
IRF3;IRF3 mediated activation of type 1 IFN
TBK1;IRF3 mediated activation of type 1 IFN
TBK1;IRF3-mediated induction of type I IFN
IRF3;IRF3-mediated induction of type I IFN
CGAS;STING mediated induction of host immune responses
STING1;STING mediated induction of host immune responses
STING1;Regulation of innate immune responses to cytosolic DNA
STING1;SARS-CoV-1 activates/modulates innate immune responses
DDX41;STING mediated induction of host immune responses
IFI16;STING mediated induction of host immune responses
TRIM21;Regulation of innate immune responses to cytosolic DNA
DDX41;Regulation of innate immune responses to cytosolic DNA
CTNNB1;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
STAT6;STAT6-mediated induction of chemokines
TBK1;STAT6-mediated induction of chemokines
MYD88;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
DHX9;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
DHX36;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
PRKDC;Cytosolic sensors of pathogen-associated DNA 
RASA1;VEGFR2 mediated cell proliferation
SPHK1;VEGFR2 mediated cell proliferation
HSPB1;VEGFA-VEGFR2 Pathway
SHC2;VEGFA-VEGFR2 Pathway
NRP1;Neurophilin interactions with VEGF and VEGFR
KDR;Neurophilin interactions with VEGF and VEGFR
FLT1;Neurophilin interactions with VEGF and VEGFR
NRP2;Neurophilin interactions with VEGF and VEGFR
FLT1;VEGF binds to VEGFR leading to receptor dimerization
FLT4;VEGF binds to VEGFR leading to receptor dimerization
EIF2AK2;Inhibition of PKR
SNCA;PKR-mediated signaling
TARBP2;PKR-mediated signaling
ILF2;PKR-mediated signaling
ILF3;PKR-mediated signaling
CDK1;PKR-mediated signaling
NPM1;PKR-mediated signaling
SPHK1;PKR-mediated signaling
UBE2L6;PKR-mediated signaling
NCK1;PKR-mediated signaling
STAT3;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
DNAJC3;PKR-mediated signaling
DHX9;PKR-mediated signaling
UBE2I;SUMOylation of immune response proteins
UBE2I;PKR-mediated signaling
EIF2AK2;SUMOylation of immune response proteins
DUS2;PKR-mediated signaling
CBX1;HCMV Early Events
MAP2K6;PKR-mediated signaling
PTPN2;PKR-mediated signaling
EIF4E2;ISG15 antiviral mechanism
NEDD4;ISG15 antiviral mechanism
FLNB;ISG15 antiviral mechanism
PPM1B;ISG15 antiviral mechanism
EIF4H;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
EIF4B;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
EIF4G1;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
EIF4E;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
EIF4EBP1;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
NXF1;Transport of the SLBP independent Mature mRNA
ALYREF;Transport of the SLBP independent Mature mRNA
EIF4E;Transport of the SLBP independent Mature mRNA
SUPT5H;mRNA Capping
RNMT;mRNA Capping
RNMT;RNA Pol II CTD phosphorylation and interaction with CE
SUPT5H;RNA Pol II CTD phosphorylation and interaction with CE
RNGTT;mRNA Capping
RNGTT;RNA Pol II CTD phosphorylation and interaction with CE
GTF2B;RNA Polymerase II Promoter Escape
GTF2B;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
NCBP1;mRNA Capping
NCBP2;mRNA Capping
NXF1;Transport of the SLBP Dependant Mature mRNA
ALYREF;Transport of the SLBP Dependant Mature mRNA
EIF4E;Transport of the SLBP Dependant Mature mRNA
NCBP1;Transport of the SLBP Dependant Mature mRNA
NCBP2;Transport of the SLBP Dependant Mature mRNA
SLBP;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
NXF1;Transport of Mature mRNA Derived from an Intronless Transcript
ALYREF;Transport of Mature mRNA Derived from an Intronless Transcript
EIF4E;Transport of Mature mRNA Derived from an Intronless Transcript
PAPOLA;Processing of Intronless Pre-mRNAs
PABPN1;Processing of Intronless Pre-mRNAs
EIF1AX;Translation initiation complex formation
EIF1AX;Ribosomal scanning and start codon recognition
EIF5;Ribosomal scanning and start codon recognition
EIF4G1;Translation initiation complex formation
PABPC1;Translation initiation complex formation
EIF4H;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF4B;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF1AX;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF4G1;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF5;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF4E;GTP hydrolysis and joining of the 60S ribosomal subunit
EIF1AX;Formation of a pool of free 40S subunits
EIF1AX;Formation of the ternary complex, and subsequently, the 43S complex
RPL13A;L13a-mediated translational silencing of Ceruloplasmin expression
NFKBIA;SUMOylation of immune response proteins
NFKB2;SUMOylation of immune response proteins
IKBKE;SUMOylation of immune response proteins
SUMO3;SUMO is conjugated to E1 (UBA2:SAE1)
SUMO3;SUMO is proteolytically processed
IKBKG;SUMOylation of immune response proteins
USP18;Regulation of IFNA/IFNB signaling
ABCE1;Interferon alpha/beta signaling
MAP2K4;Oxidative Stress Induced Senescence
CXCL8;Senescence-Associated Secretory Phenotype (SASP)
IL1A;Senescence-Associated Secretory Phenotype (SASP)
IL6;Transcriptional Regulation by VENTX
IL6;Senescence-Associated Secretory Phenotype (SASP)
IGFBP7;Senescence-Associated Secretory Phenotype (SASP)
TP53;Transcriptional Regulation by VENTX
CSF1R;Transcriptional Regulation by VENTX
CASP1;TP53 Regulates Transcription of Caspase Activators and Caspases
CASP6;TP53 Regulates Transcription of Caspase Activators and Caspases
PIDD1;TP53 Regulates Transcription of Caspase Activators and Caspases
CASP2;TP53 Regulates Transcription of Caspase Activators and Caspases
CRADD;TP53 Regulates Transcription of Caspase Activators and Caspases
IGFBP3;TP53 Regulates Transcription of Death Receptors and Ligands
TMEM219;TP53 Regulates Transcription of Death Receptors and Ligands
FAS;TP53 Regulates Transcription of Death Receptors and Ligands
IGFBP2;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFBP4;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFBP3;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFALS;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFBP5;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFBP1;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
IGFBP6;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of IGF Activity by IGFBP
PIN1;RHO GTPases Activate NADPH Oxidases
SEC13;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
SEC31A;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
SEC23A;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
TAPBP;ER-Phagosome pathway
CALR;ER-Phagosome pathway
SEC22B;ER-Phagosome pathway
STX4;ER-Phagosome pathway
SNAP23;ER-Phagosome pathway
L3MBTL1;Regulation of TP53 Activity through Methylation
JMY;Regulation of TP53 Activity through Methylation
EP300;Regulation of TP53 Activity through Methylation
TTC5;Regulation of TP53 Activity through Methylation
PRMT5;Regulation of TP53 Activity through Methylation
REG3A;Antimicrobial peptides
LYZ;Antimicrobial peptides
LTF;Metal sequestration by antimicrobial proteins
ATOX1;Ion influx/efflux at host-pathogen interface
DCD;Antimicrobial peptides
DEFA5;Alpha-defensins
CD4;Alpha-defensins
DEFA1;Alpha-defensins
DEFB103A;Beta defensins
CCR6;Beta defensins
CCR2;Beta defensins
BPI;Antimicrobial peptides
CAMP;Antimicrobial peptides
LEAP2;Antimicrobial peptides
GNLY;Antimicrobial peptides
TLR9;Toll Like Receptor 9 (TLR9) Cascade
TRAF3;TICAM1-dependent activation of IRF3/IRF7,TLR3-mediated TICAM1-dependent activation of IRF3/IRF7,TLR3-mediated TRIF-dependent activation of IRF3/IRF7,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
TANK;TICAM1-dependent activation of IRF3/IRF7,TLR3-mediated TICAM1-dependent activation of IRF3/IRF7,TLR3-mediated TRIF-dependent activation of IRF3/IRF7,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
RIPK3;TLR3-mediated TICAM1-dependent programmed cell death
KIR2DS5;DAP12 interactions
TICAM2;Toll Like Receptor 4 (TLR4) Cascade
AGER;Advanced glycosylation endproduct receptor signaling
PKN1;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
KDM4C;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
NCOA2;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
KDM1A;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
PPP1R14A;RHO GTPases activate PKNs
CDKN1B;RHO GTPases activate CIT
PRC1;RHO GTPases activate CIT
KIF14;RHO GTPases activate CIT
DLG4;RHO GTPases activate CIT
CLIP1;RHO GTPases activate IQGAPs
MEN1;RHO GTPases activate IQGAPs
APP;Amyloid fiber formation
SORL1;Amyloid fiber formation
SIAH1;Amyloid fiber formation
SNCA;Amyloid fiber formation
UBE2L6;Amyloid fiber formation
BACE1;Amyloid fiber formation
USP9X;Amyloid fiber formation
APCS;Amyloid fiber formation
HSPG2;Amyloid fiber formation
APOE;Amyloid fiber formation
SNCAIP;Amyloid fiber formation
PRKN;Amyloid fiber formation
CALB1;Amyloid fiber formation
HNRNPK;HCMV Late Events
CEBPD;HCMV Late Events
VPS4A;HCMV Late Events
CHMP1A;HCMV Late Events
XPO1;NEP/NS2 Interacts with the Cellular Export Machinery
KPNB1;Transport of Ribonucleoproteins into the Host Nucleus
KPNA1;Transport of Ribonucleoproteins into the Host Nucleus
PABPN1;Inhibition of Host mRNA Processing and RNA Silencing
CPSF4;Inhibition of Host mRNA Processing and RNA Silencing
SLC25A6;Influenza Virus Induced Apoptosis
CCNT1;Interactions of Tat with host cellular proteins
CDK9;Interactions of Tat with host cellular proteins
KPNA1;Vpr-mediated nuclear import of PICs
SKP1;Vpu mediated degradation of CD4
BTRC;Vpu mediated degradation of CD4
CD4;Vpu mediated degradation of CD4
NPM1;Nuclear import of Rev protein
KPNB1;Nuclear import of Rev protein
RANBP1;Rev-mediated nuclear export of HIV RNA
XPO1;Rev-mediated nuclear export of HIV RNA
TCEA1;Formation of HIV elongation complex in the absence of HIV Tat
ELL;Formation of HIV elongation complex in the absence of HIV Tat
ELOC;RNA Polymerase II Pre-transcription Events
ELOB;RNA Polymerase II Pre-transcription Events
SUPT16H;RNA Polymerase II Pre-transcription Events
SSRP1;RNA Polymerase II Pre-transcription Events
NELFCD;RNA Polymerase II Pre-transcription Events
NELFE;RNA Polymerase II Pre-transcription Events
NELFA;RNA Polymerase II Pre-transcription Events
NELFB;RNA Polymerase II Pre-transcription Events
CTDP1;Formation of the HIV-1 Early Elongation Complex
CTDP1;Formation of the Early Elongation Complex
SUPT4H1;RNA Polymerase II Pre-transcription Events
SUPT5H;RNA Polymerase II Pre-transcription Events
CDK9;RNA Polymerase II Pre-transcription Events
MLLT1;Formation of RNA Pol II elongation complex 
EAF2;Formation of RNA Pol II elongation complex 
MLLT3;Formation of RNA Pol II elongation complex 
AFF4;Formation of RNA Pol II elongation complex 
EAF1;Formation of RNA Pol II elongation complex 
ELL;Formation of RNA Pol II elongation complex 
IWS1;Formation of RNA Pol II elongation complex 
TCEA1;Formation of RNA Pol II elongation complex 
SUPT6H;Formation of RNA Pol II elongation complex 
TCEA1;Formation of HIV-1 elongation complex containing HIV-1 Tat
ELL;Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2B;RNA Polymerase II HIV Promoter Escape
GTF2B;RNA Polymerase II Pre-transcription Events
GTF2B;HIV Transcription Initiation
RNMT;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
SUPT5H;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
RNGTT;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
RPRD2;RNA polymerase II transcribes snRNA genes
RPAP2;RNA polymerase II transcribes snRNA genes
TBP;RNA polymerase II transcribes snRNA genes
CDK7;RNA polymerase II transcribes snRNA genes
GTF2B;RNA polymerase II transcribes snRNA genes
ZNF143;RNA polymerase II transcribes snRNA genes
SP1;RNA polymerase II transcribes snRNA genes
SRRT;RNA polymerase II transcribes snRNA genes
PHAX;RNA polymerase II transcribes snRNA genes
MED23;Generic Transcription Pathway
MED1;Generic Transcription Pathway
MED25;Generic Transcription Pathway
CDK8;Generic Transcription Pathway
MED14;Generic Transcription Pathway
MED10;Generic Transcription Pathway
MED8;Generic Transcription Pathway
MED12;Generic Transcription Pathway
MED15;Generic Transcription Pathway
MED4;Generic Transcription Pathway
MED17;Generic Transcription Pathway
MED7;Generic Transcription Pathway
MED16;Generic Transcription Pathway
MED24;Generic Transcription Pathway
MED26;Generic Transcription Pathway
MED6;Generic Transcription Pathway
MED13;Generic Transcription Pathway
CCNC;Generic Transcription Pathway
CREBBP;Notch-HLH transcription pathway
SNW1;Notch-HLH transcription pathway
RBPJ;Notch-HLH transcription pathway
DEK;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
TFAP2C;Activation of the TFAP2 (AP-2) family of transcription factors
APOE;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
MYC;TFAP2 (AP-2) family regulates transcription of cell cycle factors
KDM5B;TFAP2 (AP-2) family regulates transcription of cell cycle factors
CDKN1A;TFAP2 (AP-2) family regulates transcription of cell cycle factors
TGFA;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
YY1;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
CGB3;Glycoprotein hormones
CGB3;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
CGA;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
EGFR;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
ESR1;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
VEGFA;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
ATAD2;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
ERBB2;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
KIT;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
CREBBP;Activation of the TFAP2 (AP-2) family of transcription factors
EP300;Activation of the TFAP2 (AP-2) family of transcription factors
YEATS4;Activation of the TFAP2 (AP-2) family of transcription factors
PITX2;TFAP2 (AP-2) family regulates transcription of other transcription factors
NPM1;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
HSPD1;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
MYBL2;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
NOP2;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
KCTD1;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
UBE2I;SUMOylation of transcription factors
UBE2I;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
WWOX;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
TFAP2C;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
KCTD15;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
SPP1;RUNX3 Regulates Immune Response and Cell Migration
CBFB;Regulation of RUNX3 expression and activity
BCL2L11;RUNX3 regulates BCL2L11 (BIM) transcription
FOXO3;RUNX3 regulates BCL2L11 (BIM) transcription
RUNX3;RUNX3 regulates CDKN1A transcription
ZFHX3;RUNX3 regulates CDKN1A transcription
CDKN1A;RUNX3 regulates CDKN1A transcription
JAG1;RUNX3 regulates NOTCH signaling
RUNX3;RUNX3 regulates NOTCH signaling
EP300;RUNX3 regulates p14-ARF
CCND1;RUNX3 regulates p14-ARF
HDAC4;RUNX3 regulates p14-ARF
SRC;Regulation of RUNX3 expression and activity
CCND1;RUNX3 regulates WNT signaling
RUNX3;RUNX3 regulates YAP1-mediated transcription
CCN2;YAP1- and WWTR1 (TAZ)-stimulated gene expression
CCN2;RUNX3 regulates YAP1-mediated transcription
DLL4;NOTCH2 Activation and Transmission of Signal to the Nucleus
CNTN1;NOTCH2 Activation and Transmission of Signal to the Nucleus
JAG2;NOTCH2 Activation and Transmission of Signal to the Nucleus
JAG1;NOTCH2 Activation and Transmission of Signal to the Nucleus
NOTCH2;NOTCH2 Activation and Transmission of Signal to the Nucleus
DLL1;NOTCH2 Activation and Transmission of Signal to the Nucleus
NOTCH2;NOTCH2 intracellular domain regulates transcription
RBPJ;NOTCH2 intracellular domain regulates transcription
FCER2;NOTCH2 intracellular domain regulates transcription
GZMB;NOTCH2 intracellular domain regulates transcription
EP300;NOTCH2 intracellular domain regulates transcription
HES1;NOTCH2 intracellular domain regulates transcription
HES5;NOTCH2 intracellular domain regulates transcription
SOX2;Transcriptional Regulation by MECP2
PTEN;Transcriptional Regulation by MECP2
DGCR8;Transcriptional Regulation by MECP2
FKBP5;MECP2 regulates neuronal receptors and channels
OPRM1;MECP2 regulates neuronal receptors and channels
GRIA2;MECP2 regulates neuronal receptors and channels
CREB1;MECP2 regulates transcription factors
GRIN2A;MECP2 regulates neuronal receptors and channels
TRPC3;MECP2 regulates neuronal receptors and channels
SLC2A3;MECP2 regulates neuronal receptors and channels
GRIN2B;MECP2 regulates neuronal receptors and channels
PTPN4;MECP2 regulates neuronal receptors and channels
PTPN1;MECP2 regulates neuronal receptors and channels
GPRIN1;MECP2 regulates neuronal receptors and channels
MET;MECP2 regulates neuronal receptors and channels
OPRK1;MECP2 regulates neuronal receptors and channels
PVALB;Transcriptional Regulation by MECP2
SGK1;Transcriptional Regulation by MECP2
GAD2;MECP2 regulates transcription of genes involved in GABA signaling
GAD1;MECP2 regulates transcription of genes involved in GABA signaling
BDNF;MECP2 regulates transcription of neuronal ligands
CRH;MECP2 regulates transcription of neuronal ligands
DLL1;MECP2 regulates transcription of neuronal ligands
IRAK1;Transcriptional Regulation by MECP2
GAMT;Transcriptional Regulation by MECP2
HTT;Regulation of MECP2 expression and activity
FOXG1;Regulation of MECP2 expression and activity
LBR;Regulation of MECP2 expression and activity
MEF2C;MECP2 regulates transcription factors
PPARG;MECP2 regulates transcription factors
RBFOX1;MECP2 regulates transcription factors
MOBP;Transcriptional Regulation by MECP2
SRF;Regulation of NPAS4 gene transcription
REST;Regulation of NPAS4 gene transcription
NPAS4;Regulation of NPAS4 mRNA translation
NPAS4;NPAS4 regulates expression of target genes
IQSEC3;NPAS4 regulates expression of target genes
MDM2;NPAS4 regulates expression of target genes
PLK2;NPAS4 regulates expression of target genes
BMAL1;NPAS4 regulates expression of target genes
INS;NPAS4 regulates expression of target genes
RBFOX3;NPAS4 regulates expression of target genes
RET;NPAS4 regulates expression of target genes
GEM;NPAS4 regulates expression of target genes
FOS;NPAS4 regulates expression of target genes
CDK5R1;NPAS4 regulates expression of target genes
CDK5;NPAS4 regulates expression of target genes
ARNT;NPAS4 regulates expression of target genes
SYT10;NPAS4 regulates expression of target genes
BDNF;NPAS4 regulates expression of target genes
ARNT2;NPAS4 regulates expression of target genes
NAMPT;NPAS4 regulates expression of target genes
NPPA;Physiological factors
NPPA;YAP1- and WWTR1 (TAZ)-stimulated gene expression
HAND2;Transcriptional regulation by RUNX2
CDKN1A;Transcriptional regulation by RUNX2
BAX;Transcriptional regulation by RUNX2
ITGA5;RUNX2 regulates genes involved in cell migration
ITGBL1;RUNX2 regulates genes involved in cell migration
MMP13;RUNX2 regulates genes involved in cell migration
SUFU;Degradation of GLI1 by the proteasome
NUMB;Hedgehog 'on' state
NUMB;Degradation of GLI1 by the proteasome
ITCH;Hedgehog 'on' state
ITCH;Degradation of GLI1 by the proteasome
SUFU;Degradation of GLI2 by the proteasome
PTCH1;Hedgehog 'off' state
KIF7;Hedgehog 'off' state
ACVRL1;Signaling by BMP
SKI;Signaling by BMP
GLI1;Hedgehog 'on' state
GLI1;GLI proteins bind promoters of Hh responsive genes to promote transcription
GPR161;Hedgehog 'on' state
CSNK1A1;Activation of SMO
GRK2;Activation of SMO
KIF3A;Activation of SMO
PTCH1;Hedgehog 'on' state
CDC73;Hedgehog 'on' state
PTCH1;Ligand-receptor interactions
CDON;Ligand-receptor interactions
GAS1;Ligand-receptor interactions
HHIP;Ligand-receptor interactions
STK3;Signaling by Hippo,Hippo signaling cascade
NPHP4;Signaling by Hippo,Hippo signaling cascade
TJP2;Signaling by Hippo,Hippo signaling cascade
STK4;Signaling by Hippo,Hippo signaling cascade
WWC1;Signaling by Hippo,Hippo signaling cascade
DVL2;Signaling by Hippo,Hippo signaling cascade
TJP1;Signaling by Hippo,Hippo signaling cascade
MED1;Nuclear Receptor transcription pathway
CITED2;FOXO-mediated transcription of cell death genes
STK11;FOXO-mediated transcription of cell death genes
BCL6;FOXO-mediated transcription of cell death genes
BBC3;FOXO-mediated transcription of cell death genes
PINK1;FOXO-mediated transcription of cell death genes
BCL2L11;FOXO-mediated transcription of cell death genes
FASLG;FOXO-mediated transcription of cell death genes
BTG1;FOXO-mediated transcription of cell cycle genes
FOXO3;FOXO-mediated transcription of cell cycle genes
CDKN1B;FOXO-mediated transcription of cell cycle genes
CAV1;FOXO-mediated transcription of cell cycle genes
GADD45A;FOXO-mediated transcription of cell cycle genes
KLF4;FOXO-mediated transcription of cell cycle genes
FOXO1;FOXO-mediated transcription of cell cycle genes
FOXG1;FOXO-mediated transcription of cell cycle genes
CCNG2;FOXO-mediated transcription of cell cycle genes
RBL2;FOXO-mediated transcription of cell cycle genes
CAT;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO1;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
G6PC1;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
PPARGC1A;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
TRIM63;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
SREBF1;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
IGFBP1;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
ATXN3;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO4;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
RETN;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
ABCA6;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
NPY;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
PCK1;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FBXO32;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO3;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
POMC;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO6;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
GCK;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
SOD2;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
PLXNA4;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
AGRP;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO3;Regulation of localization of FOXO transcription factors
FOXO1;Regulation of localization of FOXO transcription factors
FOXO4;Regulation of localization of FOXO transcription factors
FOXO1;Regulation of FOXO transcriptional activity by acetylation
FOXO4;Regulation of FOXO transcriptional activity by acetylation
FOXO3;Regulation of FOXO transcriptional activity by acetylation
CREBBP;Regulation of FOXO transcriptional activity by acetylation
EP300;Regulation of FOXO transcriptional activity by acetylation
TXN;Regulation of FOXO transcriptional activity by acetylation
E2F6;Transcriptional Regulation by E2F6
TFDP2;Transcriptional Regulation by E2F6
RBBP8;Transcriptional Regulation by E2F6
TFDP1;Transcriptional Regulation by E2F6
APAF1;Transcriptional Regulation by E2F6
EPC1;Transcriptional Regulation by E2F6
RBBP4;Transcriptional Regulation by E2F6
RAD51;Transcriptional Regulation by E2F6
CBX5;Transcriptional Regulation by E2F6
E2F1;Transcriptional Regulation by E2F6
CBX3;Transcriptional Regulation by E2F6
PCGF6;Transcriptional Regulation by E2F6
L3MBTL2;Transcriptional Regulation by E2F6
UXT;Transcriptional Regulation by E2F6
CDC7;Transcriptional Regulation by E2F6
RRM2;G1/S-Specific Transcription
RRM2;Transcriptional Regulation by E2F6
BRCA1;Transcriptional Regulation by E2F6
MED27;Generic Transcription Pathway
MED20;Generic Transcription Pathway
MED31;Generic Transcription Pathway
MED30;Generic Transcription Pathway
MLLT1;RNA Polymerase II Pre-transcription Events
EAF2;RNA Polymerase II Pre-transcription Events
MLLT3;RNA Polymerase II Pre-transcription Events
AFF4;RNA Polymerase II Pre-transcription Events
EAF1;RNA Polymerase II Pre-transcription Events
TCEA1;RNA Polymerase II Pre-transcription Events
ELL;RNA Polymerase II Pre-transcription Events
CTDP1;RNA Polymerase II Pre-transcription Events
IWS1;RNA Polymerase II Pre-transcription Events
SUPT6H;RNA Polymerase II Pre-transcription Events
HCK;Nef and signal transduction
LCK;Nef and signal transduction
DOCK2;Nef and signal transduction
ELMO1;Nef and signal transduction
RAC1;Nef and signal transduction
PAK2;Nef and signal transduction
FYN;Nef and signal transduction
ATP6V1H;Nef Mediated CD4 Down-regulation
LCK;Nef Mediated CD4 Down-regulation
ARF1;Nef Mediated CD4 Down-regulation
CD4;Nef Mediated CD4 Down-regulation
ATP6V1H;Nef Mediated CD8 Down-regulation
AP2M1;Nef mediated downregulation of CD28 cell surface expression
CD28;Nef mediated downregulation of CD28 cell surface expression
PACS1;Nef mediated downregulation of MHC class I complex cell surface expression
HBEGF;Extra-nuclear estrogen signaling
S1PR3;Extra-nuclear estrogen signaling
PLCG1;Activated NTRK3 signals through PLCG1
NELFB;NTRK3 as a dependence receptor
NTRK3;NTRK3 as a dependence receptor
BAX;NTRK3 as a dependence receptor
NTRK3;NTF3 activates NTRK3 signaling
SRC;Activated NTRK3 signals through PI3K
IRS1;Activated NTRK3 signals through PI3K
PTPRD;Receptor-type tyrosine-protein phosphatases
LRRC4B;Receptor-type tyrosine-protein phosphatases
NTRK3;Receptor-type tyrosine-protein phosphatases
PTPRS;Receptor-type tyrosine-protein phosphatases
DLG4;Synaptic adhesion-like molecules
LRFN3;Synaptic adhesion-like molecules
LRFN2;Synaptic adhesion-like molecules
LRFN4;Synaptic adhesion-like molecules
RTN3;Synaptic adhesion-like molecules
LRFN1;Synaptic adhesion-like molecules
CASK;Neurexins and neuroligins
SHARPIN;Neurexins and neuroligins
SIPA1L1;Neurexins and neuroligins
BEGAIN;Neurexins and neuroligins
DBNL;Neurexins and neuroligins
PDLIM5;Neurexins and neuroligins
FRS2;Activated NTRK2 signals through FRS2 and FRS3
FRS3;Activated NTRK2 signals through FRS2 and FRS3
NTRK2;NTF4 activates NTRK2 (TRKB) signaling
NTRK2;BDNF activates NTRK2 (TRKB) signaling
PTPN11;Activated NTRK2 signals through FRS2 and FRS3
TIAM1;Activated NTRK2 signals through CDK5
PLCG1;Activated NTRK2 signals through PLCG1
NTRK2;NTF3 activates NTRK2 (TRKB) signaling
GRIN2B;Activated NTRK2 signals through FYN
NTRK2;Activated NTRK2 signals through FYN
DOCK3;NTRK2 activates RAC1
PTPN11;FRS-mediated FGFR2 signaling
HNRNPM;FGFR2 alternative splicing
ESRP1;FGFR2 alternative splicing
ESRP2;FGFR2 alternative splicing
HNRNPA1;FGFR2 alternative splicing
PTBP1;FGFR2 alternative splicing
PLCG1;Downstream signal transduction
SRC;Downstream signal transduction
RASA1;Downstream signal transduction
RAPGEF1;Downstream signal transduction
BCAR1;Downstream signal transduction
GRB7;Downstream signal transduction
PTPN11;Downstream signal transduction
PDGFRA;Signaling by PDGF
DLG4;Signaling by ERBB4
PTPN11;Prolactin receptor signaling
CBL;Regulation of signaling by CBL
RAPGEF1;Regulation of signaling by CBL
VAV1;Regulation of signaling by CBL
BLNK;Regulation of signaling by CBL
YWHAZ;Interleukin-3, Interleukin-5 and GM-CSF signaling
VAV1;Interleukin-3, Interleukin-5 and GM-CSF signaling
TEC;Interleukin-3, Interleukin-5 and GM-CSF signaling
PTPN11;Interleukin-3, Interleukin-5 and GM-CSF signaling
TJP1;RUNX1 regulates expression of components of tight junctions
OCLN;RUNX1 regulates expression of components of tight junctions
CLDN5;RUNX1 regulates expression of components of tight junctions
PTPN11;STAT5 Activation
PTPN11;FLT3 Signaling
PTPN11;RAF/MAP kinase cascade
OAS1;OAS antiviral response
RIGI;OAS antiviral response
OASL;OAS antiviral response
OAS3;OAS antiviral response
FLNA;OAS antiviral response
RNASEL;OAS antiviral response
ABCE1;OAS antiviral response
SNUPN;snRNP Assembly
IL17RB;Interleukin-17 signaling
IL17RE;Interleukin-17 signaling
IL19;Interleukin-20 family signaling
IL19;MAPK1/MAPK3 signaling,ERK1/ERK2 pathway
IL20RB;Interleukin-20 family signaling
IL20RA;Interleukin-20 family signaling
GSK3B;Maturation of nucleoprotein
ZCRB1;Replication of the SARS-CoV-1 genome
RB1;Replication of the SARS-CoV-1 genome
VHL;Replication of the SARS-CoV-1 genome
DDX5;Replication of the SARS-CoV-1 genome
MAP1LC3B;Translation of Replicase and Assembly of the Replication Transcription Complex
TMPRSS2;Attachment and Entry
ACE2;Induction of Cell-Cell Fusion
PRMT1;Maturation of nucleoprotein
RB1;Replication of the SARS-CoV-2 genome
ZCRB1;Replication of the SARS-CoV-2 genome
VHL;Replication of the SARS-CoV-2 genome
DDX5;Replication of the SARS-CoV-2 genome
BCL2L1;SARS-CoV-1-mediated effects on programmed cell death
NPIPB3;SARS-CoV-1 activates/modulates innate immune responses
TKFC;SARS-CoV-1 activates/modulates innate immune responses
RIGI;SARS-CoV-1 activates/modulates innate immune responses
NLRP3;SARS-CoV-1 activates/modulates innate immune responses
TOMM70;SARS-CoV-1 activates/modulates innate immune responses
IRF3;SARS-CoV-1 activates/modulates innate immune responses
MAVS;SARS-CoV-1 activates/modulates innate immune responses
PCBP2;SARS-CoV-1 activates/modulates innate immune responses
ITCH;SARS-CoV-1 activates/modulates innate immune responses
RCAN3;SARS-CoV-1 activates/modulates innate immune responses
TRIM25;SARS-CoV-1 activates/modulates innate immune responses
KPNA2;SARS-CoV-1 activates/modulates innate immune responses
NMI;SARS-CoV-1 activates/modulates innate immune responses
KPNB1;SARS-CoV-1 activates/modulates innate immune responses
TRAF3;SARS-CoV-1 activates/modulates innate immune responses
RUNX1;SARS-CoV-1 activates/modulates innate immune responses
HNRNPA1;SARS-CoV-1-host interactions
HNRNPA1;SARS-CoV-1 modulates host translation machinery
EEF1A1;SARS-CoV-1 modulates host translation machinery
NPM1;SARS-CoV-1-host interactions
PSMC6;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
UBE2I;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SMAD3;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SMAD4;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
EP300;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SP1;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
PDPK1;SARS-CoV-1 targets host intracellular signalling and regulatory pathways
EEF1A1;Eukaryotic Translation Elongation
EEF1G;Eukaryotic Translation Elongation
EEF1B2;Eukaryotic Translation Elongation
EEF1D;Eukaryotic Translation Elongation
EEF2;Peptide chain elongation
ORC1;G1/S-Specific Transcription
TYMS;G1/S-Specific Transcription
DHFR;G1/S-Specific Transcription
POLA1;G1/S-Specific Transcription
CDT1;G1/S-Specific Transcription
FBXO5;G1/S-Specific Transcription
CCNA1;G1/S-Specific Transcription
TK1;G1/S-Specific Transcription
SYCE2;Meiotic synapsis
HSPA2;Meiotic synapsis
FKBP6;Meiotic synapsis
UBE2I;Meiotic synapsis
SYCE1;Meiotic synapsis
TEX12;Meiotic synapsis
SYCE3;Meiotic synapsis
SYCP1;Meiotic synapsis
LMNB1;Meiotic synapsis
SUN1;Meiotic synapsis
SYNE1;Meiotic synapsis
SYNE2;Meiotic synapsis
SUN2;Meiotic synapsis
SYCP2;Meiotic synapsis
SYCP3;Meiotic synapsis
PRDM9;Meiotic recombination
ATR;Meiotic synapsis
BRCA1;Meiotic synapsis
MSH5;Meiotic recombination
MSH4;Meiotic recombination
TOP3A;Meiotic recombination
BRCA2;Meiotic recombination
BLM;Meiotic recombination
CDK4;Meiotic recombination
CDK2;Meiotic recombination
MLH3;Meiotic recombination
MLH1;Meiotic recombination
RAD51;Meiotic recombination
DMC1;Meiotic recombination
ATM;Meiotic recombination
BRCA1;Meiotic recombination
SHQ1;Telomere Extension By Telomerase
H3-4;Inhibition of DNA recombination at telomere
H3-3A;Inhibition of DNA recombination at telomere
ATRX;Inhibition of DNA recombination at telomere
DAXX;Inhibition of DNA recombination at telomere
NPHS1;Nephrin family interactions
FYN;Nephrin family interactions
KIRREL1;Nephrin family interactions
CD2AP;Nephrin family interactions
WASL;Nephrin family interactions
IQGAP1;Nephrin family interactions
CASK;Nephrin family interactions
SKAP2;Signal regulatory protein family interactions
CD47;Signal regulatory protein family interactions
SIRPA;Signal regulatory protein family interactions
PTK2B;Signal regulatory protein family interactions
SIRPG;Signal regulatory protein family interactions
FYB1;Signal regulatory protein family interactions
DELE1;Cellular response to mitochondrial stress
EIF2AK1;Cellular response to mitochondrial stress
PGRMC2;Heme signaling
NR1D1;Circadian Clock
NR1D1;Heme signaling
HDAC3;Circadian Clock
HDAC3;Heme signaling
NCOR1;Circadian Clock
NCOR1;Heme signaling
XPO1;Heme signaling
LY96;Heme signaling
TLR4;Heme signaling
ALB;Heme biosynthesis
ALB;Heme degradation
ALB;Cytoprotection by HMOX1
STAB1;Scavenging by Class H Receptors
STAB2;Scavenging by Class H Receptors
ALB;Scavenging of heme from plasma
HPX;Scavenging of heme from plasma
LRP1;Scavenging of heme from plasma
AMBP;Scavenging of heme from plasma
CD163;Scavenging of heme from plasma
SSC5D;Scavenging by Class B Receptors
SCARF1;Scavenging by Class F Receptors
HSF1;HSF1 activation
PTGES3;HSF1 activation
SIRT1;Regulation of HSF1-mediated heat shock response
CCAR2;Regulation of HSF1-mediated heat shock response
HIKESHI;Regulation of HSF1-mediated heat shock response
HSF1;Regulation of HSF1-mediated heat shock response
MAFK;Regulation of NFE2L2 gene expression
MAP1LC3B;KEAP1-NFE2L2 pathway
SQSTM1;KEAP1-NFE2L2 pathway
SQSTM1;Nuclear events mediated by NFE2L2
MAFG;Nuclear events mediated by NFE2L2
NFE2L2;Neddylation
UBXN7;Neddylation
UBXN7;KEAP1-NFE2L2 pathway
NEDD8;Neddylation
UBE2M;Neddylation
CAND1;Neddylation
NEDD8;UCH proteinases
UBE2F;Neddylation
MAFK;NFE2L2 regulating MDR associated enzymes
ABCG2;NFE2L2 regulating MDR associated enzymes
ABCC3;NFE2L2 regulating MDR associated enzymes
ABCC1;NFE2L2 regulating MDR associated enzymes
ABCF2;NFE2L2 regulating MDR associated enzymes
MAFK;NFE2L2 regulating ER-stress associated genes
ATF4;NFE2L2 regulating ER-stress associated genes
ATF4;Response of EIF2AK1 (HRI) to heme deficiency
ATF4;Response of EIF2AK4 (GCN2) to amino acid deficiency
ATF4;PERK regulates gene expression
EIF2AK3;PERK regulates gene expression
ATF2;Response of EIF2AK4 (GCN2) to amino acid deficiency
DDIT3;Response of EIF2AK1 (HRI) to heme deficiency
DDIT3;Response of EIF2AK4 (GCN2) to amino acid deficiency
ASNS;Response of EIF2AK1 (HRI) to heme deficiency
ASNS;ATF4 activates genes in response to endoplasmic reticulum  stress
ASNS;Response of EIF2AK4 (GCN2) to amino acid deficiency
TRIB3;Response of EIF2AK1 (HRI) to heme deficiency
TRIB3;Response of EIF2AK4 (GCN2) to amino acid deficiency
CEBPB;Response of EIF2AK4 (GCN2) to amino acid deficiency
ATF3;ATF4 activates genes in response to endoplasmic reticulum  stress
ATF3;Response of EIF2AK4 (GCN2) to amino acid deficiency
IMPACT;Response of EIF2AK4 (GCN2) to amino acid deficiency
MAFK;Nuclear events mediated by NFE2L2
NFE2L2;Nuclear events mediated by NFE2L2
CDKN2A;Nuclear events mediated by NFE2L2
MAFG;NFE2L2 regulates pentose phosphate pathway genes
SP1;NFE2L2 regulating tumorigenic genes
MAFK;NFE2L2 regulating tumorigenic genes
BCL2;NFE2L2 regulating tumorigenic genes
NOTCH1;NFE2L2 regulating tumorigenic genes
EGF;NFE2L2 regulating tumorigenic genes
AREG;NFE2L2 regulating tumorigenic genes
PDGFA;NFE2L2 regulating tumorigenic genes
BCL2L1;NFE2L2 regulating tumorigenic genes
PDK2;Regulation of pyruvate dehydrogenase (PDH) complex
KEAP1;Nuclear events mediated by NFE2L2
ATF4;NFE2L2 regulating anti-oxidant/detoxification enzymes
MAFK;NFE2L2 regulating anti-oxidant/detoxification enzymes
TXNRD1;NFE2L2 regulating anti-oxidant/detoxification enzymes
TXN;NFE2L2 regulating anti-oxidant/detoxification enzymes
SLC7A11;NFE2L2 regulating anti-oxidant/detoxification enzymes
GCLM;NFE2L2 regulating anti-oxidant/detoxification enzymes
GCLC;NFE2L2 regulating anti-oxidant/detoxification enzymes
SOD3;NFE2L2 regulating anti-oxidant/detoxification enzymes
SMDT1;Processing of SMDT1
MCUB;Processing of SMDT1
MCU;Processing of SMDT1
MICU1;Processing of SMDT1
CFTR;ABC-family proteins mediated transport
ABCF1;ABC-family proteins mediated transport
RHO;Inactivation, recovery and regulation of the phototransduction cascade
SAG;Inactivation, recovery and regulation of the phototransduction cascade
RHO;Activation of the phototransduction cascade
RHO;The canonical retinoid cycle in rods (twilight vision)
RLBP1;The canonical retinoid cycle in rods (twilight vision)
RBP1;The canonical retinoid cycle in rods (twilight vision)
STRA6;The canonical retinoid cycle in rods (twilight vision)
SLC5A2;Cellular hexose transport
SLC25A4;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
ARL2BP;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
FABP6;Recycling of bile acids and salts
NR1H4;Recycling of bile acids and salts
SLC12A3;Cation-coupled Chloride cotransporters
APOB;VLDL assembly,VLDL biosynthesis
APOC4;VLDL assembly,VLDL biosynthesis
APOC1;VLDL assembly,VLDL biosynthesis
APOA1;HDL assembly
APOB;Chylomicron assembly
APOA4;Chylomicron assembly
APOA2;Chylomicron assembly
APOA1;Chylomicron assembly
LPA;LDL remodeling
LCAT;HDL remodeling
ALB;HDL remodeling
APOC2;HDL remodeling
APOC3;HDL remodeling
APOE;HDL remodeling
GPIHBP1;Assembly of active LPL and LIPC lipase complexes
APOE;Chylomicron remodeling
LPL;Assembly of active LPL and LIPC lipase complexes
CREB3L3;Assembly of active LPL and LIPC lipase complexes
ANGPTL8;Assembly of active LPL and LIPC lipase complexes
ANGPTL3;Assembly of active LPL and LIPC lipase complexes
LDLR;Chylomicron clearance
LDLR;LDL clearance
APOA1;HDL clearance
HDLBP;HDL clearance
VLDLR;VLDL clearance
VLDLR;VLDLR internalisation and degradation
PCSK9;VLDLR internalisation and degradation
NPC1;LDL clearance
NPC2;LDL clearance
PCSK9;LDL clearance
DMTN;Miscellaneous transport and binding events
PIP;Miscellaneous transport and binding events
AZGP1;Miscellaneous transport and binding events
ANO1;Stimuli-sensing channels
TRPV1;TRP channels
NAT1;Acetylation
NAT2;Acetylation
PODXL2;Cytosolic sulfonation of small molecules
STAT3;Cytoprotection by HMOX1
HMOX1;Regulation of HMOX1 expression and activity
CCL2;NFE2L2 regulating inflammation associated genes
MAFK;NFE2L2 regulating inflammation associated genes
STIP1;HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,HSP90 chaperone cycle for SHRs
PTGES3;HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,HSP90 chaperone cycle for SHRs
FKBP4;HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,HSP90 chaperone cycle for SHRs
FKBP5;HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,HSP90 chaperone cycle for SHRs
STAR;Pregnenolone biosynthesis
CREB3L1;CREB3 factors activate genes
CREB3;CREB3 factors activate genes
CREBRF;CREB3 factors activate genes
ATF6;ATF6 (ATF6-alpha) activates chaperones
CREB3L4;CREB3 factors activate genes
CREB3L3;CREB3 factors activate genes
CREB3L2;CREB3 factors activate genes
ATF6B;ATF6B (ATF6-beta) activates chaperones
CXCL8;ATF4 activates genes in response to endoplasmic reticulum  stress
IGFBP1;ATF4 activates genes in response to endoplasmic reticulum  stress
DDIT3;ATF6 (ATF6-alpha) activates chaperone genes
DDIT3;ATF4 activates genes in response to endoplasmic reticulum  stress
CCL2;ATF4 activates genes in response to endoplasmic reticulum  stress
HERPUD1;ATF4 activates genes in response to endoplasmic reticulum  stress
ERN1;IRE1alpha activates chaperones
PDIA6;XBP1(S) activates chaperone genes
CTDSP2;XBP1(S) activates chaperone genes
HYOU1;XBP1(S) activates chaperone genes
ARFGAP1;XBP1(S) activates chaperone genes
LMNA;XBP1(S) activates chaperone genes
EXTL2;XBP1(S) activates chaperone genes
PLA2G4B;XBP1(S) activates chaperone genes
SHC1;XBP1(S) activates chaperone genes
ACADVL;XBP1(S) activates chaperone genes
SEC31A;XBP1(S) activates chaperone genes
KDELR3;XBP1(S) activates chaperone genes
CUL7;XBP1(S) activates chaperone genes
PDIA5;XBP1(S) activates chaperone genes
ZBTB17;XBP1(S) activates chaperone genes
TSPYL2;XBP1(S) activates chaperone genes
ATP6V0D1;XBP1(S) activates chaperone genes
DNAJB9;XBP1(S) activates chaperone genes
SRPRB;XBP1(S) activates chaperone genes
FKBP14;XBP1(S) activates chaperone genes
KLHDC3;XBP1(S) activates chaperone genes
HDGF;XBP1(S) activates chaperone genes
GSK3A;XBP1(S) activates chaperone genes
DDX11;XBP1(S) activates chaperone genes
WFS1;XBP1(S) activates chaperone genes
SULT1A3;XBP1(S) activates chaperone genes
WIPI1;XBP1(S) activates chaperone genes
PPP2R5B;XBP1(S) activates chaperone genes
SERP1;XBP1(S) activates chaperone genes
MYDGF;XBP1(S) activates chaperone genes
SSR1;XBP1(S) activates chaperone genes
EDEM1;XBP1(S) activates chaperone genes
GOSR2;XBP1(S) activates chaperone genes
GFPT1;XBP1(S) activates chaperone genes
CXXC1;XBP1(S) activates chaperone genes
DNAJC3;XBP1(S) activates chaperone genes
DCTN1;XBP1(S) activates chaperone genes
TATDN2;XBP1(S) activates chaperone genes
EXTL1;XBP1(S) activates chaperone genes
PREB;XBP1(S) activates chaperone genes
EXTL3;XBP1(S) activates chaperone genes
SYVN1;XBP1(S) activates chaperone genes
DNAJB11;XBP1(S) activates chaperone genes
SRPRA;XBP1(S) activates chaperone genes
TPP1;XBP1(S) activates chaperone genes
TLN1;XBP1(S) activates chaperone genes
YIF1A;XBP1(S) activates chaperone genes
ADD1;XBP1(S) activates chaperone genes
HSP90B1;ATF6 (ATF6-alpha) activates chaperone genes
CALR;ATF6 (ATF6-alpha) activates chaperone genes
HSPA5;ATF6 (ATF6-alpha) activates chaperone genes
ATF5;Response of EIF2AK1 (HRI) to heme deficiency
PPP1R15A;Response of EIF2AK1 (HRI) to heme deficiency
CHAC1;Response of EIF2AK1 (HRI) to heme deficiency
ATF3;Response of EIF2AK1 (HRI) to heme deficiency
CEBPB;Response of EIF2AK1 (HRI) to heme deficiency
GRB10;Response of EIF2AK1 (HRI) to heme deficiency
MT1E;Metallothioneins bind metals
MT1A;Metallothioneins bind metals
MT1X;Metallothioneins bind metals
MT3;Metallothioneins bind metals
MT1B;Metallothioneins bind metals
MT2A;Metallothioneins bind metals
MT1F;Metallothioneins bind metals
MT1M;Metallothioneins bind metals
MT1G;Metallothioneins bind metals
MT1H;Metallothioneins bind metals
MT4;Metallothioneins bind metals
CSRP1;MTF1 activates gene expression
SNCB;MTF1 activates gene expression
BRWD1;Interleukin-7 signaling
BRWD1;Chromatin modifying enzymes
SMARCA4;Interleukin-7 signaling
SMARCA4;Chromatin modifying enzymes
KMT2A;Formation of WDR5-containing histone-modifying complexes
DPY30;Formation of WDR5-containing histone-modifying complexes
WDR5;Formation of WDR5-containing histone-modifying complexes
RBBP5;Formation of WDR5-containing histone-modifying complexes
ASH2L;Formation of WDR5-containing histone-modifying complexes
SETD1A;Formation of WDR5-containing histone-modifying complexes
SETD1B;Formation of WDR5-containing histone-modifying complexes
KMT2B;Formation of WDR5-containing histone-modifying complexes
KMT2C;Formation of WDR5-containing histone-modifying complexes
KMT2D;Formation of WDR5-containing histone-modifying complexes
H4C1;PKMTs methylate histone lysines
ATF7IP;PKMTs methylate histone lysines
SETDB1;PKMTs methylate histone lysines
H4C1;HDMs demethylate histones
DNMT3A;RMTs methylate histone arginines
H4C1;RMTs methylate histone arginines
COPRS;RMTs methylate histone arginines
WDR5;RMTs methylate histone arginines
PRMT5;RMTs methylate histone arginines
RPS2;Protein methylation
RPS2;RMTs methylate histone arginines
RBBP7;RMTs methylate histone arginines
WDR77;RMTs methylate histone arginines
KAT14;Formation of WDR5-containing histone-modifying complexes
DR1;Formation of WDR5-containing histone-modifying complexes
ZZZ3;Formation of WDR5-containing histone-modifying complexes
TADA2A;Formation of WDR5-containing histone-modifying complexes
KAT2B;Formation of WDR5-containing histone-modifying complexes
YEATS2;Formation of WDR5-containing histone-modifying complexes
MBIP;Formation of WDR5-containing histone-modifying complexes
TADA3;Formation of WDR5-containing histone-modifying complexes
SGF29;Formation of WDR5-containing histone-modifying complexes
KAT2A;Formation of WDR5-containing histone-modifying complexes
H4C1;HATs acetylate histones,Histone acetyltransferases acetylate histones
KAT6A;HATs acetylate histones,Histone acetyltransferases acetylate histones
NCOA2;HATs acetylate histones,Histone acetyltransferases acetylate histones
NCOA1;HATs acetylate histones,Histone acetyltransferases acetylate histones
PAX3;HATs acetylate histones,Histone acetyltransferases acetylate histones
CRY1;Circadian Clock
PER1;Circadian Clock
CRY2;Circadian Clock
PER2;Circadian Clock
SREBF1;RORA activates gene expression
EP300;RORA activates gene expression
RORA;RORA activates gene expression
CPT1A;PPARA activates gene expression
CPT1A;RORA activates gene expression
BTRC;Circadian Clock
NR1D1;NR1D1 (REV-ERBA) represses gene expression
HDAC3;NR1D1 (REV-ERBA) represses gene expression
NCOR1;NR1D1 (REV-ERBA) represses gene expression
FBXL3;Circadian Clock
AVP;BMAL1:CLOCK,NPAS2 activates circadian gene expression
NAMPT;BMAL1:CLOCK,NPAS2 activates circadian gene expression
KLF15;BMAL1:CLOCK,NPAS2 activates circadian gene expression
BHLHE41;BMAL1:CLOCK,NPAS2 activates circadian gene expression
NOCT;BMAL1:CLOCK,NPAS2 activates circadian gene expression
BHLHE40;BMAL1:CLOCK,NPAS2 activates circadian gene expression
F7;BMAL1:CLOCK,NPAS2 activates circadian gene expression
SERPINE1;BMAL1:CLOCK,NPAS2 activates circadian gene expression
DBP;BMAL1:CLOCK,NPAS2 activates circadian gene expression
NCOR1;Activation of anterior HOX genes in hindbrain development during early embryogenesis
NCOA3;Activation of anterior HOX genes in hindbrain development during early embryogenesis
EP300;Activation of anterior HOX genes in hindbrain development during early embryogenesis
EGR2;Activation of anterior HOX genes in hindbrain development during early embryogenesis
AJUBA;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HDAC3;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXA4;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXB1;Activation of anterior HOX genes in hindbrain development during early embryogenesis
PCGF2;Activation of anterior HOX genes in hindbrain development during early embryogenesis
CREBBP;Activation of anterior HOX genes in hindbrain development during early embryogenesis
PAX6;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXB4;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXB3;Activation of anterior HOX genes in hindbrain development during early embryogenesis
JUN;Activation of anterior HOX genes in hindbrain development during early embryogenesis
MAFB;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXA2;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXB2;Activation of anterior HOX genes in hindbrain development during early embryogenesis
MEIS1;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXD4;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXD3;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXA1;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXC4;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXD1;Activation of anterior HOX genes in hindbrain development during early embryogenesis
HOXA3;Activation of anterior HOX genes in hindbrain development during early embryogenesis
LGI4;LGI-ADAM interactions
LGI3;LGI-ADAM interactions
LGI2;LGI-ADAM interactions
ADAM23;LGI-ADAM interactions
ADAM11;LGI-ADAM interactions
TBX6;Formation of paraxial mesoderm
TBXT;Germ layer formation at gastrulation,Primitive streak formation
TBPL2;Germ layer formation at gastrulation,Primitive streak formation
CTNNB1;Germ layer formation at gastrulation,Primitive streak formation
MSGN1;Formation of paraxial mesoderm
PSEN1;Formation of paraxial mesoderm
DLL1;Formation of paraxial mesoderm
LFNG;Somitogenesis
MSGN1;Somitogenesis
RIPPLY2;Somitogenesis
TBX6;Somitogenesis
MESP2;Somitogenesis
FOXC1;Somitogenesis
FOXC2;Somitogenesis
HES7;Somitogenesis
RBPJ;Somitogenesis
NOTCH1;Somitogenesis
DLL1;Somitogenesis
DLL3;Somitogenesis
EPHA4;Somitogenesis
DLL3;Formation of paraxial mesoderm
NOTCH1;Formation of paraxial mesoderm
BMP4;Formation of paraxial mesoderm
NOG;Formation of paraxial mesoderm
BMP4;Formation of lateral plate mesoderm
SMO;Formation of lateral plate mesoderm
FOXF1;Formation of lateral plate mesoderm
FOXH1;Formation of axial mesoderm
TBXT;Formation of axial mesoderm
FOXA2;Formation of axial mesoderm
SHH;Formation of axial mesoderm
NOTO;Formation of axial mesoderm
PAX8;Formation of the nephric duct
PAX8;Formation of intermediate mesoderm
PAX2;Formation of the nephric duct
PAX2;Formation of intermediate mesoderm
OSR1;Formation of intermediate mesoderm
LHX1;Formation of intermediate mesoderm
SNAI1;Epithelial-Mesenchymal Transition (EMT) during gastrulation
EOMES;Epithelial-Mesenchymal Transition (EMT) during gastrulation
TBXT;Epithelial-Mesenchymal Transition (EMT) during gastrulation
EOMES;Germ layer formation at gastrulation,Primitive streak formation
SOX2;Germ layer formation at gastrulation,Primitive streak formation
TFAP2A;Specification of the neural plate border
PAX7;Specification of the neural plate border
TFAP2B;Specification of the neural plate border
GBX2;Specification of the neural plate border
MSX1;Specification of the neural plate border
TFAP2C;Specification of the neural plate border
POU5F1;Specification of the neural plate border
SOX2;Specification of the neural plate border
MYB;Specification of the neural plate border
DLX5;Specification of the neural plate border
PAX3;Specification of the neural plate border
ZIC1;Specification of the neural plate border
TCF7L1;Specification of the neural plate border
CTNNB1;Specification of the neural plate border
FOXA2;Formation of definitive endoderm
EOMES;Formation of definitive endoderm
TBXT;Formation of definitive endoderm
GATA6;Formation of definitive endoderm
SOX17;Formation of definitive endoderm
MIXL1;Germ layer formation at gastrulation,Primitive streak formation
GATA4;Formation of definitive endoderm
MIXL1;Formation of definitive endoderm
GSC;Formation of definitive endoderm
CDH1;Formation of definitive endoderm
CXCR4;Formation of definitive endoderm
GSC;Germ layer formation at gastrulation,Primitive streak formation
GBX2;Formation of the posterior neural plate
ZEB2;Formation of the anterior neural plate
ZEB2;Formation of the posterior neural plate
SOX2;Formation of the anterior neural plate
SOX2;Formation of the posterior neural plate
ZNF521;Formation of the anterior neural plate
ZNF521;Formation of the posterior neural plate
POU3F1;Formation of the anterior neural plate
SOX1;Formation of the anterior neural plate
SOX1;Formation of the posterior neural plate
GATA4;Formation of lateral plate mesoderm
ZIC2;Formation of the anterior neural plate
PAX6;Formation of the anterior neural plate
OTX2;Formation of the anterior neural plate
CDON;Myogenesis
TCF3;Myogenesis
ABL1;Myogenesis
SPAG9;Myogenesis
BNIP2;Myogenesis
FOXO3;Signaling by NODAL
FOXH1;Signaling by Activin
FOXH1;Signaling by NODAL
FLI1;Transcriptional regulation of granulopoiesis
RUNX1;Transcriptional regulation of granulopoiesis
TAL1;Transcriptional regulation of granulopoiesis
MYB;Transcriptional regulation of granulopoiesis
GATA2;Transcriptional regulation of granulopoiesis
CEBPA;Transcriptional regulation of granulopoiesis
CEBPB;Transcriptional regulation of granulopoiesis
CDKN1A;Transcriptional regulation of granulopoiesis
CEBPE;Transcriptional regulation of granulopoiesis
KLF5;Transcriptional regulation of granulopoiesis
GFI1;Transcriptional regulation of granulopoiesis
MYC;Transcriptional regulation of granulopoiesis
LEF1;Transcriptional regulation of granulopoiesis
CDK4;Transcriptional regulation of granulopoiesis
DEK;Transcriptional regulation of granulopoiesis
CDK2;Transcriptional regulation of granulopoiesis
IL6R;Transcriptional regulation of granulopoiesis
CSF3R;Transcriptional regulation of granulopoiesis
EP300;Transcriptional regulation of granulopoiesis
PABPN1;Z-decay: degradation of maternal mRNAs by zygotically expressed factors
DIS3L2;Z-decay: degradation of maternal mRNAs by zygotically expressed factors
DUX4;Zygotic genome activation (ZGA)
DPPA2;Zygotic genome activation (ZGA)
DPPA4;Zygotic genome activation (ZGA)
DUXB;Zygotic genome activation (ZGA)
TPRX2;Zygotic genome activation (ZGA)
TPRXL;Zygotic genome activation (ZGA)
TPRX1;Zygotic genome activation (ZGA)
DUXA;Zygotic genome activation (ZGA)
LEUTX;Zygotic genome activation (ZGA)
KDM4E;Zygotic genome activation (ZGA)
ZSCAN4;Zygotic genome activation (ZGA)
CREBBP;Zygotic genome activation (ZGA)
EP300;Zygotic genome activation (ZGA)
ago-02;M-decay: degradation of maternal mRNAs by maternally stored factors
PABPN1L;M-decay: degradation of maternal mRNAs by maternally stored factors
BTG4;M-decay: degradation of maternal mRNAs by maternally stored factors
ZFP36L2;M-decay: degradation of maternal mRNAs by maternally stored factors
NPM2;Replacement of protamines by nucleosomes in the male pronucleus
HIRA;Replacement of protamines by nucleosomes in the male pronucleus
H3-3A;Replacement of protamines by nucleosomes in the male pronucleus
PRM1;Replacement of protamines by nucleosomes in the male pronucleus
H1-8;Replacement of protamines by nucleosomes in the male pronucleus
H4C1;Replacement of protamines by nucleosomes in the male pronucleus
H2AX;Replacement of protamines by nucleosomes in the male pronucleus
DPPA3;Chromatin modifications during the maternal to zygotic transition (MZT)
STPG4;Chromatin modifications during the maternal to zygotic transition (MZT)
METTL23;Chromatin modifications during the maternal to zygotic transition (MZT)
DNMT3A;Chromatin modifications during the maternal to zygotic transition (MZT)
DNMT1;Chromatin modifications during the maternal to zygotic transition (MZT)
IRX1;Nephron development
HNF1B;Nephron development
LHX1;Nephron development
WNT9B;Nephron development
IRX2;Nephron development
DLL1;Nephron development
JAG1;Nephron development
POU3F3;Nephron development
WT1;Nephron development
HNF4A;Nephron development
LFNG;Nephron development
WNT4;Nephron development
SIX1;Formation of the ureteric bud
SALL1;Formation of the ureteric bud
OSR1;Formation of the ureteric bud
EYA1;Formation of the ureteric bud
SIX2;Formation of the ureteric bud
PAX2;Formation of the ureteric bud
NPNT;Formation of the ureteric bud
NPNT;Formation of the nephric duct
LHX1;Formation of the nephric duct
BMP4;Formation of the ureteric bud
GREM1;Formation of the ureteric bud
GDNF;Formation of the ureteric bud
RET;Formation of the nephric duct
GATA3;Formation of the nephric duct
WNT11;Formation of the ureteric bud
SLIT2;Signaling by ROBO receptors
SLIT2;Formation of the ureteric bud
ROBO2;Signaling by ROBO receptors
ROBO2;Formation of the ureteric bud
ROBO2;Regulation of expression of SLITs and ROBOs
LHX2;Regulation of expression of SLITs and ROBOs
HOXA2;Regulation of expression of SLITs and ROBOs
SLIT2;Regulation of expression of SLITs and ROBOs
WFDC2;Formation of the nephric duct
PLAC8;Formation of the nephric duct
PCDH19;Formation of the nephric duct
ID4;Formation of the nephric duct
EMX2;Formation of the nephric duct
MECOM;Formation of the nephric duct
POU5F1;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation
NANOG;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation
SOX2;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation
FOXD3;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
ZIC3;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
SALL1;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
EPHA1;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
DPPA4;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
DHH;Transcriptional regulation of testis differentiation
SOX9;Transcriptional regulation of testis differentiation
SRY;Transcriptional regulation of testis differentiation
NR5A1;Transcriptional regulation of testis differentiation
GATA4;Transcriptional regulation of testis differentiation
ZFPM2;Transcriptional regulation of testis differentiation
WT1;Transcriptional regulation of testis differentiation
AMH;Transcriptional regulation of testis differentiation
DMRT1;Transcriptional regulation of testis differentiation
PTGDS;Transcriptional regulation of testis differentiation
FGF9;Transcriptional regulation of testis differentiation
NCK2;Regulation of cortical dendrite branching
SLIT1;Regulation of cortical dendrite branching
ROBO1;Regulation of expression of SLITs and ROBOs
ROBO1;Signaling by ROBO receptors
NRP1;Signaling by ROBO receptors
SLIT1;Regulation of expression of SLITs and ROBOs
MSI1;Regulation of expression of SLITs and ROBOs
EIF4G1;Regulation of expression of SLITs and ROBOs
PABPC1;Regulation of expression of SLITs and ROBOs
ETF1;Regulation of expression of SLITs and ROBOs
DCC;Netrin-1 signaling
DCC;Regulation of commissural axon pathfinding by SLIT and ROBO
SLIT3;Signaling by ROBO receptors
NELL2;Regulation of commissural axon pathfinding by SLIT and ROBO
ARHGAP39;Inactivation of CDC42 and RAC1
MYO9B;SLIT2:ROBO1 increases RHOA activity
PRKCA;ROBO receptors bind AKAP5
AKAP5;ROBO receptors bind AKAP5
ROBO2;ROBO receptors bind AKAP5
PPP3CB;ROBO receptors bind AKAP5
FLRT3;Signaling by ROBO receptors
UPF1;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
PNRC2;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
DCP1A;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
SMG6;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
SMG5;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
SMG7;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
UPF1;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
EIF4G1;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
PABPC1;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
L1CAM;L1CAM interactions
ALCAM;L1CAM interactions
NFASC;Neurofascin interactions
ANK1;Neurofascin interactions
NRCAM;Neurofascin interactions
DCX;Neurofascin interactions
SDCBP;Neurofascin interactions
CNTN6;CHL1 interactions
CHL1;CHL1 interactions
HSPA8;CHL1 interactions
ANK1;CHL1 interactions
NRP1;CHL1 interactions
CNTN1;L1CAM interactions
EPHB2;L1CAM interactions
L1CAM;Recycling pathway of L1
SH3GL2;Recycling pathway of L1
SHTN1;Recycling pathway of L1
MAPK1;Recycling pathway of L1
RANBP9;L1CAM interactions
CD24;L1CAM interactions
CNTN2;L1CAM interactions
NRCAM;NrCAM interactions
ANK1;NrCAM interactions
NRP2;NrCAM interactions
CNTN2;NrCAM interactions
GAP43;L1CAM interactions
L1CAM;Signal transduction by L1
PAK1;Signal transduction by L1
VAV2;Signal transduction by L1
NRP1;Signal transduction by L1
EGFR;Signal transduction by L1
NCAM1;Signal transduction by L1
NCAN;L1CAM interactions
TIAM1;EPH-ephrin mediated repulsion of cells
DNM1;EPH-ephrin mediated repulsion of cells
ADAM10;EPH-ephrin mediated repulsion of cells
ARHGEF7;Ephrin signaling
GIT1;Ephrin signaling
NCK2;Ephrin signaling
MYL12A;Ephrin signaling
SDCBP;Ephrin signaling
WASL;EPHB-mediated forward signaling
ITSN1;EPHB-mediated forward signaling
TIAM1;EPHB-mediated forward signaling
KALRN;EPHB-mediated forward signaling
SDC2;EPHB-mediated forward signaling
RASA1;EPHB-mediated forward signaling
FRS2;RET signaling
PTPN11;RET signaling
PLCG1;RET signaling
NTN1;Netrin mediated repulsion signals
DCC;Netrin mediated repulsion signals
PTPN11;Netrin mediated repulsion signals
NEO1;Netrin-1 signaling
MYO10;Netrin-1 signaling
EZR;Netrin-1 signaling
WASL;DCC mediated attractive signaling
NTN1;Netrin-1 signaling
DSCAM;DSCAM interactions
MAPK8;DSCAM interactions
DCC;DSCAM interactions
NTN1;DSCAM interactions
SIAH1;Netrin-1 signaling
PLCG1;Role of second messengers in netrin-1 signaling
PITPNA;Role of second messengers in netrin-1 signaling
SIAH2;Netrin-1 signaling
NTN4;Netrin-1 signaling
AGAP2;Netrin-1 signaling
UNC5B;Netrin-1 signaling
SH3KBP1;Reelin signalling pathway
DAB1;Reelin signalling pathway
RELN;Reelin signalling pathway
VLDLR;Reelin signalling pathway
PERP;Formation of the cornified envelope
KAZN;Formation of the cornified envelope
PPL;Formation of the cornified envelope
FLG;Formation of the cornified envelope
KLK5;Formation of the cornified envelope
SPINK9;Formation of the cornified envelope
CELA2A;Formation of the cornified envelope
SPINK5;Formation of the cornified envelope
KLK8;Formation of the cornified envelope
LORICRIN;Formation of the cornified envelope
TGM1;Formation of the cornified envelope
IVL;Formation of the cornified envelope
EVPL;Formation of the cornified envelope
SPINK6;Formation of the cornified envelope
KLK14;Formation of the cornified envelope
KLK12;Formation of the cornified envelope
CDSN;Formation of the cornified envelope
KLK13;Formation of the cornified envelope
EOMES;Cardiogenesis
KAT2A;Cardiogenesis
WDR5;Cardiogenesis
TBXT;Cardiogenesis
GATA4;Cardiogenesis
TBX20;Cardiogenesis
NKX2-5;Cardiogenesis
MEF2C;Cardiogenesis
MESP1;Cardiogenesis
SRF;Cardiogenesis
TBX5;Cardiogenesis
KAT5;Cardiogenesis
FOXO4;Cardiogenesis
ISL1;Cardiogenesis
GATA6;Cardiogenesis
MYOCD;Cardiogenesis
HAND2;Cardiogenesis
HAND1;Cardiogenesis
SMYD1;Cardiogenesis
ADIPOQ;Transcriptional regulation of white adipocyte differentiation
CEBPA;Transcriptional regulation of white adipocyte differentiation
FABP4;Transcriptional regulation of white adipocyte differentiation
HDAC3;Transcriptional regulation of white adipocyte differentiation
NCOR2;Transcriptional regulation of white adipocyte differentiation
NCOR1;Transcriptional regulation of white adipocyte differentiation
FAM120B;Transcriptional regulation of white adipocyte differentiation
NCOA3;Transcriptional regulation of white adipocyte differentiation
THRAP3;Transcriptional regulation of white adipocyte differentiation
NCOA2;Transcriptional regulation of white adipocyte differentiation
CREBBP;Transcriptional regulation of white adipocyte differentiation
EP300;Transcriptional regulation of white adipocyte differentiation
PPARGC1A;Transcriptional regulation of white adipocyte differentiation
NCOA1;Transcriptional regulation of white adipocyte differentiation
HELZ2;Transcriptional regulation of white adipocyte differentiation
PPARG;Transcriptional regulation of white adipocyte differentiation
RXRA;Transcriptional regulation of white adipocyte differentiation
KLF5;Transcriptional regulation of white adipocyte differentiation
CEBPB;Transcriptional regulation of white adipocyte differentiation
CEBPD;Transcriptional regulation of white adipocyte differentiation
EBF1;Transcriptional regulation of white adipocyte differentiation
PLIN1;Transcriptional regulation of white adipocyte differentiation
LEP;Transcriptional regulation of white adipocyte differentiation
CD36;PPARA activates gene expression
CD36;Transcriptional regulation of white adipocyte differentiation
PCK1;Transcriptional regulation of white adipocyte differentiation
ANGPTL4;PPARA activates gene expression
ANGPTL4;Transcriptional regulation of white adipocyte differentiation
LPL;Transcriptional regulation of white adipocyte differentiation
PDX1;Regulation of gene expression in early pancreatic precursor cells
ONECUT1;Regulation of gene expression in early pancreatic precursor cells
PTF1A;Regulation of gene expression in early pancreatic precursor cells
ONECUT3;Regulation of gene expression in early pancreatic precursor cells
NKX6-1;Regulation of gene expression in early pancreatic precursor cells
INSM1;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
NEUROG3;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
PAX4;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
NKX2-2;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
NEUROD1;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
ONECUT3;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
HNF1B;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
NKX6-1;Regulation of gene expression in beta cells
IAPP;Regulation of gene expression in beta cells
SLC2A2;Regulation of gene expression in beta cells
FOXO1;AKT-mediated inactivation of FOXO1A
HNF4G;Regulation of gene expression in beta cells
FOXA3;Regulation of gene expression in beta cells
INS;Regulation of gene expression in beta cells
F8;Defective F8 accelerates dissociation of the A2 domain
TFPI;Extrinsic Pathway of Fibrin Clot Formation,Generation of extrinsic Factor X activating complex
SERPING1;Intrinsic Pathway of Fibrin Clot Formation,Generation of intrinsic Factor X activating complex
SERPINC1;Common Pathway of Fibrin Clot Formation
F2R;Common Pathway of Fibrin Clot Formation
F8;Common Pathway of Fibrin Clot Formation
PROS1;Common Pathway of Fibrin Clot Formation
SERPIND1;Common Pathway of Fibrin Clot Formation
FGB;Common Pathway of Fibrin Clot Formation
FGA;Common Pathway of Fibrin Clot Formation
F13B;Common Pathway of Fibrin Clot Formation
F13A1;Common Pathway of Fibrin Clot Formation
SERPINA5;Common Pathway of Fibrin Clot Formation
F8;Defective F8 sulfation at Y1699
F8;Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation
RCCD1;Protein hydroxylation
RPS23;Protein hydroxylation
RPL8;Protein hydroxylation
U2AF2;Protein hydroxylation
RPL27A;Protein hydroxylation
ETF1;Protein hydroxylation
F9;Protein hydroxylation
RPS6;Protein hydroxylation
F2;Gamma-carboxylation of protein precursors
PROS1;Gamma-carboxylation of protein precursors
F9;Gamma-carboxylation of protein precursors
F7;Gamma-carboxylation of protein precursors
BGLAP;Gamma-carboxylation of protein precursors
PROZ;Gamma-carboxylation of protein precursors
GAS6;Gamma-carboxylation of protein precursors
F2;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
PROS1;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
PROZ;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
GAS6;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
F7;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
BGLAP;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
F9;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
GAS6;Removal of aminoterminal propeptides from gamma-carboxylated proteins
F2;Removal of aminoterminal propeptides from gamma-carboxylated proteins
PROZ;Removal of aminoterminal propeptides from gamma-carboxylated proteins
F9;Removal of aminoterminal propeptides from gamma-carboxylated proteins
F10;Removal of aminoterminal propeptides from gamma-carboxylated proteins
PROC;Removal of aminoterminal propeptides from gamma-carboxylated proteins
F7;Removal of aminoterminal propeptides from gamma-carboxylated proteins
PROS1;Removal of aminoterminal propeptides from gamma-carboxylated proteins
BGLAP;Removal of aminoterminal propeptides from gamma-carboxylated proteins
EEF2;Synthesis of diphthamide-EEF2
F10;Defective factor IX causes thrombophilia,Hyperactivation of factor X by FIXa R384L
MET;InlB-mediated entry of Listeria monocytogenes into host cell
SRC;InlA-mediated entry of Listeria monocytogenes into host cells
CTNND1;InlA-mediated entry of Listeria monocytogenes into host cells
MAP2K1;Uptake and function of anthrax toxins
FURIN;Potential therapeutics for SARS
FURIN;Uptake and function of anthrax toxins
MAP2K4;Uptake and function of anthrax toxins
MAP2K2;Uptake and function of anthrax toxins
MAP2K7;Uptake and function of anthrax toxins
SNAP25;Toxicity of botulinum toxin type E (botE)
VAMP1;Toxicity of botulinum toxin type F (botF)
VAMP2;Toxicity of botulinum toxin type F (botF)
VAMP2;Toxicity of tetanus toxin (tetX)
SNAP25;Toxicity of botulinum toxin type A (botA)
SNAP25;Toxicity of botulinum toxin type C (botC)
VAMP1;Toxicity of botulinum toxin type D (botD)
VAMP2;Toxicity of botulinum toxin type D (botD)
VAMP1;Toxicity of botulinum toxin type G (botG)
SYT1;Toxicity of botulinum toxin type G (botG)
VAMP2;Toxicity of botulinum toxin type G (botG)
VAMP2;Toxicity of botulinum toxin type B (botB)
HBEGF;Uptake and function of diphtheria toxin
CD9;Uptake and function of diphtheria toxin
EEF2;Uptake and function of diphtheria toxin
ATP6V1H;Blockage of phagosome acidification
NOS2;Inhibition of nitric oxide production
HGS;Inhibition of membrane repair
HGS;Prevention of phagosomal-lysosomal fusion
VPS33B;Prevention of phagosomal-lysosomal fusion
CORO1A;Prevention of phagosomal-lysosomal fusion
PGK1;Manipulation of host energy metabolism
ENO1;Manipulation of host energy metabolism
CTSG;Suppression of apoptosis
MAPK3;Suppression of apoptosis
SFPQ;Suppression of apoptosis
GSK3A;Suppression of apoptosis
RNF213;Suppression of apoptosis
TRIM27;Suppression of apoptosis
MAPK1;Suppression of apoptosis
DUSP16;Suppression of autophagy
RAB7A;Suppression of autophagy
B2M;Modulation by Mtb of host immune system
TLR2;Modulation by Mtb of host immune system
MRC1;Modulation by Mtb of host immune system
CRBN;Potential therapeutics for SARS
BRD4;Potential therapeutics for SARS
COMT;Enzymatic degradation of dopamine by COMT
COMT;Potential therapeutics for SARS
RIPK1;Potential therapeutics for SARS
TUBB;Potential therapeutics for SARS
SIGMAR1;Potential therapeutics for SARS
CD4;Binding and entry of HIV virion
PPIA;Integration of provirus
BANF1;Integration of provirus
HMGA1;Integration of provirus
PSIP1;Integration of provirus
PPIA;Assembly Of The HIV Virion
NEDD4L;Budding and maturation of HIV virion
PDCD6IP;Budding and maturation of HIV virion
NCL;Respiratory syncytial virus (RSV) attachment and entry
IL10;FCGR3A-mediated IL10 synthesis
ADAM17;CD163 mediating an anti-inflammatory response
MYH9;CD163 mediating an anti-inflammatory response
CD163;CD163 mediating an anti-inflammatory response
IL6;ADORA2B mediated anti-inflammatory cytokines production
FZD7;WNT5:FZD7-mediated leishmania damping
WNT5A;WNT5:FZD7-mediated leishmania damping
MAPK8;WNT5:FZD7-mediated leishmania damping
JUN;WNT5:FZD7-mediated leishmania damping
PLCG1;Signaling by FGFR1 in disease
FRS2;Signaling by FGFR1 in disease
PIK3CA;Signaling by cytosolic FGFR1 fusion mutants
PIK3R1;Signaling by cytosolic FGFR1 fusion mutants
PIK3CA;Signaling by FGFR1 in disease
PIK3CA;Signaling by FGFR3 in disease
FRS2;Signaling by FGFR3 in disease
PLCG1;Signaling by FGFR3 in disease
PLCG1;Signaling by FGFR2 in disease
FGFR2;Signaling by FGFR2 IIIa TM
PIK3CA;Signaling by FGFR2 in disease
FRS2;Signaling by FGFR2 in disease
FRS2;Signaling by FGFR4 in disease
PIK3CA;Signaling by FGFR4 in disease
FGFR4;FGFR4 mutant receptor activation
PLCG1;Signaling by FGFR4 in disease
JAK2;Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
LRP5;Signaling by LRP5 mutants 
CSNK1A1;APC truncation mutants have impaired AXIN binding
AMER1;APC truncation mutants have impaired AXIN binding
AXIN1;APC truncation mutants have impaired AXIN binding
GSK3B;APC truncation mutants have impaired AXIN binding
PORCN;LGK974 inhibits PORCN
CSNK1A1;Truncations of AMER1 destabilize the destruction complex
AXIN1;Truncations of AMER1 destabilize the destruction complex
APC;Truncations of AMER1 destabilize the destruction complex
GSK3B;Truncations of AMER1 destabilize the destruction complex
CSNK1A1;AXIN missense mutants destabilize the destruction complex
AMER1;AXIN missense mutants destabilize the destruction complex
APC;AXIN missense mutants destabilize the destruction complex
GSK3B;AXIN missense mutants destabilize the destruction complex
GAB2;Signaling by FLT3 ITD and TKD mutants
GRB2;Signaling by FLT3 ITD and TKD mutants
PIK3R1;Signaling by FLT3 ITD and TKD mutants
PTPN11;Signaling by FLT3 ITD and TKD mutants
CDKN1A;Signaling by FLT3 fusion proteins
CDKN1A;STAT5 activation downstream of FLT3 ITD mutants
NOX4;Signaling by FLT3 fusion proteins
NOX4;STAT5 activation downstream of FLT3 ITD mutants
PIM1;Signaling by FLT3 fusion proteins
PIM1;STAT5 activation downstream of FLT3 ITD mutants
BCL2L1;STAT5 activation downstream of FLT3 ITD mutants
SOS1;Signaling by FLT3 ITD and TKD mutants
PIK3CA;Signaling by FLT3 ITD and TKD mutants
PIK3CA;FLT3 Signaling
GRB10;FLT3 Signaling
SYK;FLT3 signaling through SRC family kinases
HCK;FLT3 signaling through SRC family kinases
FYN;FLT3 signaling through SRC family kinases
LCK;FLT3 signaling through SRC family kinases
GRAP2;FLT3 Signaling
CBL;Negative regulation of FLT3
SLA2;Negative regulation of FLT3
SLA;Negative regulation of FLT3
ABL2;Negative regulation of FLT3
SOCS2;Negative regulation of FLT3
SOCS6;Negative regulation of FLT3
CSK;Negative regulation of FLT3
SH2B3;Negative regulation of FLT3
BCL2L11;FLT3 Signaling
CDKN1B;FLT3 Signaling
FOXO3;FLT3 Signaling
GAB2;Signaling by FLT3 fusion proteins
SOS1;Signaling by FLT3 fusion proteins
PIK3R1;Signaling by FLT3 fusion proteins
PIK3CA;Signaling by FLT3 fusion proteins
SHC1;Signaling by ERBB2 TMD/JMD mutants
ERBIN;Signaling by ERBB2 TMD/JMD mutants
PLCG1;Signaling by ERBB2 TMD/JMD mutants
ERBIN;Signaling by ERBB2 KD Mutants
SHC1;Signaling by ERBB2 KD Mutants
PLCG1;Signaling by ERBB2 KD Mutants
ERBIN;Signaling by ERBB2 ECD mutants
SHC1;Signaling by ERBB2 ECD mutants
PLCG1;Signaling by ERBB2 ECD mutants
SHC1;Constitutive Signaling by Overexpressed ERBB2
ERBIN;Constitutive Signaling by Overexpressed ERBB2
AKT1;Constitutive Signaling by AKT1 E17K in Cancer
BAD;Constitutive Signaling by AKT1 E17K in Cancer
CHUK;Constitutive Signaling by AKT1 E17K in Cancer
MDM2;Constitutive Signaling by AKT1 E17K in Cancer
TSC2;Constitutive Signaling by AKT1 E17K in Cancer
AKT1S1;Constitutive Signaling by AKT1 E17K in Cancer
NR4A1;Constitutive Signaling by AKT1 E17K in Cancer
CASP9;Constitutive Signaling by AKT1 E17K in Cancer
CREB1;Constitutive Signaling by AKT1 E17K in Cancer
RPS6KB2;Constitutive Signaling by AKT1 E17K in Cancer
P4HB;Hedgehog ligand biogenesis
DISP2;Release of Hh-Np from the secreting cell
SCUBE2;Release of Hh-Np from the secreting cell
GPC5;Release of Hh-Np from the secreting cell
SMAD4;SMAD2/3 MH2 Domain Mutants in Cancer
PDGFRA;Regorafenib-resistant PDGFR mutants
PDGFRA;Sunitinib-resistant PDGFR mutants
DLL4;
JAG2;
DLL1;
JAG1;
NOTCH1;
DLL4;Constitutive Signaling by NOTCH1 PEST Domain Mutants
CREBBP;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CREBBP;Constitutive Signaling by NOTCH1 PEST Domain Mutants
EP300;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
EP300;Constitutive Signaling by NOTCH1 PEST Domain Mutants
NOTCH1;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
NOTCH1;Constitutive Signaling by NOTCH1 PEST Domain Mutants
HES5;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HES5;Constitutive Signaling by NOTCH1 PEST Domain Mutants
JAG2;Constitutive Signaling by NOTCH1 PEST Domain Mutants
JAG1;Constitutive Signaling by NOTCH1 PEST Domain Mutants
HES1;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HES1;Constitutive Signaling by NOTCH1 PEST Domain Mutants
MYC;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MYC;Constitutive Signaling by NOTCH1 PEST Domain Mutants
DLL1;Constitutive Signaling by NOTCH1 PEST Domain Mutants
NOTCH1;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
DLL1;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
DLL4;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
JAG1;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
JAG2;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
DLL4;Constitutive Signaling by NOTCH1 HD Domain Mutants
JAG1;Constitutive Signaling by NOTCH1 HD Domain Mutants
JAG2;Constitutive Signaling by NOTCH1 HD Domain Mutants
NOTCH1;Constitutive Signaling by NOTCH1 HD Domain Mutants
DLL1;Constitutive Signaling by NOTCH1 HD Domain Mutants
SHC1;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
EGF;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
EGFR;Constitutive Signaling by EGFRvIII
CBL;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
PLCG1;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
EGF;Constitutive Signaling by EGFRvIII
SHC1;Constitutive Signaling by EGFRvIII
CBL;Constitutive Signaling by EGFRvIII
PLCG1;Constitutive Signaling by EGFRvIII
EGFR;Inhibition of Signaling by Overexpressed EGFR
ALK;Signaling by ALK
ALK;MDK and PTN in ALK signaling
MDK;MDK and PTN in ALK signaling
PTN;MDK and PTN in ALK signaling
STAT3;Signaling by ALK
FRS2;Signaling by ALK
JAK3;Signaling by ALK
MYCN;Signaling by ALK
PTPRZ1;MDK and PTN in ALK signaling
IRS1;Signaling by ALK
IL2RG;STAT3 nuclear events downstream of ALK signaling
SIN3A;STAT3 nuclear events downstream of ALK signaling
DNMT1;STAT3 nuclear events downstream of ALK signaling
HIF1A;STAT3 nuclear events downstream of ALK signaling
PRDM1;STAT3 nuclear events downstream of ALK signaling
CD274;STAT3 nuclear events downstream of ALK signaling
PLCG1;Signaling by ALK
STAT3;Interleukin-10 signaling
IL10;Interleukin-10 signaling
STAT3;Interleukin-20 family signaling
PTPN11;Interleukin-20 family signaling
IL22;Interleukin-20 family signaling
IL22RA2;Interleukin-20 family signaling
IL22RA1;Interleukin-20 family signaling
PTGS2;Interleukin-4 and Interleukin-13 signaling
PTGS2;Interleukin-10 signaling
PIK3CA;Signaling by ALK fusions and activated point mutants
PIK3R1;Signaling by ALK fusions and activated point mutants
STAT3;Signaling by ALK fusions and activated point mutants
PLCG1;Signaling by ALK fusions and activated point mutants
IRS1;Signaling by ALK fusions and activated point mutants
MDM2;Signaling by ALK fusions and activated point mutants
CDKN1A;Signaling by ALK fusions and activated point mutants
JUN;Signaling by ALK fusions and activated point mutants
GRB2;Signaling by ALK fusions and activated point mutants
CCNB1;Nuclear events stimulated by ALK signaling in cancer
FOXM1;Nuclear events stimulated by ALK signaling in cancer
NPM1;Nuclear events stimulated by ALK signaling in cancer
GZMB;Nuclear events stimulated by ALK signaling in cancer
JUNB;Nuclear events stimulated by ALK signaling in cancer
BCL2A1;Nuclear events stimulated by ALK signaling in cancer
PTPN6;Nuclear events stimulated by ALK signaling in cancer
HDAC1;Nuclear events stimulated by ALK signaling in cancer
DNMT1;Nuclear events stimulated by ALK signaling in cancer
STAT5A;Nuclear events stimulated by ALK signaling in cancer
RB1;Nuclear events stimulated by ALK signaling in cancer
IL10RA;Nuclear events stimulated by ALK signaling in cancer
ZAP70;Nuclear events stimulated by ALK signaling in cancer
PRF1;Nuclear events stimulated by ALK signaling in cancer
TWIST1;Nuclear events stimulated by ALK signaling in cancer
CEBPB;Nuclear events stimulated by ALK signaling in cancer
IRF4;Nuclear events stimulated by ALK signaling in cancer
TYK2;Signaling by ALK fusions and activated point mutants
MCL1;Signaling by ALK fusions and activated point mutants
MOCS2;Molybdenum cofactor biosynthesis
TCN1;Transport of RCbl within the body
FOLR2;Metabolism of folate and pterines
FASN;Vitamin B5 (pantothenate) metabolism
CBLIF;Defective CBLIF causes IFD,Defective CBLIF causes intrinsic factor deficiency
TCN2;Defective TCN2 causes TCN2 deficiency,Defective TCN2 causes hereditary megaloblastic anemia
CD320;Defective CD320 causes MMATC,Defective CD320 causes methylmalonic aciduria
SERPINA6;Glucocorticoid biosynthesis
SRD5A2;Androgen biosynthesis
CYP19A1;Estrogen biosynthesis
AHRR;Aryl hydrocarbon receptor signalling
CYP3A4;Phase I - Functionalization of compounds
NCOA2;Recycling of bile acids and salts
NCOA1;Recycling of bile acids and salts
RXRA;Recycling of bile acids and salts
ALB;Recycling of bile acids and salts
STARD5;Recycling of bile acids and salts
DAG1;Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
DAG1;O-linked glycosylation
DAG1;Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
DAG1;Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
MC2R;Defective ACTH causes obesity and POMCD,Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
SFTPC;Surfactant metabolism
TTF1;Surfactant metabolism
CCDC59;Surfactant metabolism
GATA6;Surfactant metabolism
SFTPB;Surfactant metabolism
CKAP4;Surfactant metabolism
DMBT1;Surfactant metabolism
LMCD1;Surfactant metabolism
SFTPC;Defective CSF2RB causes SMDP5,Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)
SFTPC;Defective CSF2RA causes SMDP4,Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
RBP4;Retinoid metabolism and transport
RBP1;Retinoid metabolism and transport
RBP2;Retinoid metabolism and transport
APOE;Retinoid metabolism and transport
APOM;Retinoid metabolism and transport
OPN1LW;The retinoid cycle in cones (daylight vision)
OPN1SW;The retinoid cycle in cones (daylight vision)
OPN1MW;The retinoid cycle in cones (daylight vision)
RLBP1;The retinoid cycle in cones (daylight vision)
CALM1;Protein methylation
GNAT1;Inactivation, recovery and regulation of the phototransduction cascade
GNGT1;Inactivation, recovery and regulation of the phototransduction cascade
GRK1;Inactivation, recovery and regulation of the phototransduction cascade
OPN1MW;Retinoid cycle disease events
OPN1LW;Retinoid cycle disease events
SKP2;Aberrant regulation of mitotic exit in cancer due to RB1 defects
RB1;Aberrant regulation of mitotic exit in cancer due to RB1 defects
DAXX;Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations
ATRX;Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations
CASP8;Microbial modulation of RIPK1-mediated regulated necrosis
MLKL;Microbial modulation of RIPK1-mediated regulated necrosis
RIPK1;Microbial modulation of RIPK1-mediated regulated necrosis
RIPK3;Microbial modulation of RIPK1-mediated regulated necrosis
CAST;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25A;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDK5;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDK5R1;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
GOLGA2;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
FOXO3;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25C;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
SOD2;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
FASLG;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
PRDX1;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
APP;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
LMNB1;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25B;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
BCL2L11;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
PRDX2;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
YWHAE;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
JUN;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
RAD51;Impaired BRCA2 binding to RAD51
PALB2;Impaired BRCA2 binding to PALB2
RAD51AP1;Impaired BRCA2 binding to PALB2
SEM1;Impaired BRCA2 binding to SEM1 (DSS1)
BARD1;Defective DNA double strand break response due to BRCA1 loss of function
PALB2;Defective homologous recombination repair (HRR) due to BRCA1 loss of function
RAD51AP1;Defective homologous recombination repair (HRR) due to BRCA1 loss of function
BRCA1;Defective DNA double strand break response due to BARD1 loss of function
RAD51AP1;Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RAD51AP1;Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
MSH6;Defective Mismatch Repair Associated With MSH2
MSH3;Defective Mismatch Repair Associated With MSH2
MSH3;Defective Mismatch Repair Associated With MSH3
MSH2;Defective Mismatch Repair Associated With MSH3
MSH6;Defective Mismatch Repair Associated With MSH6
MSH2;Defective Mismatch Repair Associated With MSH6
MLH1;Defective Mismatch Repair Associated With PMS2
PMS2;Defective Mismatch Repair Associated With MLH1
NEIL3;Recognition and association of DNA glycosylase with site containing an affected purine
OGG1;Recognition and association of DNA glycosylase with site containing an affected purine
MPG;Recognition and association of DNA glycosylase with site containing an affected purine
OGG1;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
NEIL2;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
NEIL3;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
TDG;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
SMUG1;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
NEIL1;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
NTHL1;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
MBD4;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
PNKP;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
POLB;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
OGG1;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
MBD4;Displacement of DNA glycosylase by APEX1
APEX1;Displacement of DNA glycosylase by APEX1
NTHL1;Displacement of DNA glycosylase by APEX1
OGG1;Displacement of DNA glycosylase by APEX1
MPG;Displacement of DNA glycosylase by APEX1
SMUG1;Displacement of DNA glycosylase by APEX1
TDG;Displacement of DNA glycosylase by APEX1
POLB;Resolution of AP sites via the multiple-nucleotide patch replacement pathway
FEN1;POLB-Dependent Long Patch Base Excision Repair
APEX1;POLB-Dependent Long Patch Base Excision Repair
LIG1;POLB-Dependent Long Patch Base Excision Repair
POLB;POLB-Dependent Long Patch Base Excision Repair
POLB;PCNA-Dependent Long Patch Base Excision Repair
FEN1;PCNA-Dependent Long Patch Base Excision Repair
LIG1;PCNA-Dependent Long Patch Base Excision Repair
APEX1;PCNA-Dependent Long Patch Base Excision Repair
APEX1;Abasic sugar-phosphate removal via the single-nucleotide replacement pathway
POLB;Abasic sugar-phosphate removal via the single-nucleotide replacement pathway
POLB;Resolution of AP sites via the single-nucleotide replacement pathway
OGG1;Defective OGG1 Substrate Processing
NEIL1;Defective Base Excision Repair Associated with NEIL1
CFTR;Defective CFTR causes cystic fibrosis
RAPGEF3;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
RAPGEF4;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
SNAP25;Regulation of insulin secretion
INS;Regulation of insulin secretion
SYT5;Regulation of insulin secretion
VAMP2;Regulation of insulin secretion
STXBP1;Regulation of insulin secretion
MARCKS;Acetylcholine regulates insulin secretion
MLXIPL;AMPK inhibits chREBP transcriptional activation activity
FASN;ChREBP activates metabolic gene expression
MLXIPL;PKA-mediated phosphorylation of key metabolic factors
AVPR2;Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)
ACHE;Neurotransmitter clearance
SLC6A4;Serotonin clearance from the synaptic cleft,Clearance of seratonin,Clearance of serotonin
SLC6A3;Dopamine clearance from the synaptic cleft,Clearance of dopamine
CDKN2A;Evasion of Oncogene Induced Senescence Due to p14ARF Defects
CDKN2A;Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects
CDK4;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4
CDK4;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4
IRAK4;IRAK4 deficiency (TLR2/4)
CHUK;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
IKBKB;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
MYD88;MyD88 deficiency (TLR2/4)
IRAK4;IRAK4 deficiency (TLR5)
IKBKG;IKBKB deficiency causes SCID
CHUK;IKBKB deficiency causes SCID
IKBKB;IKBKB deficiency causes SCID
TLR3;UNC93B1 deficiency - HSE
TRAF3;TRAF3 deficiency - HSE
REV1;Translesion synthesis by POLK,Translesion Synthesis by DNA Polymerase Kappa
REV1;Termination of translesion DNA synthesis
POLH;Translesion Synthesis by POLH
RCHY1;Translesion Synthesis by POLH
SPRTN;Translesion Synthesis by POLH
REV3L;Translesion synthesis by REV1
MAD2L2;Translesion synthesis by REV1
REV1;Translesion synthesis by REV1
REV1;Translesion synthesis by POLI
USP10;Termination of translesion DNA synthesis
UBA7;Termination of translesion DNA synthesis
USP43;Termination of translesion DNA synthesis
ISG15;Termination of translesion DNA synthesis
PCLAF;Termination of translesion DNA synthesis
WDR48;Recognition of DNA damage by PCNA-containing replication complex
USP1;Recognition of DNA damage by PCNA-containing replication complex
SERPINA6;Prednisone ADME
ALB;Prednisone ADME
ALB;Aspirin ADME
ALB;Ciprofloxacin ADME
HSPG2;Laminin interactions
OPTC;Degradation of the extracellular matrix
DCN;Degradation of the extracellular matrix
SPP1;Degradation of the extracellular matrix
HSPG2;Degradation of the extracellular matrix
CD44;Degradation of the extracellular matrix
NID1;Degradation of the extracellular matrix
MMP10;Activation of Matrix Metalloproteinases
MMP7;Activation of Matrix Metalloproteinases
MMP14;Activation of Matrix Metalloproteinases
TIMP2;Activation of Matrix Metalloproteinases
MMP2;Activation of Matrix Metalloproteinases
MMP13;Activation of Matrix Metalloproteinases
MMP9;Activation of Matrix Metalloproteinases
TIMP1;Activation of Matrix Metalloproteinases
MMP1;Activation of Matrix Metalloproteinases
MMP8;Activation of Matrix Metalloproteinases
MMP3;Activation of Matrix Metalloproteinases
MMP11;Activation of Matrix Metalloproteinases
SCUBE3;Degradation of the extracellular matrix
FBLN5;Elastic fibre formation
ELN;Elastic fibre formation
COL18A1;Assembly of collagen fibrils and other multimeric structures
COL15A1;Assembly of collagen fibrils and other multimeric structures
CD151;Assembly of collagen fibrils and other multimeric structures
P4HB;Collagen biosynthesis and modifying enzymes
SERPINH1;Collagen biosynthesis and modifying enzymes
FN1;Extracellular matrix organization
DMD;Non-integrin membrane-ECM interactions
NRXN1;Non-integrin membrane-ECM interactions
HSPG2;Non-integrin membrane-ECM interactions
NTN4;Non-integrin membrane-ECM interactions
THBS1;Syndecan interactions
ACTN1;Syndecan interactions
TRAPPC4;Syndecan interactions
CASK;Syndecan interactions
TGFB1;Syndecan interactions
FGF2;Syndecan interactions
TNC;Syndecan interactions
VTN;Syndecan interactions
DAG1;ECM proteoglycans
AGRN;ECM proteoglycans
VTN;ECM proteoglycans
IBSP;ECM proteoglycans
DCN;ECM proteoglycans
DMP1;ECM proteoglycans
DSPP;ECM proteoglycans
SERPINE1;ECM proteoglycans
HSPG2;ECM proteoglycans
SPARC;ECM proteoglycans
HAPLN1;ECM proteoglycans
CBX3;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a),Activation of rRNA Expression by Cockayne Syndrome Protein CSB and Histone Methyltransferase G9a
EHMT2;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a),Activation of rRNA Expression by Cockayne Syndrome Protein CSB and Histone Methyltransferase G9a
TTF1;RNA Polymerase I Transcription Termination
TTF1;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
TTF1;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a),Activation of rRNA Expression by Cockayne Syndrome Protein CSB and Histone Methyltransferase G9a
RRN3;RNA Polymerase I Promoter Escape
TAF1D;RNA Polymerase I Transcription Initiation
TAF1B;RNA Polymerase I Transcription Initiation
TAF1A;RNA Polymerase I Transcription Initiation
TBP;RNA Polymerase I Transcription Initiation
TAF1C;RNA Polymerase I Transcription Initiation
UBTF;RNA Polymerase I Promoter Opening
RRN3;RNA Polymerase I Transcription Initiation
POLR2K;RNA Polymerase I Transcription Initiation
POLR1H;RNA Polymerase I Transcription Initiation
POLR1E;RNA Polymerase I Transcription Initiation
POLR1D;RNA Polymerase I Transcription Initiation
POLR1G;RNA Polymerase I Transcription Initiation
POLR1C;RNA Polymerase I Transcription Initiation
POLR1F;RNA Polymerase I Transcription Initiation
POLR1B;RNA Polymerase I Transcription Initiation
POLR1A;RNA Polymerase I Transcription Initiation
POLR2H;RNA Polymerase I Transcription Initiation
POLR2F;RNA Polymerase I Transcription Initiation
POLR2L;RNA Polymerase I Transcription Initiation
POLR2E;RNA Polymerase I Transcription Initiation
KAT2B;B-WICH complex positively regulates rRNA expression
KAT2A;B-WICH complex positively regulates rRNA expression
EP300;B-WICH complex positively regulates rRNA expression
ACTB;B-WICH complex positively regulates rRNA expression
DDX21;B-WICH complex positively regulates rRNA expression
MYBBP1A;B-WICH complex positively regulates rRNA expression
BAZ1B;B-WICH complex positively regulates rRNA expression
DEK;B-WICH complex positively regulates rRNA expression
SMARCA5;B-WICH complex positively regulates rRNA expression
SF3B1;B-WICH complex positively regulates rRNA expression
PAGR1;Formation of WDR5-containing histone-modifying complexes
PAXIP1;Formation of WDR5-containing histone-modifying complexes
MCRS1;Formation of WDR5-containing histone-modifying complexes
HCFC1;Formation of WDR5-containing histone-modifying complexes
KAT8;Formation of WDR5-containing histone-modifying complexes
KANSL3;Formation of WDR5-containing histone-modifying complexes
OGT;Formation of WDR5-containing histone-modifying complexes
KANSL2;Formation of WDR5-containing histone-modifying complexes
KANSL1;Formation of WDR5-containing histone-modifying complexes
PSIP1;Formation of WDR5-containing histone-modifying complexes
MEN1;Formation of WDR5-containing histone-modifying complexes
BOD1;Formation of WDR5-containing histone-modifying complexes
WDR82;Formation of WDR5-containing histone-modifying complexes
CXXC1;Formation of WDR5-containing histone-modifying complexes
AKAP8L;Formation of WDR5-containing histone-modifying complexes
NCOA6;Formation of WDR5-containing histone-modifying complexes
KDM6A;Formation of WDR5-containing histone-modifying complexes
BOD1L1;Formation of WDR5-containing histone-modifying complexes
DNMT1;DNA methylation
UHRF1;DNA methylation
TDG;TET1,2,3 and TDG demethylate DNA,Active DNA Demethylation by TET1,2,3,Oxidative demethylation of DNA
DNMT3B;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
HDAC1;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
HDAC2;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
DNMT1;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
MBD2;NoRC negatively regulates rRNA expression,Methylation of histones and DNA negatively regulates rRNA expression
SIRT1;SIRT1 negatively regulates rRNA expression,Regulation of rRNA Expression by NAD-dependent Deacetylase Sirtuin-1
SUV39H1;SIRT1 negatively regulates rRNA expression,Regulation of rRNA Expression by NAD-dependent Deacetylase Sirtuin-1
RRP8;SIRT1 negatively regulates rRNA expression,Regulation of rRNA Expression by NAD-dependent Deacetylase Sirtuin-1
CAVIN1;RNA Polymerase I Transcription Termination
TFAM;Mitochondrial transcription initiation
MTERF1;Mitochondrial transcription termination
TNRC6A;Transcriptional regulation by small RNAs
IPO8;Transcriptional regulation by small RNAs
MAEL;PIWI-interacting RNA (piRNA) biogenesis
TDRKH;PIWI-interacting RNA (piRNA) biogenesis
TDRD9;PIWI-interacting RNA (piRNA) biogenesis
GTF3A;RNA Polymerase III Transcription Initiation From Type 1 Promoter
POU2F1;RNA Polymerase III Transcription Initiation From Type 3 Promoter
ZNF143;RNA Polymerase III Transcription Initiation From Type 3 Promoter
ABL1;Factors involved in megakaryocyte development and platelet production
CDK5;Factors involved in megakaryocyte development and platelet production
NFE2;Factors involved in megakaryocyte development and platelet production
HBG1;Factors involved in megakaryocyte development and platelet production
HBB;Factors involved in megakaryocyte development and platelet production
HBE1;Factors involved in megakaryocyte development and platelet production
HBD;Factors involved in megakaryocyte development and platelet production
HBG2;Factors involved in megakaryocyte development and platelet production
KIFC1;Kinesins
RACGAP1;Kinesins
KIF9;Kinesins
KIFAP3;Kinesins
KIF3A;Kinesins
KIF11;Kinesins
KIF15;Kinesins
KIF18A;Kinesins
CENPE;Kinesins
VPS45;Factors involved in megakaryocyte development and platelet production
RAB5A;Factors involved in megakaryocyte development and platelet production
RBSN;Factors involved in megakaryocyte development and platelet production
IRF1;Factors involved in megakaryocyte development and platelet production
CARMIL1;Factors involved in megakaryocyte development and platelet production
CAPZB;Factors involved in megakaryocyte development and platelet production
CBX5;Factors involved in megakaryocyte development and platelet production
CDK2;Factors involved in megakaryocyte development and platelet production
WEE1;Factors involved in megakaryocyte development and platelet production
CABLES1;Factors involved in megakaryocyte development and platelet production
SIN3A;Factors involved in megakaryocyte development and platelet production
MYB;Factors involved in megakaryocyte development and platelet production
IRF2;Factors involved in megakaryocyte development and platelet production
RAD51C;Factors involved in megakaryocyte development and platelet production
RAD51B;Factors involved in megakaryocyte development and platelet production
JAK2;Factors involved in megakaryocyte development and platelet production
RAF1;GP1b-IX-V activation signalling
VWF;GP1b-IX-V activation signalling
FLNA;GP1b-IX-V activation signalling
PIK3R1;GP1b-IX-V activation signalling
AAMP;Thromboxane signalling through TP receptor
CALU;Platelet degranulation 
HSPA5;Platelet degranulation 
STXBP3;Disinhibition of SNARE formation
STX4;Disinhibition of SNARE formation
ARRB2;Thrombin signalling through proteinase activated receptors (PARs)
F2R;Thrombin signalling through proteinase activated receptors (PARs)
ARRB1;Thrombin signalling through proteinase activated receptors (PARs)
THPO;Platelet Aggregation (Plug Formation)
MPL;Platelet Aggregation (Plug Formation)
TLN1;Integrin signaling
APBB1IP;Integrin signaling
SHC1;Integrin signaling
BCAR1;p130Cas linkage to MAPK signaling for integrins
PTK2;Integrin signaling
CSK;Integrin signaling
CRK;p130Cas linkage to MAPK signaling for integrins
SYK;Integrin signaling
SOS1;GRB2:SOS provides linkage to MAPK signaling for Integrins 
PTK2;GRB2:SOS provides linkage to MAPK signaling for Integrins 
PDPN;GPVI-mediated activation cascade
LAT;GPVI-mediated activation cascade
MPIG6B;GPVI-mediated activation cascade
PLG;Dissolution of Fibrin Clot
HRG;Dissolution of Fibrin Clot
PLAT;Dissolution of Fibrin Clot
PLAU;Dissolution of Fibrin Clot
PLAUR;Dissolution of Fibrin Clot
SERPINE1;Dissolution of Fibrin Clot
SERPINF2;Dissolution of Fibrin Clot
SERPINB2;Dissolution of Fibrin Clot
JAK2;Signaling by CSF3 (G-CSF)
HCK;Signaling by CSF3 (G-CSF)
SYK;Signaling by CSF3 (G-CSF)
TYK2;Signaling by CSF3 (G-CSF)
RNF7;Inactivation of CSF3 (G-CSF) signaling
ELOC;Inactivation of CSF3 (G-CSF) signaling
ELOB;Inactivation of CSF3 (G-CSF) signaling
CUL5;Inactivation of CSF3 (G-CSF) signaling
SOCS3;Inactivation of CSF3 (G-CSF) signaling
SOCS1;Inactivation of CSF3 (G-CSF) signaling
GRB2;Signaling by CSF3 (G-CSF)
SHC1;Signaling by CSF3 (G-CSF)
GAB2;Signaling by CSF3 (G-CSF)
PTPN11;Signaling by CSF3 (G-CSF)
KRAS;Signaling by CSF3 (G-CSF)
PTPN6;Growth hormone receptor signaling
LYN;Growth hormone receptor signaling
PTPN1;Growth hormone receptor signaling
TRAF3;TNFR2 non-canonical NF-kB pathway,TNFRSF mediated non-canonical NF-kB pathway
TNFRSF12A;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
TNFRSF13C;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
LTBR;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
TNFRSF11A;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
EDAR;TNFs bind their physiological receptors
EDA;TNFs bind their physiological receptors
TNFRSF25;TNFs bind their physiological receptors
TNFSF15;TNFs bind their physiological receptors
EDA2R;TNFs bind their physiological receptors
TNFRSF9;TNFs bind their physiological receptors
TNFRSF4;TNFs bind their physiological receptors
CD27;TNFs bind their physiological receptors
TNFRSF6B;TNFs bind their physiological receptors
TNFSF8;TNFs bind their physiological receptors
TNFRSF8;TNFs bind their physiological receptors
TNFRSF11B;TNFs bind their physiological receptors
TNFSF18;TNFs bind their physiological receptors
TNFRSF18;TNFs bind their physiological receptors
EDARADD;TNFs bind their physiological receptors
STAT3;Interleukin-7 signaling
TSLP;Interleukin-7 signaling
HGF;Interleukin-7 signaling
IL24;Interleukin-20 family signaling
IL20;Interleukin-20 family signaling
IL26;Interleukin-20 family signaling
STAT1;Interleukin-20 family signaling
IL13;Interleukin-4 and Interleukin-13 signaling
TYK2;Interleukin-4 and Interleukin-13 signaling
IL13RA1;Interleukin-4 and Interleukin-13 signaling
GATA3;Interleukin-4 and Interleukin-13 signaling
FASLG;Interleukin-4 and Interleukin-13 signaling
IL13RA2;Interleukin-4 and Interleukin-13 signaling
SOCS1;Interleukin-4 and Interleukin-13 signaling
MAOA;Interleukin-4 and Interleukin-13 signaling
HSP90B1;Interleukin-4 and Interleukin-13 signaling
HMOX1;Interleukin-4 and Interleukin-13 signaling
CD36;Interleukin-4 and Interleukin-13 signaling
IL27;Interleukin-27 signaling
CRLF1;Interleukin-27 signaling
STAT3;Interleukin-27 signaling
STAT1;Interleukin-27 signaling
IL27RA;Interleukin-27 signaling
JAK1;Interleukin-27 signaling
CANX;Interleukin-27 signaling
EBI3;Interleukin-27 signaling
IL12RB1;Interleukin-12 signaling
TYK2;Interleukin-12 signaling
BOLA2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
MSN;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
MIF;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
SOD2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
HNRNPF;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
PDCD4;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
PITPNA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
RALA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
LMNB1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
LCP1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
HNRNPDL;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
ARF1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
MTAP;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
IFNG;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
CA1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
GSTO1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
TALDO1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
SNRPA1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
ANXA2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
IL10;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
RAP1B;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
HNRNPA2B1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
CAPZA1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
CNN2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
CDC42;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
PAK2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
SERPINB2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
PPIA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
AIP;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
GSTA2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
TCP1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
RPLP0;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
SOD1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
PSME2;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
CFL1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
HSPA9;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
JAK2;Interleukin-12 signaling
IL12RB2;Interleukin-12 signaling
IL12B;Interleukin-12 signaling
IL12A;Interleukin-12 signaling
STAT4;Interleukin-12 signaling
CANX;Interleukin-35 Signalling
IL12A;Interleukin-35 Signalling
STAT1;Interleukin-35 Signalling
STAT3;Interleukin-35 Signalling
STAT4;Interleukin-35 Signalling
EBI3;Interleukin-35 Signalling
STAT4;Interleukin-23 signaling
STAT3;Interleukin-23 signaling
JAK2;Interleukin-23 signaling
IL23R;Interleukin-23 signaling
IL23A;Interleukin-23 signaling
IL12B;Interleukin-23 signaling
CSF1R;Signaling by CSF1 (M-CSF) in myeloid cells
CBL;Signaling by CSF1 (M-CSF) in myeloid cells
GRAP2;Signaling by CSF1 (M-CSF) in myeloid cells
SHC1;Signaling by CSF1 (M-CSF) in myeloid cells
INPP5D;Signaling by CSF1 (M-CSF) in myeloid cells
FYN;Signaling by CSF1 (M-CSF) in myeloid cells
SRC;Signaling by CSF1 (M-CSF) in myeloid cells
LYN;Signaling by CSF1 (M-CSF) in myeloid cells
YES1;Signaling by CSF1 (M-CSF) in myeloid cells
THOC5;Signaling by CSF1 (M-CSF) in myeloid cells
PLCG2;Signaling by CSF1 (M-CSF) in myeloid cells
INPPL1;Signaling by CSF1 (M-CSF) in myeloid cells
PTPN11;Signaling by CSF1 (M-CSF) in myeloid cells
RAP1GAP2;Rap1 signalling
RAF1;Rap1 signalling
CD160;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CD99;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
SELL;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KIR2DL1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
NECTIN2;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CRTAM;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KIR3DL1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
PILRA;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KLRC1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KLRD1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
PVR;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CD226;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KIR2DL4;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KIR3DL2;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
KLRG1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CDH1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CD96;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CLEC2D;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CD200;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
CD200R1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
SLAMF6;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
OSCAR;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
SLAMF7;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
LAIR2;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
NCR3LG1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
LAIR1;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
SH3GL2;MHC class II antigen presentation
CANX;MHC class II antigen presentation
LAG3;MHC class II antigen presentation
CD74;MHC class II antigen presentation
SPTBN2;MHC class II antigen presentation
XDH;Butyrophilin (BTN) family interactions
BTN1A1;Butyrophilin (BTN) family interactions
BTN2A2;Butyrophilin (BTN) family interactions
PPL;Butyrophilin (BTN) family interactions
BTNL8;Butyrophilin (BTN) family interactions
BTNL9;Butyrophilin (BTN) family interactions
BTN2A1;Butyrophilin (BTN) family interactions
CD209;Butyrophilin (BTN) family interactions
BTNL2;Butyrophilin (BTN) family interactions
MTMR7;Synthesis of PIPs at the late endosome membrane
MTMR7;Synthesis of IP2, IP, and Ins in the cytosol
MTMR9;Synthesis of PIPs at the late endosome membrane
MTMR9;Synthesis of IP2, IP, and Ins in the cytosol
LIPE;Triglyceride catabolism,Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
PLIN1;Triglyceride catabolism,Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
ABHD5;Triglyceride catabolism,Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
FABP4;Triglyceride catabolism,Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
KPNB1;Regulation of cholesterol biosynthesis by SREBP (SREBF)
TM7SF2;Activation of gene expression by SREBF (SREBP)
SP1;Activation of gene expression by SREBF (SREBP)
GGPS1;Activation of gene expression by SREBF (SREBP)
ELOVL6;Activation of gene expression by SREBF (SREBP)
GPAM;Activation of gene expression by SREBF (SREBP)
MVD;Activation of gene expression by SREBF (SREBP)
PMVK;Activation of gene expression by SREBF (SREBP)
FDPS;Activation of gene expression by SREBF (SREBP)
DHCR7;Activation of gene expression by SREBF (SREBP)
LSS;Activation of gene expression by SREBF (SREBP)
ACACB;Activation of gene expression by SREBF (SREBP)
IDI1;Activation of gene expression by SREBF (SREBP)
SCD;Activation of gene expression by SREBF (SREBP)
HMGCS1;PPARA activates gene expression
HMGCS1;Activation of gene expression by SREBF (SREBP)
FDFT1;PPARA activates gene expression
FDFT1;Activation of gene expression by SREBF (SREBP)
SC5D;Activation of gene expression by SREBF (SREBP)
FASN;Activation of gene expression by SREBF (SREBP)
ACACA;Activation of gene expression by SREBF (SREBP)
SQLE;Activation of gene expression by SREBF (SREBP)
CYP51A1;Activation of gene expression by SREBF (SREBP)
MVK;Activation of gene expression by SREBF (SREBP)
HILPDA;Lipid particle organization
HSD17B13;Lipid particle organization
ACSL1;PPARA activates gene expression
ANKRD1;PPARA activates gene expression
APOA2;PPARA activates gene expression
RGL1;PPARA activates gene expression
SULT2A1;PPARA activates gene expression
GLIPR1;PPARA activates gene expression
CPT2;PPARA activates gene expression
PLIN2;PPARA activates gene expression
TNFRSF21;PPARA activates gene expression
TIAM2;PPARA activates gene expression
TRIB3;PPARA activates gene expression
CYP1A1;PPARA activates gene expression
ABCA1;PPARA activates gene expression
ABCB4;PPARA activates gene expression
HMGCS2;PPARA activates gene expression
APOA5;PPARA activates gene expression
UGT1A9;PPARA activates gene expression
G0S2;PPARA activates gene expression
ME1;PPARA activates gene expression
FADS1;PPARA activates gene expression
APOA1;PPARA activates gene expression
CYP4A11;PPARA activates gene expression
TXNRD1;PPARA activates gene expression
PEX11A;PPARA activates gene expression
SLC27A1;PPARA activates gene expression
FABP1;PPARA activates gene expression
GRHL1;PPARA activates gene expression
CYP7A1;PPARA activates gene expression
FHL2;PPARA activates gene expression
ACADM;PPARA activates gene expression
ALAS1;Transcriptional activation of mitochondrial biogenesis
ALAS1;PPARA activates gene expression
PPARGC1B;Transcriptional activation of mitochondrial biogenesis
NRF1;Transcriptional activation of mitochondrial biogenesis
PPARGC1A;Activation of PPARGC1A (PGC-1alpha) by phosphorylation
FASN;Fatty acyl-CoA biosynthesis
THRSP;Carnitine metabolism,Import of palmitoyl-CoA into the mitochondrial matrix
MID1IP1;Carnitine metabolism,Import of palmitoyl-CoA into the mitochondrial matrix
STARD7;Synthesis of PC
STARD10;Synthesis of PC
LPCAT1;Synthesis of PC
PCTP;Synthesis of PC
MTMR2;Synthesis of PIPs at the ER membrane
SBF1;Synthesis of PIPs at the ER membrane
MTMR8;Synthesis of PIPs at the plasma membrane
MTMR9;Synthesis of PIPs at the plasma membrane
RUFY1;Synthesis of PIPs at the plasma membrane
MTMR2;Synthesis of PIPs at the plasma membrane
ARF1;Synthesis of PIPs at the plasma membrane
MTMR6;Synthesis of PIPs at the plasma membrane
MTMR2;Synthesis of PIPs at the early endosome membrane
MTMR10;Synthesis of PIPs at the early endosome membrane
MTMR12;Synthesis of PIPs at the early endosome membrane
MTM1;Synthesis of PIPs at the early endosome membrane
TTPA;Vitamin E
NUBP2;Cytosolic iron-sulfur cluster assembly
GLRX5;Mitochondrial iron-sulfur cluster biogenesis
TXN;Protein repair
RNF152;E3 ubiquitin ligases ubiquitinate target proteins
HLTF;E3 ubiquitin ligases ubiquitinate target proteins
RNF181;E3 ubiquitin ligases ubiquitinate target proteins
BCL10;E3 ubiquitin ligases ubiquitinate target proteins
SHPRH;E3 ubiquitin ligases ubiquitinate target proteins
UBE2N;E3 ubiquitin ligases ubiquitinate target proteins
PRKDC;E3 ubiquitin ligases ubiquitinate target proteins
RNF144A;E3 ubiquitin ligases ubiquitinate target proteins
WAC;E3 ubiquitin ligases ubiquitinate target proteins
UBE2L3;E3 ubiquitin ligases ubiquitinate target proteins
UBA1;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
RPS27A;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
UBC;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
UBA52;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
UBB;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
UBA6;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
RABGGTA;RAB geranylgeranylation
RABGGTB;RAB geranylgeranylation
PTP4A2;RAB geranylgeranylation
HSPA8;Protein methylation
EEF1A1;Protein methylation
ETFB;Protein methylation
EEF2;Protein methylation
KIN;Protein methylation
VCP;Protein methylation
UBE2I;SUMOylation of chromatin organization proteins
L3MBTL2;SUMOylation of chromatin organization proteins
H4C1;SUMOylation of chromatin organization proteins
CHD3;SUMOylation of chromatin organization proteins
HDAC4;SUMOylation of chromatin organization proteins
SATB1;SUMOylation of chromatin organization proteins
SUZ12;SUMOylation of chromatin organization proteins
HDAC2;SUMOylation of chromatin organization proteins
HDAC1;SUMOylation of chromatin organization proteins
SATB2;SUMOylation of chromatin organization proteins
CBX5;SUMOylation of chromatin organization proteins
DNMT1;SUMOylation of DNA methylation proteins
UBE2I;SUMOylation of DNA methylation proteins
DNMT3A;SUMOylation of DNA methylation proteins
DNMT3B;SUMOylation of DNA methylation proteins
UBE2I;SUMOylation of RNA binding proteins
HNRNPK;SUMOylation of RNA binding proteins
NOP58;SUMOylation of RNA binding proteins
HNRNPC;SUMOylation of RNA binding proteins
FOXL2;SUMOylation of transcription factors
MITF;SUMOylation of transcription factors
SP3;SUMOylation of transcription factors
TP53BP1;SUMOylation of transcription factors
TP53;SUMOylation of transcription factors
HIC1;SUMOylation of transcription factors
MTA1;SUMOylation of transcription factors
RORA;SUMOylation of intracellular receptors
THRB;SUMOylation of intracellular receptors
PPARA;SUMOylation of intracellular receptors
NR4A2;SUMOylation of intracellular receptors
PPARG;SUMOylation of intracellular receptors
RARA;SUMOylation of intracellular receptors
PGR;SUMOylation of intracellular receptors
NR5A1;SUMOylation of intracellular receptors
ESR1;SUMOylation of intracellular receptors
NR2C1;SUMOylation of intracellular receptors
NR3C2;SUMOylation of intracellular receptors
AR;SUMOylation of intracellular receptors
RXRA;SUMOylation of intracellular receptors
UBE2I;SUMOylation of DNA damage response and repair proteins
BRCA1;SUMOylation of DNA damage response and repair proteins
SP100;SUMOylation of DNA damage response and repair proteins
RPA1;SUMOylation of DNA damage response and repair proteins
TDG;SUMOylation of DNA damage response and repair proteins
XPC;SUMOylation of DNA damage response and repair proteins
RNF168;SUMOylation of DNA damage response and repair proteins
HERC2;SUMOylation of DNA damage response and repair proteins
WRN;SUMOylation of DNA damage response and repair proteins
PARP1;SUMOylation of DNA damage response and repair proteins
PML;SUMOylation of DNA damage response and repair proteins
XRCC4;SUMOylation of DNA damage response and repair proteins
BLM;SUMOylation of DNA damage response and repair proteins
CETN2;SUMOylation of DNA damage response and repair proteins
RAD52;SUMOylation of DNA damage response and repair proteins
MDC1;SUMOylation of DNA damage response and repair proteins
UBE2I;SUMOylation of DNA replication proteins
PCNA;SUMOylation of DNA replication proteins
TOP2A;SUMOylation of DNA replication proteins
TOP1;SUMOylation of DNA replication proteins
TOP2B;SUMOylation of DNA replication proteins
AURKA;SUMOylation of DNA replication proteins
UBE2I;SUMOylation of transcription cofactors
SAFB;SUMOylation of transcription cofactors
CTBP1;SUMOylation of transcription cofactors
ZNF131;SUMOylation of transcription cofactors
MBD1;SUMOylation of transcription cofactors
NCOA1;SUMOylation of transcription cofactors
HIPK2;SUMOylation of transcription cofactors
PPARGC1A;SUMOylation of transcription cofactors
SIN3A;SUMOylation of transcription cofactors
NPM1;SUMOylation of transcription cofactors
DAXX;SUMOylation of transcription cofactors
DDX5;SUMOylation of transcription cofactors
MRTFA;SUMOylation of transcription cofactors
EP300;SUMOylation of transcription cofactors
CASP8AP2;SUMOylation of transcription cofactors
NRIP1;SUMOylation of transcription cofactors
CREBBP;SUMOylation of transcription cofactors
PARK7;SUMOylation of transcription cofactors
DDX17;SUMOylation of transcription cofactors
NCOR2;SUMOylation of transcription cofactors
NCOA2;SUMOylation of transcription cofactors
ING2;SUMOylation of transcription cofactors
UBE2I;SUMOylation of ubiquitinylation proteins
MDM2;SUMOylation of ubiquitinylation proteins
VHL;SUMOylation of ubiquitinylation proteins
UBE2I;SUMOylation of SUMOylation proteins
RANBP2;SUMOylation of SUMOylation proteins
PIAS4;SUMOylation of SUMOylation proteins
TOPORS;SUMOylation of SUMOylation proteins
PLAUR;Attachment of GPI anchor to uPAR
DCUN1D3;Neddylation
BIRC5;Neddylation
PRKN;Josephin domain DUBs
ATXN3;Josephin domain DUBs
BAP1;UCH proteinases
HCFC1;UCH proteinases
BARD1;UCH proteinases
UCHL5;UCH proteinases
ADRM1;UCH proteinases
STAM;Metalloprotease DUBs
STAMBP;Metalloprotease DUBs
USP19;Ub-specific processing proteases
USP13;Ub-specific processing proteases
USP14;Ub-specific processing proteases
SIAH2;Ub-specific processing proteases
YOD1;Ovarian tumor domain proteases
VCP;Ovarian tumor domain proteases
TNFAIP3;Ovarian tumor domain proteases
VCPIP1;Ovarian tumor domain proteases
PTEN;Ovarian tumor domain proteases
SPHK1;Association of TriC/CCT with target proteins during biosynthesis
ACTB;Folding of actin by CCT/TriC
TBCA;Post-chaperonin tubulin folding pathway
TBCB;Post-chaperonin tubulin folding pathway
TBCE;Post-chaperonin tubulin folding pathway
TBCC;Post-chaperonin tubulin folding pathway
TBCD;Post-chaperonin tubulin folding pathway
SMDT1;Mitochondrial protein degradation
TFAM;Mitochondrial protein degradation
NDUFA13;Mitochondrial protein degradation
POMC;Peptide hormone biosynthesis
FSHB;Glycoprotein hormones
TSHB;Glycoprotein hormones
ACE;Metabolism of Angiotensinogen to Angiotensins
INS;Insulin processing
P4HB;Insulin processing
EXOC7;Insulin processing
EXOC4;Insulin processing
EXOC1;Insulin processing
EXOC3;Insulin processing
EXOC6;Insulin processing
EXOC2;Insulin processing
EXOC5;Insulin processing
EXOC8;Insulin processing
GIP;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
DPP4;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
TSFM;Mitochondrial translation elongation
MTIF2;Mitochondrial translation initiation
MTIF3;Mitochondrial translation initiation
MRRF;Mitochondrial translation termination
ADAR;Formation of editosomes by ADAR proteins
ADARB1;Formation of editosomes by ADAR proteins
IGF2BP2;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
IGF2BP3;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
IGF2BP1;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
XPOT;tRNA processing in the nucleus
YWHAB;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
ZFP36L1;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
DCP1A;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
XRN1;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
DCP2;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
TNPO1;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
ZFP36;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
DCP1A;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
XRN1;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
DCP2;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
YWHAB;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
PARN;KSRP (KHSRP) binds and destabilizes mRNA
DCP2;KSRP (KHSRP) binds and destabilizes mRNA
KHSRP;KSRP (KHSRP) binds and destabilizes mRNA
YWHAZ;KSRP (KHSRP) binds and destabilizes mRNA
HSPA1A;AUF1 (hnRNP D0) binds and destabilizes mRNA
EIF4G1;AUF1 (hnRNP D0) binds and destabilizes mRNA
HSPA8;AUF1 (hnRNP D0) binds and destabilizes mRNA
HSPB1;AUF1 (hnRNP D0) binds and destabilizes mRNA
PABPC1;AUF1 (hnRNP D0) binds and destabilizes mRNA
ELAVL1;HuR (ELAVL1) binds and stabilizes mRNA
TNFSF13;HuR (ELAVL1) binds and stabilizes mRNA
XPO1;HuR (ELAVL1) binds and stabilizes mRNA
SET;HuR (ELAVL1) binds and stabilizes mRNA
ANP32A;HuR (ELAVL1) binds and stabilizes mRNA
NUP214;HuR (ELAVL1) binds and stabilizes mRNA
CSNK1D;Major pathway of rRNA processing in the nucleolus and cytosol
RIOK2;Major pathway of rRNA processing in the nucleolus and cytosol
BYSL;Major pathway of rRNA processing in the nucleolus and cytosol
LTV1;Major pathway of rRNA processing in the nucleolus and cytosol
CSNK1E;Major pathway of rRNA processing in the nucleolus and cytosol
RIOK3;Major pathway of rRNA processing in the nucleolus and cytosol
TSR1;Major pathway of rRNA processing in the nucleolus and cytosol
NOB1;Major pathway of rRNA processing in the nucleolus and cytosol
RIOK1;Major pathway of rRNA processing in the nucleolus and cytosol
PNO1;Major pathway of rRNA processing in the nucleolus and cytosol
PAPOLA;Processing of Capped Intron-Containing Pre-mRNA
PABPN1;Processing of Capped Intron-Containing Pre-mRNA
SUGP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPP1R8;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DNAJC8;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
HTATSF1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CCAR1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SRRM1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
ALYREF;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
IK;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SMU1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRPF4B;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SF1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
LUC7L3;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RBM7;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CDC40;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
TCERG1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RBM5;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RBM25;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RBM39;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRPF40A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DHX9;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CWC27;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RNF113A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
GPKOW;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DHX16;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PPIL1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
EIF4A3;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
TXNL4A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
WBP11;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRPF6;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
WBP4;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PQBP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
UBL5;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
ZMAT2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
PRPF38A;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
MFAP1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
RBM42;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
DDX23;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
USP39;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SART1;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SNRNP27;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
UPF3B;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SYF2;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
CASC3;mRNA Splicing - Major Pathway,pre-mRNA splicing,U2 Dependent Splicing
SRSF1;mRNA Splicing - Minor Pathway,U12 Dependent Splicing
ZRSR2;mRNA Splicing - Minor Pathway,U12 Dependent Splicing
SRSF7;mRNA Splicing - Minor Pathway,U12 Dependent Splicing
SRSF6;mRNA Splicing - Minor Pathway,U12 Dependent Splicing
SRSF2;mRNA Splicing - Minor Pathway,U12 Dependent Splicing
GRSF1;Mitochondrial RNA degradation
FASTKD2;FASTK family proteins regulate processing and stability of mitochondrial RNAs
TBRG4;FASTK family proteins regulate processing and stability of mitochondrial RNAs
FASTKD5;FASTK family proteins regulate processing and stability of mitochondrial RNAs
DYSF;Smooth Muscle Contraction
TRIM72;Smooth Muscle Contraction
CAV3;Smooth Muscle Contraction
ANXA1;Smooth Muscle Contraction
ANXA6;Smooth Muscle Contraction
ANXA2;Smooth Muscle Contraction
TNNI3;Ion homeostasis
NOS1;Ion homeostasis
ATP2B4;Ion homeostasis
NPPC;Physiological factors
NPR2;Physiological factors
TTBK2;Anchoring of the basal body to the plasma membrane
CEP89;Anchoring of the basal body to the plasma membrane
CEP164;Anchoring of the basal body to the plasma membrane
CEP83;Anchoring of the basal body to the plasma membrane
SCLT1;Anchoring of the basal body to the plasma membrane
FBF1;Anchoring of the basal body to the plasma membrane
C2CD3;Anchoring of the basal body to the plasma membrane
CEP97;Anchoring of the basal body to the plasma membrane
CCP110;Anchoring of the basal body to the plasma membrane
MARK4;Anchoring of the basal body to the plasma membrane
RAB3IP;Anchoring of the basal body to the plasma membrane
IFT122;Intraflagellar transport
IFT140;Intraflagellar transport
WDR19;Intraflagellar transport
TTC21B;Intraflagellar transport
IFT43;Intraflagellar transport
WDR35;Intraflagellar transport
IFT20;Intraflagellar transport
TRIP11;Intraflagellar transport
TNPO1;Intraflagellar transport
CLUAP1;Intraflagellar transport
IFT56;Intraflagellar transport
IFT81;Intraflagellar transport
IFT172;Intraflagellar transport
IFT80;Intraflagellar transport
TRAF3IP1;Intraflagellar transport
IFT22;Intraflagellar transport
IFT25;Intraflagellar transport
IFT52;Intraflagellar transport
IFT74;Intraflagellar transport
IFT88;Intraflagellar transport
IFT46;Intraflagellar transport
IFT57;Intraflagellar transport
IFT27;Intraflagellar transport
PDE6D;ARL13B-mediated ciliary trafficking of INPP5E
INPP5E;ARL13B-mediated ciliary trafficking of INPP5E
ARL13B;ARL13B-mediated ciliary trafficking of INPP5E
RAB3IP;BBSome-mediated cargo-targeting to cilium
BBS1;BBSome-mediated cargo-targeting to cilium
BBS9;BBSome-mediated cargo-targeting to cilium
BBS4;BBSome-mediated cargo-targeting to cilium
TTC8;BBSome-mediated cargo-targeting to cilium
BBS7;BBSome-mediated cargo-targeting to cilium
BBS5;BBSome-mediated cargo-targeting to cilium
BBIP1;BBSome-mediated cargo-targeting to cilium
BBS2;BBSome-mediated cargo-targeting to cilium
UNC119B;Trafficking of myristoylated proteins to the cilium
RP2;Trafficking of myristoylated proteins to the cilium
SIRT3;Transcriptional activation of mitochondrial biogenesis
PPRC1;Transcriptional activation of mitochondrial biogenesis
HCFC1;Transcriptional activation of mitochondrial biogenesis
GABPA;Transcriptional activation of mitochondrial biogenesis
PERM1;Transcriptional activation of mitochondrial biogenesis
MTERF1;Transcriptional activation of mitochondrial biogenesis
TFB2M;Transcriptional activation of mitochondrial biogenesis
SSBP1;Transcriptional activation of mitochondrial biogenesis
POLRMT;Transcriptional activation of mitochondrial biogenesis
ESRRA;Transcriptional activation of mitochondrial biogenesis
TFAM;Transcriptional activation of mitochondrial biogenesis
ATP5F1B;Transcriptional activation of mitochondrial biogenesis
TFB1M;Transcriptional activation of mitochondrial biogenesis
CYCS;Transcriptional activation of mitochondrial biogenesis
POLG2;Transcriptional activation of mitochondrial biogenesis
TWNK;Transcriptional activation of mitochondrial biogenesis
APOO;Cristae formation
DNAJC11;Cristae formation
IMMT;Cristae formation
MICOS10;Cristae formation
CHCHD6;Cristae formation
CHCHD3;Cristae formation
APOOL;Cristae formation
HSPA9;Cristae formation
TMEM11;Cristae formation
MICOS13;Cristae formation
TIMM10B;Mitochondrial protein import
TIMM22;Mitochondrial protein import
PEX7;Peroxisomal protein import
ZFAND6;Peroxisomal protein import
USP9X;Peroxisomal protein import
ACAA1;TYSND1 cleaves peroxisomal proteins
ACOX1;TYSND1 cleaves peroxisomal proteins
HSD17B4;TYSND1 cleaves peroxisomal proteins
TYSND1;TYSND1 cleaves peroxisomal proteins
AGPS;TYSND1 cleaves peroxisomal proteins
PHYH;TYSND1 cleaves peroxisomal proteins
SCP2;TYSND1 cleaves peroxisomal proteins
PEX16;Class I peroxisomal membrane protein import
PEX3;Class I peroxisomal membrane protein import
PEX19;Class I peroxisomal membrane protein import
POU5F1;Specification of primordial germ cells
SOX17;Specification of primordial germ cells
TFAP2C;Specification of primordial germ cells
NANOG;Specification of primordial germ cells
CXCR4;Specification of primordial germ cells
PDPN;Specification of primordial germ cells
CBFA2T2;Specification of primordial germ cells
TET2;Specification of primordial germ cells
PRDM1;Specification of primordial germ cells
NANOS3;Specification of primordial germ cells
B4GALT1;Interaction With Cumulus Cells And The Zona Pellucida
SPAM1;Interaction With Cumulus Cells And The Zona Pellucida
ACR;Acrosome Reaction and Sperm:Oocyte Membrane Binding
CD9;Acrosome Reaction and Sperm:Oocyte Membrane Binding
GRM4;Sensory perception of sweet, bitter, and umami (glutamate) taste
GRM1;Sensory perception of sweet, bitter, and umami (glutamate) taste
RTP2;Expression and translocation of olfactory receptors
EHMT1;Expression and translocation of olfactory receptors
EHMT2;Expression and translocation of olfactory receptors
EBF1;Expression and translocation of olfactory receptors
LHX2;Expression and translocation of olfactory receptors
FOXO3;MAPK6/MAPK4 signaling
MAPK6;MAPK6/MAPK4 signaling
MAPKAPK5;MAPK6/MAPK4 signaling
HSPB1;MAPK6/MAPK4 signaling
CCND3;MAPK6/MAPK4 signaling
JUN;MAPK6/MAPK4 signaling
DNAJB1;MAPK6/MAPK4 signaling
MAPK4;MAPK6/MAPK4 signaling
MYC;MAPK6/MAPK4 signaling
NCOA3;MAPK6/MAPK4 signaling
FOXO1;MAPK6/MAPK4 signaling
ETV4;MAPK6/MAPK4 signaling
IGF2BP1;MAPK6/MAPK4 signaling
SEPTIN7;MAPK6/MAPK4 signaling
KALRN;MAPK6/MAPK4 signaling
RHOBTB3;RHOBTB3 ATPase cycle
LIN7B;RHO GTPases Activate Rhotekin and Rhophilins
RTKN;RHO GTPases Activate Rhotekin and Rhophilins
RHPN2;RHO GTPases Activate Rhotekin and Rhophilins
TAX1BP3;RHO GTPases Activate Rhotekin and Rhophilins
RND1;RND1 GTPase cycle
ARHGDIA;RAC2 GTPase cycle
RHOH;RHOH GTPase cycle
RHOBTB2;RHOBTB2 GTPase cycle
RHOBTB1;RHOBTB1 GTPase cycle
ARHGDIA;RHOC GTPase cycle
RND3;RND3 GTPase cycle
RND2;RND2 GTPase cycle
FST;Antagonism of Activin by Follistatin
FSTL3;Antagonism of Activin by Follistatin
GPRC6A;Class C/3 (Metabotropic glutamate/pheromone receptors)
SMO;Class B/2 (Secretin family receptors)
CRHBP;Class B/2 (Secretin family receptors)
CRH;Class B/2 (Secretin family receptors)
CD55;Class B/2 (Secretin family receptors)
ADGRE5;Class B/2 (Secretin family receptors)
GAB1;Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
SHC1;Erythropoietin activates RAS
EBAG9;Estrogen-dependent gene expression
KDM1A;Estrogen-dependent gene expression
H2AC6;Estrogen-dependent gene expression
NCOA1;Estrogen-dependent gene expression
CITED1;Estrogen-dependent gene expression
TFF3;Estrogen-dependent gene expression
DDX5;Estrogen-dependent gene expression
MYB;Estrogen-dependent gene expression
NCOA3;Estrogen-dependent gene expression
MYC;Estrogen-dependent gene expression
NR5A2;Estrogen-dependent gene expression
ZNF217;Estrogen-dependent gene expression
KDM4B;Estrogen-dependent gene expression
TGFA;Estrogen-dependent gene expression
CHD1;Estrogen-dependent gene expression
CXXC5;Estrogen-dependent gene expression
PTGES3;Estrogen-dependent gene expression
FKBP4;Estrogen-dependent gene expression
TLE3;Estrogen-dependent gene expression
NRIP1;Estrogen-dependent gene expression
MED1;Estrogen-dependent gene expression
SP1;Estrogen-dependent gene expression
USF2;Estrogen-dependent gene expression
USF1;Estrogen-dependent gene expression
BCL2;Estrogen-dependent gene expression
CREBBP;Estrogen-dependent gene expression
GREB1;Estrogen-dependent gene expression
KPNA2;Estrogen-dependent gene expression
TBP;Estrogen-dependent gene expression
TFF1;Estrogen-dependent gene expression
PRMT1;Estrogen-dependent gene expression
CARM1;Estrogen-dependent gene expression
FABP5;Signaling by Retinoic Acid
CRABP1;RA biosynthesis pathway
CRABP2;Signaling by Retinoic Acid
PLIN1;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,LXRs regulate gene expression linked to triglyceride lipolysis in adipose
APOC4;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
GPS2;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
APOE;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
ABCG5;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
ABCG8;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
APOC1;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
ABCG1;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
EEPD1;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
NCOA1;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
CETP;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
APOC2;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
NR1H3;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
EP300;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
APOD;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
ARL4C;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
ABCA1;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,LXRs regulate gene expression linked to cholesterol transport and efflux
NCOA1;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,LXRs regulate gene expression to control bile acid homeostasis
UGT1A3;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,LXRs regulate gene expression to control bile acid homeostasis
FABP6;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,LXRs regulate gene expression to control bile acid homeostasis
MYLIP;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,LXRs regulate gene expression to limit cholesterol uptake 
NRIP1;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,LXRs regulate gene expression linked to gluconeogenesis 
PCK1;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,LXRs regulate gene expression linked to gluconeogenesis 
NRIP1;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,LXRs regulate gene expression linked to lipogenesis
FASN;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,LXRs regulate gene expression linked to lipogenesis
SCD;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,LXRs regulate gene expression linked to lipogenesis
ANGPTL3;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,LXRs regulate gene expression linked to lipogenesis
MST1;Signaling by MST1
SOCS3;Signaling by Leptin
PTPN11;Signaling by Leptin
DENND3;RAB GEFs exchange GTP for GDP on RABs
ULK1;TBC/RABGAPs
TBC1D14;TBC/RABGAPs
TBC1D17;TBC/RABGAPs
TBC1D10A;TBC/RABGAPs
SYTL1;TBC/RABGAPs
TBC1D3;TBC/RABGAPs
TBC1D20;TBC/RABGAPs
RABGAP1;TBC/RABGAPs
TBC1D7;TBC/RABGAPs
TBC1D25;TBC/RABGAPs
SYS1;Retrograde transport at the Trans-Golgi-Network
RABEPK;Retrograde transport at the Trans-Golgi-Network
PLIN3;Retrograde transport at the Trans-Golgi-Network
ARFIP2;Retrograde transport at the Trans-Golgi-Network
USP6NL;Retrograde transport at the Trans-Golgi-Network
STX16;Retrograde transport at the Trans-Golgi-Network
VAMP3;Retrograde transport at the Trans-Golgi-Network
STX10;Retrograde transport at the Trans-Golgi-Network
VTI1A;Retrograde transport at the Trans-Golgi-Network
SCOC;Retrograde transport at the Trans-Golgi-Network
VAMP4;Retrograde transport at the Trans-Golgi-Network
STX6;Retrograde transport at the Trans-Golgi-Network
PAFAH1B1;COPI-independent Golgi-to-ER retrograde traffic
GBF1;COPI-dependent Golgi-to-ER retrograde traffic
SEC22B;COPI-dependent Golgi-to-ER retrograde traffic
USE1;COPI-dependent Golgi-to-ER retrograde traffic
STX18;COPI-dependent Golgi-to-ER retrograde traffic
BNIP1;COPI-dependent Golgi-to-ER retrograde traffic
YKT6;Intra-Golgi traffic
GOSR1;Intra-Golgi traffic
STX5;Intra-Golgi traffic
BET1L;Intra-Golgi traffic
TBC1D1;Translocation of SLC2A4 (GLUT4) to the plasma membrane
SLC2A4;Translocation of SLC2A4 (GLUT4) to the plasma membrane
ASPSCR1;Translocation of SLC2A4 (GLUT4) to the plasma membrane
STXBP3;Translocation of SLC2A4 (GLUT4) to the plasma membrane
SNAP23;Translocation of SLC2A4 (GLUT4) to the plasma membrane
VAMP2;Translocation of SLC2A4 (GLUT4) to the plasma membrane
STX4;trans-Golgi Network Vesicle Budding
VAMP7;trans-Golgi Network Vesicle Budding
SNAP23;trans-Golgi Network Vesicle Budding
ARRB1;Lysosome Vesicle Biogenesis
DNM2;Lysosome Vesicle Biogenesis
SH3GL2;Lysosome Vesicle Biogenesis
BLOC1S4;Golgi Associated Vesicle Biogenesis
BLOC1S6;Golgi Associated Vesicle Biogenesis
DTNBP1;Golgi Associated Vesicle Biogenesis
BLOC1S1;Golgi Associated Vesicle Biogenesis
BLOC1S3;Golgi Associated Vesicle Biogenesis
TXNDC5;Golgi Associated Vesicle Biogenesis
NAPA;Golgi Associated Vesicle Biogenesis
ARRB1;Golgi Associated Vesicle Biogenesis
DNM2;Golgi Associated Vesicle Biogenesis
SH3GL2;Golgi Associated Vesicle Biogenesis
ACBD3;Golgi Associated Vesicle Biogenesis
SH3D19;Golgi Associated Vesicle Biogenesis
PUM1;Golgi Associated Vesicle Biogenesis
CLINT1;Golgi Associated Vesicle Biogenesis
VAMP2;trans-Golgi Network Vesicle Budding
AP1G2;Lysosome Vesicle Biogenesis
CHMP2A;Lysosome Vesicle Biogenesis
HGS;Lysosome Vesicle Biogenesis
APP;Lysosome Vesicle Biogenesis
VAMP8;trans-Golgi Network Vesicle Budding
PIK3C2A;Clathrin-mediated endocytosis
VAMP7;Cargo recognition for clathrin-mediated endocytosis
AGFG1;Cargo recognition for clathrin-mediated endocytosis
DAB2;Cargo recognition for clathrin-mediated endocytosis
LRP2;Cargo recognition for clathrin-mediated endocytosis
AAK1;Clathrin-mediated endocytosis
REPS1;Clathrin-mediated endocytosis
SGIP1;Clathrin-mediated endocytosis
EPS15;Clathrin-mediated endocytosis
NEDD8;Cargo recognition for clathrin-mediated endocytosis
CHMP7;Endosomal Sorting Complex Required For Transport (ESCRT)
CHMP6;Endosomal Sorting Complex Required For Transport (ESCRT)
CHMP3;Endosomal Sorting Complex Required For Transport (ESCRT)
